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Abstract 
Preliminary  attempts  were  made  to  isolate  hexokinase 
from  human  erythrocytes  and  placenta.  The  final  purifi- 
cations  were  made  from  heart,  which  contained  more  enzyme 
than  other  tissues.  From  1.15  kg  of  heart,  25  mg  of  hexo- 
kinase  was  obtained  of  specific  activity  58  units/rng. 
This  represents  a  1,700-fold  purification  and  a  yield  of 
I+7%  over  six  steps.  A  critical  development  in  isolating 
"  this  enzyme  was  the  use  of  affinity  chromatography,  using 
glucosamine  linked  to  Sepharose". 
The  material  contained"a  single  protein  component 
according  to  electrophoresis  on  starch  gel,  cellulose 
acetate  and  polyacrylamide  gel.  It  gave  a  single  peak  on 
gel  filtration,  and  on  sedimentation  in  the  ultracentrifuge. 
However,  a  heterogeneity  in  size  was  indicated  by 
electrophoresis  on  SDS-polyacrylamide  gels  which  gave  two 
bands  of  approximately  equal  intensity.  The  apparent 
molecular  weights  of  these  components  were  109,000  and 
124,000.  The  small  difference  in'size  has  not  resolved 
by  the  other  techniques  used. 
Gel  filtration  on  Sephadex  G-200  suggested  a  molecul- 
ar  weight-of  106,000,  as  did  the  combination  of  the  'sedi- 
mentation  coefficient  of  5.5  S  and  diffusion  coefficient 
of  47  µm2/s.. 6 
Hexokinase  takes  part  in  an  association  equilibrium 
with  polymers  of  large  size  as  shown  by  the  concentration 
gradients  in  sedimentation  equilibrium  experiments.  It 
is  difficult  to  determine  the  species  involved  in  this 
equilibrium  as  the  average  molecular  weights  observed  at 
the  meniscus  of  the  solution  varied  from  110,000  to  140,000. 
Study  of  the  kinetic  properties  of  hexokinase  gave  an 
optimum  at  pH  =  8.0,  I=0.05.  However,  the  usual  kinetic 
parameters  were  more  reliably  measured  at  pH  7,  and  gave  a 
Km  for  glucose  of  51  µM  and  for  MgATP2  0.32  mM. 
The  usual  inhibitor  of  hexokinase,  glucose  6-phosphate, 
caused  an  association  to  probably  dimers.  This  phenomenon 
was  investigated,  as  it  provides  a  possible  means  of 
control  (by  association  or  conformational  change)  on  the 
properties  of  hexokinase. 7 
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Introduction 
CHAPTER  1 
Mammalian  hexokinases 
(a)'  Isoenzymes 
Hexokinase  is  known  to  exist  in  four  esoenzymic  forms 
in  a  variety  of  mammalian  tissues.  In  the  rat  liver  where 
all  four  isoenzymes  are  present  they  are  characterized 
either  as-hexokinase  types  I,  II9  III  and  IV  in  the 
sequence  of  increasing  electrophoretic  mobility  (Grossbard 
and  Schinike,  1966)  or  as  A,  B,  C  and  D  according  to  their 
elution  from  DEAE-cellulose  columns  (Gonzalez  et  al., 
1964). 
For  the  correlation  of  the  rat  liver  isoenzymes  with 
the  isoenzymes  found  in  other  mammalian  species,  the  foll- 
owing  properties  are  usually  considered.  Hexokinase  types 
I,  II  and  III  have  low  Km  for  glucose.  (E.  C.  2.7.1.1)  and 
hexokinase  type  IV  has  high  Km  for  the  same  substrate  and 
is  named  glucokinase  (E.  C.  2.7.1.2).  Hexokinase  type  III 
is  inhibited  at  high  glucose  concentrations  (Gonzalez 
et  al.,  1964;  Grossbard  and  Schimke,  1966).  Hexokinase 
type  II  is  discriminated  from  the  type  I.  by  its  faster 
relative  mobility  on  starch  gel  electrophoresis,  its  later 20 
elution  from  DEAE-cellulose  chromatography.  or-its  greater 
lability  to  heat  inactivation  in  the  absence  of  glucose 
(Grossbard 
and  Schimke,  1966).  A  summary  of  the  prop- 
erties  of  the  four  hexokinase  isoenzymes  of  rat  (Schimke 
and  Grossbard,  1968)  is  given  in  Table  1.1. 
The  hexokinase  isoenzymic  profile  (i.  e.  types  of  iso- 
enzymes  present  and  their  relative  proportions)  of  mammal- 
ian  tissues  is  not  constant.  Tissue  specific  differences 
within  a  certain  species  and  species-specific  differences 
for  a  certain  tissue  are  reported.  Furthermore  develop- 
mental,  nutritional  and  hormonal  factors  were  shown  to 
influence  the  isoenzymic  profile  of  some  tissues.  Also 
one  hexokinase  isoenzyme  differs  in  structure  (as  shown 
by  amino  acid  composition,  electrophoretic  and  chromato- 
graphic  studies)  and  function  (as  shown  by  study  of  cata- 
lytic  properties)  between  different  species.  However  these 
differences  are  minor  as  compared  with  differences  between 
distinct  hexokinase  isoenzymes.  One  type  of  hexokiinase 
appears  rather  unaltered  in  the  various  tissues  of  a  single 
species.  Certain  examples  of  these  general  conclusions 
are  presented  below. 
Rat  brain  and  kidney  contain  mainly  HK  I  while  skelet- 
al  muscle  contains  mainly  HIC  II.  Fat  pad,  intestine  and 
heart  contain  about  equal  amounts  of  HK  I  and  HK  II. 
Kidney  and  intestine  appeared  to  have  also  detectable, 
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amounts  of  HK  III,  while  liver  contains  all  four  isoenzymes 
(Schinike  and  Grossbard,  1968). 
With  man,  HK  I  was  found  in  all  tissues  tested  (i.  e. 
heart,  erythrocytes,  placenta,  liver,  lung.,  spleen,  kidney, 
skeletal  muscle  and  fat)  while  HK'II  was  found  in  skeletal 
muscle  (Neumann  et  al.,  1974;  Rogers  et  al.,  1975b).  HK  II 
was  also  found  in  erythrocytes  (Rogers  et  al.  )  and  ,  1975b 
occasionally  in  liver  (Brown  et  al.,  1967).  HK  III  was 
found  in  liver  (Rogers  et  al.,  1975b;  Neumann  et  al.,  197+; 
Brown  at  al.,  1967),  in  lung,  spleen,  erythrocytes  (Neumann 
et  al.,  1974)  and  white  blood  cells  (Rogers  et  al.,  1975b; 
Povey  et  al.,  1975)"  HK  IV  was  found  in  liver  (Brown 
at  al.,  1967)  and  brain  (Bachelard,  1967b).  ' 
Similarities  in  the  tissue  distribution  of  hexokinase 
isoenzymes,  by  starch  gel  electrophoresis,  for  various 
mammalian  species  were  shown  by  Grossbard  et'al.  0 
(1966). 
Developmental  changes  of  the  isoenzymic  profile  of 
tissues  are  reported.  for  several  mammalian  species,  i.  e. 
guinea  pig  (Faulkner  and  Jones,  1976),  rat  (Katzen  and 
Schimke,  1965),  rabbit  (Dean  and  Gusseck,  1976)  and  man 
(Holmes  et  al.,  1967;  Malone  et  al.,  1968;  Schröter  and 
Tillman,  1968;  Rogers  et  al.,  1975b).  In  rat,  liver  hexo- 
kinase  types  I  to  IV  showed  their  maximal  levels  of  activ- 
ity  at  different  postnatal  times  (Ureta,  1975;  Ureta  et  al., 
1975). 
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With  man,  HK  II  appears  specifically  in  newborn's 
erythrocytes  (Holmes  et  al.,  1967)  and  in  foetal  liver, 
heart,  brain  and  muscle  (Rogers  et  al.,  1975b).  Also  in 
adult  human  erythrocytes  two  bands  of  HK  I  were  observed 
and  the  relative  activity  of  these  bands  changed  during 
maturation  of  the  cells  (Kaplan  and  Beutler,  1968;  Rogers 
et  al.,  1975a;  Rijksen  and  Staal,  1977). 
The  effect  of  nutritional  and  hormonal  factors  on  the 
isoenzymic  profile  of  some  tissues  is  well  documented. 
Glucokinase  disappears  preferentially  during  starvation 
or  diabetes  and  reappears  upon  refeeding  with  a  carbo- 
hydrate  rich  diet  or  insulin  administration  probably  by_ 
"de  novo"  synthesis  (Sharma  et  al.,  1963;  Niemeyer  et  al., 
1963;  Salas  et  al.,  1963;  Clark-Turri  et  al.,  1974). 
Glucagon  and  epinephrine  are  reported  to  be  powerful  inhib- 
-itors  of  glucokinase  induction  (Niemeyer  at  al.,  1966; 
Ureta  et  al.,  1970). 
HK  II  in  insulin-sensitive  tissues  (including  heart) 
diminishes  in  diabetes  (McLean  et  al.,  1966;  Katzen,  1966) 
and  starvation  (Katzen  and  Schinike,  1965),  while  it  inc- 
reases  preferentially  upon  refeeding  (Moore  at  al.,  1964) 
or  by  insulin  administration  (Borrebaek,  1966). 
Certain  diseases  are  connected  with  abnormal  iso- 
enzymic  patterns  or  low  levels  of  hexokiriase  activity. 
Thus  HK  II  was  observed  in  seven  malignant  tissues  whose 25 
normal  counterparts  either  did  not  possess  this  isoenzyme 
or  had  it  in  low  levels  (Kamel  and  Schwarzfischer,  1975). 
Also  HK  II  -appeared  specifically  in  erythrocytes  of  adults 
with  hereditary  persistence  of  foetal  haemoglobin  (Holmes 
et  al.,  1967).  A  replacement  of  HK  IV  by  HK  II  was  observ- 
ed  with  rat  (Sato  et  al.,  1969)  and  human  (Balinsky  et  al., 
1973)  hepatomas.  Hemolytic  anaemias  connected  with  hexo- 
kinase  deficiency  are  also  reported  (Valentine  et.  al.,  1967; 
Keitt,  1969;  Gilsanz  et  al.,  1978;  Beutler  et  al.,  1978; 
Board  et  al.,  1978). 
The  four  hexokinase  types  -seem  to  represent  the  trans- 
lation  of  four  separate  genes  as  suggested  by  various  res- 
ults.  Hoxokinase  isoenzymes  are  not  polymeric  forms, 
differ  in  their  kinetic  properties  and  immunogenic  response 
and  present  different  ontogenetic  patterns. 
Antiserum  against  rat  brain  HK  I  did  not  crossreact 
with  HK  II  and  HK  III  from  the  same  species  (Ouchi  and 
Ishibashi,  1975).  Also  lack  of  crossreactivity  was  ob- 
served  between  human  heart  HIC  I  and  spleen  HK  III  with 
antiserum  against  HIC  III  and  HIC  I  respectively  (Neumann 
et  al.,  1974;  Neumann  and  Pfleiderer,  1974).  Antibodies 
prepared  against  rat  liver  glucokinase  did  not  crossreact 
with  isoenzymes  I,  II9  III  whereas  they  crossreacted  with 
HK  IV  from  other  mammalian  species 
(Pilkis  and  Hansen, 
1968;  Clark-Terri  et  al.,  1974). 26 
Amino  acid  composition  of  HK  I  from  brain  (Schwartz 
and  Basford,.  1967;  Chou  and  Wilson,  1972)  and  heart 
(Easterby  and  O'Brien,  1973),  HK  II  from  skeletal  muscle 
(Holroyde  and  Trayer,  1976)  and  glucokinase  (Holroyde  et  al 
1976b)  show  striking  similarities  leading  to  the  specul- 
ation  that  low  Km  hexokinases  have  arisen  from  an  ancestral 
glucokinase-like  gene  by  gene  duplication  and  divergent 
evolution  (Easterby  and  O'Brien,  1973;  Holroyde  and  Trayer 
1976). 
-Genetic  polymorphism  is  rather  restricted.  A  rare 
allele  of  HK  III  was  found  in  human  leucocytes  (Povey 
et  al.,  1975).  Four  alleles  of  HK  I  were  reported  to  exist 
for  the  primate  Macaca  irus  (Ritter  et  al.,  1974).  However 
screening  of  erythrocyte  lysates  of  800  unrelated  Europeans 
revealed  no  genetic  variant  for  HK  I  and  HK  II  (Rogers 
et  al.,  "1975b).  Also  no  polymorphism  was  observed  with 
rather  small  samples  (20-50  individuals)  of  heart  tissue 
from  man  and  two  monkey  species  (Ritter  et  al.,  197+). 
(b)  Subcollular  distribution 
The  appearance  of  hexokinase  in  the  soluble  and  part- 
iculate  states  is  a  widespread  phenomenon  in  mammalian 
species,  initially.  observed  by.  Crane  and  Sols  (1953). 
In  many  cases  particulate  hexokinase  was  established 27 
as  mitochondrial  i.  e.  for*rat  tissues  (Wilson,  1967; 
Vallejo  et  al.,  1970;  Mayer  and  Hübscher,  1971;  Wilson  and 
Feigner,  1977),  for  ascites  tumor  (Rose  and  Warms,  1967; 
-:  Saito  and  Sato,  1971),  for  pig  heart  (Font  at  al.,  1975), 
for  calf  brain  (Vallejo  at  al.,  1970)  and  small  intestine 
of-guinea  pig  (Mayer  and  Hübscher,  1971).  In  other  cases 
hexokinase  was  shown  to  bind  both  to  mitochondria  and 
microsomes  as  for  rat  tissues  (Spydevoid  and  Borrebaek, 
1968;  Katze11  et  al.,  1970)  or  to.  plasma  membranes  of  hepa- 
tomas  but  not  to  plasma  membranes  of  normal  liver  (Emmelot 
and  Bos,  1966;  Davidova  at  al.,  1968)  and  to  plasma  mem- 
branes  and  microsomes  of  Ehrlich  ascites  carcinoma  cells 
(Kang  and  Coe,  19_76). 
The  percentage  of  the  total  hexokinase  activity  found 
in  soluble  and  particulate  states-is  a  function  of  animal 
-species  and  of  tissue  type.  It  also  depends  on  the  types 
of  hexokinase  isoenzymes  present  and  the  extraction  method 
used.  Some  examples  of  these  general  considerations  are 
given  below. 
The  tissue-specific  subcellular  distribution  of  hexo- 
kinase  was  shown  by  fractionation  of  rat  tissue  homogenates. 
The  ratio  of  soluble  to  particulate  hexokinase  was  found 
to  be  80:  20  for  lung,  55:  45  for  small  intestine,  75:  25  for 
heart-and  25:  75  for  brain  while  no  particulate  activity 
was  found  in  liver  (Wilson  and  Felgner,  1977). 
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Species-specific  differences  of  subcellular  distrib- 
ution  of  hexokinase  are  also  reported.  In  heart  of  rat, 
dog  and  guinea  pig  most  of  hexokinase  activity  was  in  the 
soluble  state,  whereas  the  opposite  was  observed  with 
rabbit  heart  (Mayer  et  al.,  1966),, 
HK  III  (Katzen  et  al.,  1970)  and  HK  IV  (Wilson  and 
Felgner,  1977)  were  found  only  in  the  soluble  form  whereas 
Berthillier  et  al  (1970)  reported  the  binding  of  rat  gluco- 
kinase  to  the  microsomal  fraction.  Hexokinase  types  I 
and  II  were  found  both  in  the  soluble  and  particulate 
states.  In  one  case  it  was  reported  that  the  relative 
proportions  of  HK  I  and  HK  II  were  the  same  in  both  sol- 
uble  and  particulate  states  (Mayer  and  Hübscher,  1971)" 
Most  of  the  evidence  points  towards  the  location  of 
bound  hexokinase  on  the  external  surface  of  the  outer  mito- 
-chondrial  membrane  (Craven  et  al.,  1969;  Kropp  and  Wilson, 
1970;  Mayer  and  Hübscher,  1971;  Font  at  al.,  1975).  Limit- 
ed  evidence  is  also  provided  for  the  binding  of  hexokin- 
ase  to  the  outer  surface  of  the  inner  mitochondrial  memb- 
rane  or  in  the  intermembrane  space  (Vallejo  at  al.,  1970; 
Mayer  and  Hübscher,  1971). 
Electrostatic  (Rose  and  Warms,  1967)  and  hydrophobic 
forces  have  been  suggested  to  be  involved  in  the  binding 
(Teichgr'tber  and  Biesold,  1968).  Wilson-(1973a)  suggested  " 
the  involvement  of  phospholipid  bound  on  hexokinase  for  the 
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interaction  of  the  enzyme  with  the  mitochondria. 
Solubilization  of  the  particulate  hexokinase  was 
achieved  by  glucose  6-phosphate  (Hernandez  and  Crane,  1966; 
Rose  and  Warms,  1967;  Wilson,  1968),  nucleotides  (Rose  and 
Warms,  1967;  Wilson,  1967,1968)  and  high  concentrations 
of  salt  (Hernandez  and  Crane,  1966;  Rose  and  Warms,  1967; 
Teichgräber  and  Biesold,  1968;  Easterby  and  O'Brien,  1973). 
Solubilization  mediated  by  the  above  agents  was  pH-depend- 
ent,  as  was  the  solubilization  in  the  absence  of  these 
agents  (Rose  and  Warms,  1967;  Teichgräber  and  Biesold, 
1968;  Easterby  and  O'Brien,  197.3,  Aleksakhina  et  al., 
1973)- 
- 
._. 
Solubilization  by  ATP  and  glucose  6-phosphate  was 
found  relatively  specific  compared  to  that  by  high"conc- 
entration  of  salt  (Wilson,  1968).  Inorganic  phosphate  was 
found  to  reverse  glucose  6-phosphate  mediated  solubiliz- 
ation  (Rosa  and  Warms,  1965,1967;  Wilson,  1968)  but'had 
no  effect  by  itself  or  on  ATP  mediated  solubilization 
(Wilson,  1968).  Magnesium  ions  at  1  mM  concentration  were 
found  to  suppress  glucose  6-phosphate-mediated  elution  from 
mitochondria  (Rose  and  Warms,  1967;  Wilson,  1968),  but  had 
no  effect  on  ATP  mediated  solubilization  even  at  higher 
concentrations  (Wilson,  1968).  The  fact  that  the  combined 
effect  on  solubilization  of  ATP  and  glucose  6-phosphate  was 
less  than  their  individual  effect  indicated  that  they  are lb 
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not  acting  independently  (Wilson,  1968). 
Several  results  point  towards  a  dynamic  equilibrium 
between  the  soluble  and  particulate  bound  hexokinäse.  -Rose 
and  Warms  (1967)  suggested  that  ascites  tumor  hexokinase 
interaction  with  mitochondria  follows  a  simple  over-all 
equation  i.  e.  (binding  sites)  +  (enzyme)  +  (Mg2+) 
(complex).  Hernandez  and  Crane  (1966)  observed  that  approx- 
imately  a  constant  proportion  of  porcine  heart  hexokinase 
was  solubilized  with  successive  extractions  and  that  the 
eluted  enzyme  could  be  rebound  to  mitochondria.  However 
Thompson  and  Bachelard  (1977)  suggested  on  kinetic  evid- 
ence  non-identity  between  the  soluble  and  bound  or  solub- 
ilized  brain"hexokinase. 
Latent  hexokinase  (bound  so  as  to  render  itself  in- 
accessible  to  exogenous  substrate)  seems  to  be  mainly 
connected  with  hexokinase  type  I  in  heart  (Katzen  et  al., 
1970)  and  brain  (Wilson,  1967)  and  was  exposed  and  extract- 
ed  by  glucose  6-phosphate  and  ATP  (Bachelard,  1967a; 
Wilson,  1967,1968),  salts  (Teichgraber  and  Biesold,  1968), 
osmotic  shock  (Wilson,  1967;  Kropp  and  Wilson,  1970),  rapid, 
freeze  thawing  (Wilson,  1967,1968)  and  detergents  such 
.  as  Triton  X-100  (Wilson,  1967;  Kropp  and  Wilson,  1970). 
In  rat  heart,  HK  I  was  unaffected  by  diabetes  but 
HK  II  decreased  to  an  equal  extent  in  both  soluble  and 
particulate  forms,  (Katzen  et  al.,  1970).  In  rat  mammary lb 
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glands  diabetes  decreased  particulate  hexokinase  from  46% 
of  the  total  enzyme  in  the  cell  to  11%,  "while  the  activity 
of  the  soluble  fraction  was  not  significantly  altered 
(Walters  and  McClean,  1967).  On  the  other  hand  intraperit- 
oneal  injection  of  insulin  increased  by  a  factor  of  3  the 
hexokinase  type  II  bound  to  hepatic  mitochondria  in  a  very 
short  time  (Bessman  and  Gots,  1975). 
(c)  Purifications 
A  summary  of  purifications  of  low  Km  mammalian  hexo- 
kinases  which  include  estimates  of  homogeneity  is  presented 
in  Table  5.3" 
HK  I 
The  main  problem  in  the  purification  of  mammalian 
hexokinases  is  the  low  level  of  enzyme-activity  in  the 
tissues.  It  is  understandable  therefore  why  the  first 
successful  purifications  dealt  with  HK  I  solubilized  from 
brain  mitochondria.  Brain  contains  only  HK  I  mainly  bound 
to  mitochondria.  Elution  of  the  enzyme  from  mitochondria 
by  detergent,  salts  or  glucose  6-phosphate  offered  a  start- 
ing  material  that  needed  only  10  to  100-fold  further  purif- 
ication  for  homogeneity. 
Schwartz  and  Basford  (1967),  purified  bovine  brain 
hexokinase  (homogeneous  by  sedimentation  velocity  ultra- 32 
centrifugation  and  electrophoresis)  by  solubilization  of 
the  mitochondrial  enzyme  by  Triton  X-10Q  and-10-fold  extra 
-- 
e_ 
purification  by  salt  fractionation  and  two  anion-exchange 
_.  .,.  chromatographic  steps.  The  specific  activity  of  the  puri-. 
fied  material  was  80  units/mg  but  the  yield  was  very  low 
(1.5%).  However  this  preparation  is  suspicious  since  mito- 
chondria  were  pretreated  with  chymotrypsin  prior  to  the 
elution  of  hexokinase. 
. 
Redkar  and  Kenkare  (1972)  purified  the  same  enzyme  to 
a  specific  activity  of  83  units/mg  by  a  similar  procedure 
to  that  of  Schwartz  and  Basford.  (1967)  with  one  notable- 
change  i.  e.  hexokinase  was  eluted  from  mitochondria  by 
_" 
NaCl.  The  homogeneity  of  their  preparation  was  'tested  by 
sedimentation  velocity  ultracentrifugation  and  electro- 
phoresis. 
The  same  year  Chou  and  Wilson  (1972)  reported  an  eleg- 
ant  purification  of  rat  brain  hexokinase  by  specific  solub- 
ilization  of  the  mitochondrial  enzyme  by  glucose  6-phos- 
phate  and  only  3-fold  extra  purification  by  anion  exchange 
chromatography.  The  purified  material  had  a  specific  act- 
ivity  of  60  units/mg  and  the  homogeneity  was  tested  by  sev- 
eral  methods  including  isoelectric  focussing,  sedimentation 
equilibrium  ultracentrifugation  and  SDS-PAGE. 
Easterby  and  d'Brien  (1973)  purified  HK  I  from  porcine 
heart  by  salt  solubilization  (DigCl2)  at  low  pH  of  the  mito- "  33 
chondrial  enzyme,  ion  and  cation  exchange  chromatographic 
steps,  and  gel  filtration.  The  purified  material  had  a 
specific  activity  of  82  units/mg  and  was  extensively 
tested  for  homogeneity  (Easterby,  1971;  Eas,  terby  and 
O'Brien,  1973). 
"  HK  II 
HK  II  was  purified  (in  a  similar  fashion  to  glucokinase) 
by  Hoiroyde  and  Trayer  (1976)  from  rat  skeletal  muscle  to 
a  particularly  high  final  specific  activity  of  210  units 
mg.  -  The  homogeneity  of  this  purified  hexokinase  was 
J 
tested  by  high  speed  sedimentation  equilibrium  and  SDS- 
PAGE.  Contamination  of  this  preparation  with  11K  I  can  not 
be  excluded  since  hexokinase  type  I  was  found  by  Grossbard 
and  Schimke  (1966)  to  represent  a  small  fraction  of  rat 
skeletal  muscle  hexokinase  activity.  " 
HK  IV 
Glucokinase  was  purified  from'rat  liver  by  Grossman 
"  et  al.,  (1974)  by  salt  fractionation,  anion  exchange  chrom- 
atographic  steps  and  gel-filtration  to  a  final  specific 
activity  of  80  units/mg.  The  enzyme  was  found  homogeneous 
by  low  protein  load  SDS-PAGE.  However  the  yield  was  very 
low  (2.4%). 
The  same  enzyme  was  purified  to  high  yield  by  Holroydo 
I ýý 
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et  al.,  (1976b)  by  anion  exchange  chromatographic  steps, 
gel  filtration  and  affinity  chromatography.  These  authors 
incorporated  for  the  first  time  a  specific  chromatographic 
.  step  (glucosamine  immobilized  on  Sepharose  4B)  for  the 
purification  of  a  hexokinase.  The  final  specific  activity 
of  the  purified  material  was  150  units/mg  and  the  homogen- 
eity  of  the  material  was  vigorously  tested. 
Human  hexokinases 
Hexokinases  from  various  species  and  tissues  have  been 
purified  to  various  levels  of  purity.  '  They  are  not  men- 
tioned  here  since  even  the  best  of  them-are  not  supported- 
by  information  concerning  the  homogeneity  of  the  purified 
enzymes.  However  it  is  interesting  to  refer  to  such  puri- 
fications  of  the  enzyme  from  human  tissues. 
Erythrocyte  hexokinase  was  purified  by  Gerber  et  al., 
(1974)  and  Rijksen  and  Staal  (1976a)  (Table  3.2).  The  best 
of  these  purification  procedures  (Rijksen  and  Staal,  1976a) 
gave  0.4  mg  of  purified  material  of  14  units/mg  specific 
activity,  by  the  use  of  salt  fractionation,  anion  exchange 
chromatographic  steps,  -  gel  filtration  and  affinity  chromato- 
graphy  (glucosamine  immobilized  on  Sepharose  4B). 
Neumann  et  al.,  (1974)  purified  HK  I  from  heart  by 
salt  fractionations,  anion  exchange  chromatographic  steps 
and  gel  filtration  to  a  final  specific  activity  of  71  units 35 
mg.  The  yield  was  very  low  (2.5%).  Using"a  similar  proc- 
edure  on  a  small  scale  these  authors  purified  HK  III  from 
spleen  to  a  final  specific  activity  of  3  units/mg:  This 
is.  the  best  attempt  to  purify  HK  III  from  mammalian  tissues. 
(d)  Molecular  size 
A  summary  of  the  molecular  weights  of  mammalian  hexo- 
kinases  reported  for  the  native  and  denatured  enzyme  is  pre- 
sented  in  Table  1.2. 
A  general  conclusion  is  that  low  Km  hexokinases  have 
molecular  weight  of  about  100,000  while  glucokinase  has  a 
molecular  weight  of  about  50,000.  Although  rare  cases  of 
subunit  structure  of  low  Km  hexokinases  have  been  reported 
(Monakhov  et  al.,  1973;  Craven  and  Basford,  1974),  the 
bulk  of  the  research  shows  that'hexokinase  types  I,  II  and 
IV  are  composed  of  a  single  polypeptide  chain  (HK  III  has 
not  yet  been  tested). 
However  the  presence  of  particularly  strong  interact- 
ions  between  subunits  can  not  be  ruled  out,  but  such  a  goss- 
ibility'seems  remote  because  a  single  band  corresponding  to 
a  molecular  weight  of  about  100,000  was  observed  by  the 
denaturing  conditions  of  SDS  polyacrylamide  gel  electro- 
phoresis.  Also  a  single  N-terminal  amino'  acid,  glycine, 
was  found  for  rat  brain  hexokinase  representing  0.8  moles 
per  98,000  g  (Chou  and  Wilson,  1972). " 
/. 
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Table  1.2.  Molecular  weights  of  mammalian  hexokinases 
The  following  abbreviations,  for  the  methods  of.  estimation 
of  mole  cular  weight,  are  used  bel  ow. 
G.  F.  :  gel  filtration  ;  D.  G.  :  Density  gradient  ultra- 
centrifugation  ;  S.  V.  :  Sedime  ntation  velocity  ; 
S.  E..  :  Sedimentation  equilibrium  ;  S.  D.  S.  :  SDS-poly- 
acrylam  ide  gel  electrophoresis. 
Tissue 
Molecular 
3 
Method  of  Reference 
weight  x  10  estimation 
of  M.  wt. 
"  Rat  96  D.  G.  Grossbard  and  Schimke 
brain  (1966) 
(HK  I) 
Rat  98  D.  G.  Wilson  (1972) 
brain  . 
Rat  98  D.  G.  Chou  and  Wilson  (1972) 
brain 
. 
Rat  130-p  100-p  45  S.  D.  S.  Craven  and  Basford, 
brain  (1972+) 
Rat  96  -  98  S.  D.  S.  Chou  and  Wilson  (.  1972) 
brain 
Rat  97.5±0.5  S.  E..  Chou  and  Wilson  (1972) 
brain 
Rat  96  D.  G.  Grossbard  and  Schinike 
muscle  (1966) 
Rat  98  S.  D.  S.  Holroyde  and  Trayer 
muscle'  (1976) 
Rat  96  S.  E.  Holroyde  and  Trayor 
muscle  (1976). 
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Molecular  Method  of 
Tissue 
weight  x  103 
Estimation  of  Reference 
M.  wt. 
Rat  kidney  99  -D.  G.  Grossb.  ard  and 
(HK  I)  Schimke  (1966) 
Rat  liver  99.5  D.  G.  Grossbard  and 
(HK  III)  Schimke  (1966) 
Rat  liver  55  120  G.  F.  Berthillier  and 
(HK  IV)  ....  Got  (1972) 
Rat  liver  49.5  G.  F.  Holroyde  et  al. 
(HK  IV)  (1976b) 
Rat  liver  52  S.  D.  S.  Holroyde  et  al. 
(HK  Iv)  (1976b)  - 
Rat  liver  48.6  S.  E.  Holroyde  et  al. 
(HK  Iv) 
.: 
(1976b) 
Rat  liver  47  G.  F.  Pilkis  (1972) 
(HK  IV) 
Rat  liver  57  G.  F.  Grossman  et  al. 
(HK  IV) 
,  ,..  _(1974)  Rat  liver  53  S.  D.  S.  Grossman  et  al. 
(HK  Iv)  (1974) 
Rat  liver  58  110  G.  F.  Nieme  er  et  al. 
(HK  Iv) 
_ 
(1975 
Rat  liver  48  - 
65  G.  F. 
" 
Pilkis  et  al. 
(HK  IV)  (1968)  - 
Rat  liver  68  D.  G.  Pilkis  et  al. 
(HK  IV)  (1968) 
Rat  fat  90  D.  G.  Grossbard  and 
pad  (HK  II)  Schimke  (1966) 
Porcine  97.5  S.  D.  S.  Easterby  (1971) 
heart 
Porcine  96  S.  E..  Easterby  (1971) 
heart 
Bovine  107  G.  F.  Redkar  and  Kenkare 
brain  (1972). 
Human  '132  G.  F.  Rijksen  and  Staal 
erythrocytes  (1976a) 
Human  104  G.  F.  Rogers  et  al, 
erythrocytes  "  (1975b) 
-  (HK  I) 
Human  108.4  G.  F.  Rogers  et  al. 
erythrocytes  (1975b) 
(HK  II) 
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Molecular 
Method  of 
Tissue 
10  i  ht 
3  Estimati  on  of  Reference 
g  x  we 
M.  wt  . 
Human  1,11  G.  F.  Neumann  et  al. 
heart  (1974) 
(HK  I) 
Human  116  G.  F.  Neumann  et  al. 
spleen  (1974) 
(HK  III) 
Human  '103.9  G.  F.  Rogers  et  al. 
fetal  (1975b) 
liver 
(  I) 
Human  107.2  G.  F.  Rogers  et  al. 
fetal  (1975b) 
liver 
(HK  III) 
Human  "  112  D.  G.  Monakhov  et  al. 
gastric  113  (1973) 
mucosa  118  "'  Monakhov  et  al. 
(Four  125  (1975) 
enzymes) 
Human  58  - 
60  S.  D.  S.  "  Monaihov  et  al. 
gastric 
(1973) 
mucosa  Monakhov  et  al. 
(1975)  (Four 
iso- 
enzymes) 
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Polymerization  of  hexokinases  was  observed  in  certain 
cases. 
Rat  glucokinase  occasionally  was  observed,  by  gel* 
filtration  experiments,  to  exist  as  species  of  58,000  and 
110,000  molecular  weight,  suggested  as  monomer  and  dimer 
respectively  (Niemeyer  et  al.,  1975).  By  gel  filtration 
microsomal  rat  hepatic  glucokinase  was  found  to  exist  as 
monomer  and  dimer  of  55,000  and  120,000  molecular,  weight, 
with  ATP  favouring  the  associated  form  (Berthillier 
and 
Got,  1972). 
The  presence  of  small  amounts  of  polymeric  forms  of 
hexokinase  were  observed  for  porcine  heart  HK  I  by  electro- 
phoresis,  ion-exchange  chromatography  and  low  speed  sedi- 
mentation  equilibrium  experiments  (Easterby,  1971,1975; 
Easterby  and  O'Brien,  1973)  and  for  bovine  brain  HK  I  by 
sedimentation  velocity  experiments  (Chalcrabarti 
and 
Kenkare,  1974). 
For  both  the  above  enzymes  the  presence  of  glucose 
6-phosphate  greatly  enhanced  the  association  to  dimers. 
Thus  in  the  presence  of  1  mM  glucose  6-phosphate,  and  at  a 
protein  concentration  of  2-3  mg/ml,  dimers  accounted  for 
50"%  for  the  porcine  heart  enzyme  (Easterby,  1975)  and  95% 
for  the  bovine  brain  enzyme  (Chakrabarti  and  Kenkare, 
1974)  of  total  hexokinase,  as  shown  by  integration  of  sedi- 
mentation  boundaries. 
i f 
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The  glucose  6-phosphate  mediated  dimerization  thus 
monitored  was  found  in  both  cases  tobe  reversible.  Max- 
imal  extent  of  dimerization  was  reached  at  50  µM  glucose 
6-phosphate  concentration  for  the  porcine  heart  hexokinase 
and  at  100  µM  for  the  bovine  brain  enzyme.  At  the  low 
protein  concentration  of  1  mg/ml,  no  dimerization  was  ob- 
served  for  the  bovine  brain  enzyme. 
Several  metabolites  modulated  the  glucose  6-phosphate 
mediated  dimerization  in  a  parallel  way  to  their  effect  on 
the  catalytic  properties  of  the  enzyme,  although  activity 
measurements  were  performed  at  much  lower  enzyme  concentra- 
tions  than  in  the  ultracentrifuge  experiments.  Thus  ATP 
alone  and  to  a  greater  extent  MgATP2  ,  and  Pi  reversed  the 
dimerization  of  procine  heart.  hexokinase  at  low  glucose  6- 
phosphate  concentrations  (Easterby,  1975).  Also  ATP  and  Pi 
-completely  reversed  the  glucose  6-phosphate  mediated  dimer- 
ization  of  bovine  brain  hexokinase  (Chakrabarti  and  Kenkare, 
1974).  Glucose,  for  both  enzymes,  had  no  effect  either  in 
promoting  dimerization  or  relieving  glucose  6-phosphate  med-- 
sated  dimerization. 
Fructose  6-phosphate  and  mannose  6-phosphate,  non- 
inhibitors  of  hexokinase  did  not  promote  dimerization  of 
porcine  heart  hexokinase  even  at  high  concentrations, 
whereas  glucose  1,6-diphosphate,  a  known  inhibitor  of 
mammalian  hexokinases  (Crane  and  Sols,  1954;  Gerber  et  al., I 
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1974;  Rose  and  Warms,  1965),  produced  detectable  dimers 
although  at  a  concentration  over  200  µM-(Easterby,  1975). 
Fructose  6-phosphate  and  ADP  did  not  promote  dimerization 
of  bovine  brain  hexokinase  (Chakrabarti,  1974). 
The  establishment  of  an  equilibrium  between  monomer 
and  dimer  of  porcine  heart  hexokinase  in  the  presence  of 
glucose  6-phosphate  was  suggested  because  the  ratio  of 
monomer  to  dimer  remained  constant  during  incubation  of  the 
enzyme  for  several  days  with  this  metabolite.  However, 
larger  polymers  were  produced  in  slow  process  as  shown  by 
sedimentation  equilibrium  experiments  (Easterby,  1975). 
Rat  brain  hexokinase  was  found  to  aggregate  at  low. 
ionic  strength  (lower  than  0.05)  at  pI1  =  7.0  as  seen  by 
increase  in  turbidity  of  the  enzyme  solution  (Wilson, 
1972).  By  sucrose  density  preparative  ultracentrifugation 
the  sedimentation  coefficient  of  the-same  enzyme  was  found 
to  increase  in  the  presence  of  1.5  mM  glucose  6-phosphate. 
A  further  increase  was  observed  by  increasing  the  protein 
concentration.  The  increase  in  sedimentation  poefficient 
was  attributed  to  some  polymerization  in  the  presence  of 
glucose  6-phosphate  (Wilson,  1973b). 
" 
(e)  Catalytic  properties 
It  is  beyond  the  scope  of'this  introduction  to  give  a 42 
full  description  of  the  voluminous  literature  on  the  cata- 
lytic  properties  of  mammalian  hexokinases.  Therefore  observ- 
ations  for  human  hexokinases  are  given  priority  with  brief 
-f.  notes  for  other  mammalian  hexokinases  where  relevant. 
Hexokinases  catalyse  the  following  reaction 
MgATP2  +  hexose  -  MgADP1  +  hexose  6-phosphate2  +  H+ 
The  catalysed  reaction-is  a  non-equilibrium  one.  For 
Rhesus  monkey  skeletal  muscle  hexokinase  the  apparent 
-equilibrium  constant  for  hexokinase  was  over  1,000  times 
larger  than  the  mass-action  ratio  (Beatty  et  al.,  1976). 
Human  erythrocyte  hexokinase  was  found  specific  for 
MgATP  as  the  nucleotide  substrate,  whereas  MgITP,  MgGTP9 
MgUTP  and  MgCTP  were  not  converted  to  their  diphosphates 
at  concentrations  of  10  mM  (Rijksen  and  Staal,  1976a).  The 
same  authors  found  that  mannose  was  phosphorylated  at  the 
same  rate  as  glucose  although  with  a  lower  affinity.  Much 
lower  rates  and  affinities  were  found  for  2-deoxy-D-glucose, 
D(+)  glucosamine  and  D(-)fructose.  N-acetyl-D-glucosamine, 
D(+)galactose,  D(+)xylose  and  L(-)sorbose  were  not  phosphor- 
ylated  at  all  by  human  erythrocyte  hexokinase.  This  is  in 
agreement  with  the  observations  by  Sols  and  Crane  (1954) 
for  the  importance  of  hydroxyl  groups  at  carbon  atoms  1, 
3,4  and  6  of  hexoses,  for  the  specificity  of  rat  brain 
hexokinase.  A  summary  of  Michaelis  constants  of  human 
hexokinases  for  glucose  and  MgATP  is  given  in  Chapter  6. 43 
"  Crane  and  Sols  (1954)  found  that  although  certain 
hexoses  were  good  substrates  for  brain  hexokinase  only 
glucose  6-phosphate  was  an  inhibitor  non-competitive 
against  glucose)  of  the  enzyme.  On  this  basis  they  post- 
ulated  the  existence  of  a  specific  binding  'site  for  gluc- 
ose  6-phosphate. 
Glucose  6-phosphate  was  observed  to  inhibit  human 
erythrocyte  hexokinase  competitively  towards  MgATP 
(Ki  =  1.1  µM)  but  non  competitively  towards  glucose  (Gerber 
"  et  al.,  1974;  Rijksen-and  Staal,  1977).  Solubilized  human 
placental  hexokinase  was  also  inhibited  in  the  same 
fashion  with  Ki  against  MgATP  and  glucose  of  27.  and  78  pMM 
respectively 
(Gustke,  1975).  These  findings  suggest  that 
glucose  6-phosphate  binds  at  a  separate  site  than  the 
hexose  binding  site  in  the  active  center  but  it  shares  the 
MgATP  binding  site.  - 
With  porcine  heart  hexokinase  (Easterby  and  O'Brien, 
1973)  competitive  inhibition  was  observed  by  Glucose  6- 
phosphate  against  MgATP  (Ki 
=  20  Pi)  and  non-competitive 
inhibition  against  fructose  or  mannose  (Ki 
=  50  pit).  For 
human  erythrocyte  hexokinase,  fructose  6-phosphato  was  not 
found  to  inhibit  the  hexokinase  reaction  by  Gerber  et  al., 
(1974)  whereas  Rijksen  and  Staal  (1977)  reported  competit- 
ive  inhibition  by  fructose  6-phosphate  against  MgATP 
(ja  =  o.  16  mii)  . 44 
Rijksen  and  Staal  (1976b)  reported  that  Mg2t  and 
ATP  inhibited  human  erythrocyte  hexokinase  non-competit- 
ively  against  glucose  but  competitively  against  MgATP2 
with  Ki  equal  to  16-18  and  1.6  mM  respectively.  The  ob- 
servation  of  Gerber  et  al.,  (1974)  that  Mg2+  at  low  conc- 
entration  is  an  activator  of  the  human  erythrocyte 
enzyme  may  arise  from  complex  formation  with  ATP  ,  which' 
normally  inhibits  the  enzyme  (Rijksen  and  Staal, 
. 
1976b). 
Contradictory  rbsults  have  been  reported  for  the 
effect  of  inorganic  phosphate  on  human  erythrocyte  hexo- 
kinase.  Thus  Pi  has  been  found  to  relieve  partly  (de 
Verdier  and  Garby,  1965;  Rijksen  and  Staal,  1977),  or 
completely 
(Kosow  et  al.,  1973)  the  inhibition  of  glucose 
6-phosphate,  whereas  Gerber  at  al.,  '(1971)  found  no  influ- 
ence  at  all. 
Ellison.  et  al.,  (1974)  suggested  a  model  for  bovine 
brain  hexokinase  which  implies  the  existence  of  an  equil- 
ibrium  between  a  free  and  a  phosphate-associated  enzyme, 
where  glucose  6-phosphate  binding.  to  the  phosphate-associ- 
ated  form  is  very  poor.  Wilson  (1973b)  proposed  a  model 
for  brain  hexokinase  according  to  which  the  enzyme  exists 
in  a  rapid  equilibrium  between  two  alternate  forms  one 
binding  preferentially  inorganic  phosphate  and  the  other 
glucose  6-phosphate.  Most  of  the  kinetic  results  for  the 
human  erythrocyte  enzyme  conform  with  these  models. '  45 
Inorganic  phosphate  was  found  to  inhibit.  human  eryth- 
rocyte  hexokinase  competitively  against  MgATP2-  with 
Ki  -  20  mM  (Rijksen  and  Staal,  1977). 
MgADP  and  MgAMP  inhibited  human  erythrocyte  hexokin- 
ase  competitively  against  MgATP  with  Ki  of  1  and  0.7  mM 
respectively  (Rijksen  and  Staal,  1977). 
Human  erythrocyte  hexokinase  was  found  to  operate 
by  a  rapid  equilibrium  random  mechanism  (Gerber  et  al., 
1974)  in  accordance  with  proposed  mechanisms  for  other 
mammalian  hexokinases,  (Kosow  and  Rose,  1968;  Bachelard 
et  al.,  1971;  Purich  and  Fromm,  1971). 
Easterby  and  O'Brien  (1973)  suggested  that  rapid  equil- 
ibrium  random  ad  compulsory  order  mechanisms  are  indist- 
inguishable  if  the  first  substrate  to  bind  to  the  enzyme 
is  in  equilibrium  with  its  enzyme-substrate  complex, 
concluding  that  for  the  porcine  heart.  enzyme'at  least  one 
of  the  enzyme  substrates  is  in  equilibrium  with  its  enzyme- 
substrate  complex. 
(f)  Stability 
The  binding  of  metabolites  to  hexokinase,  observed  by 
various  conformational  changes  of  the  enzyme  molecule  lead- 
ing  to  release  from  mitochondria,  polymerization  and  cata- 
lysis  has  already  been  mentioned. 46 
Further  information  of  enzyme-ligand  interactions  has 
been  obtained  from  assessments  of  protection  (of  the  en- 
zyme  by  ligands)  against  inactivation  by  heat,  proteolysis, 
sulfhydryl  reagents,  glutaraldehyde  and  Ellman's  reagent. 
From  the  protective  effects  dissociation  constants  of 
enzyme-ligand  complexes  have  been  estimated. 
According  to  Redkar  and  Keakare  (1975),  glucose  6- 
phosphate  completely  protected  bovine  brain  hexokinase 
against  DTNB,  while  glucose  protected  to  a  lesser  extent. 
Although  ATP,  MgATP9  ADP,  MgADP  and  Pi  changed  the  react- 
ivity  of  some  sulfhydryl  groups  on  the  enzyme  they  did 
not  protect  hexokinase  against  inactivation.  Protection 
by  fructose  6-phosphate  was  similar  to  that  by  glucose. 
These  authors  interpreted  these  and  other  results  as  indi- 
cating  that  glucose  6-phosphate  and  inorganic  phosphate 
share  the  same  locus  on  the  enzyme  as  y-phosphate  of  ATP 
and  that  nucleotides  ATP  and  ADP  bind  to  the  enzyme  in  the 
absence  of  Mgt+ 
Similar  results  were  presented  by  Chou  and  Wilson 
(197+)  who  also  studied  the  interaction  of  DTNB  with  -SH 
groups  on  the  rat  brain  enzyme,  which  showed.  a  pronounced 
conformational-change  of  the  enzyme  molecule  upon  binding 
of  glucose  6-phosphate. 
Wilson  (1978)  observed  that  UTP,  ITP,  GTP  and  CTP 
were  much  less  effective  than.  ATP  at  protecting  rat  brain 47 
hexokinase  against  inactivation.  by  chymotrypsin.  With 
glutaraldehyde  only  good  substrates  (glucose,  mannose, 
2-deoxyglucose)  protected,  while  nonsubstrates  (galactose, 
arabinose,  N-acetyl  glucosamine)  were  not  effective.  Also 
with  glutaraldehyde,  glucose  6-phosphate  was  more  effect- 
ive-at  protecting  the  enzyme's  molecule  than  mannose  6- 
phosphate  or  fructose  6-phosphate.  A  model  was  proposed 
by  this  author  based  on  these  and  his  previous  observations, 
taking  into  account  ligand-induced  conformations  at  various 
points  of  the  catalytic  cycle. 
The  differences  in  heat  and  proteolytic  inactivation 
-of  hexokinase  types  I  to  IV  were  investigated  by  Grossbard 
and  Schimke  (1966)  and  Salas  et  al.,  (1965).  "  HK  II  and 
HK  IV  were  found  unstable,  whereas  in  the  presence  of  gluc- 
ose  they  were  stabilized.  In  addition  KC1  was  needed  for 
"the  stability  of  M.  IV. 
Murakami  and  Rose  (197+)  investigated  the  heat  inact- 
ivation  of  hexokinase  type  II.  Glucose  at  10  mM  protected 
the  enzyme,  whereas  at  lower  concentration  (0.1  mM)  it  did 
not,  except  if  glucose  6-phosphate,  Pi  or  ADP  were  also 
present. 
ýg)  Regulation 
Hexokinase  catalyses  an  irreversible  reaction  and  to- 48 
Bether  with  phosphofructokinase  has  been  accepted  as  a  key 
point  in  the  regulation  of  glycolytic  flux  in  human  erythro- 
cytes 
(Rapoport  et  al.,  1974;  Heinrich  and  Rapoport,  1974). 
Hexokinase  catalyses  the  first  step  of  glycolysis, 
phosphorylating  glucose  entering  in  the  cell.  Its  prod- 
uct,  glucose  6-phosphate,  appears  in  a  central  position  in 
the  carbohydrate  metabolism.  It  is  also  derived  from 
glycogenolysis  and  is  chanelled  to  glycolysis,  pentose 
phosphate  pathway,  glycogenesis  or  is  returned  to  glucose 
via  phosphatase  action,  the  direction(s)  determined  by  the 
metabolism  of  the  tissue  involved. 
Under  intracellular  conditions  the  glucose  6-phosphate 
concentration  in  human  erythrocytes  is  such  that  most  of 
hexokinase  is  expected  to  be  in  an  inhibited  form  (Rose 
and  OtConnell,  1964;  Gerber  et  al..,  1974;  Rijksen  and 
'Staal,  1977)  and  is  therefore  strongly  regulated  by  the 
glucose  6-phosphate  level.  Also  rat  skeletal  muscle  hexo- 
kinase  was  estimated  to  be  80%  inhibited  under  intracellul- 
ar  conditions,  increased  to  96%  under  tetanic  muscular 
contraction 
(Lueck  and  Fromm,  1974). 
In  human  erythrocytes,  inorganic  phosphate,  was  found 
to  exert  its  most  pronounced  influence  in  relieving  gluc- 
ose  6-phosphate  inhibition  at  concentrations  that  are 
physiologically  important,  so  that  Pi  was  suggested  to 
have  a  regulatory  role  (Rijkspn  and  Staal,  1977).  The  same 49 
authors  suggested  that  glucose  has  no  regulatory  role, 
since  it  exists  in  saturating  levels  in  erythrocytes,  while 
factors  affecting  the  concentration  of  MgATP  (that  is  near 
the  Km  for  this  metabolite)  must  be  potential  regulators 
too. 
Purich  et  al.,  (1973)  proposed  a  model  for  the  cont- 
rol  of  glycolytic  flux  in  brain  and  erythrocytes  at  the 
hexokinase"and  phosphofructokinase  catalysed  reactions 
taking  into  consideration  the  effect  of  glucose  6-phosphate, 
Pi  and  nucleotides  (Figure  1.1). 
The  regulation  on  hexokinase  should  be  exerted  at 
other  levels  too.  Thus  the  amount  and  typo  of  hexokin-- 
ase(s)  in  the  cell  determined  by  synthesis  and  inactiv- 
ation  of  each  isoenzyme  seem  significant.  The  variations 
of  activity  levels  of  HK  II  and  HK  IV  with  diabetes  and 
starvation,  as  well  as  ontogenetic  variations  fall  into 
this  type  of  regulation.  Another  factor  of  regulation 
seems  to  be  the  intracellular  localization  of  hexokinaso. 
Glucose  6-phosphate  had  little  effect  on  the  activ- 
ity  of  the  particulate  hexokinase  from  rat  brain  (Tuttle 
and  Wilson,  1970).  Therefore  the  inhibition-by  glucose 
6-phosphate  acts  in  two  steps:  the  transfer  of  hexokinase 
from  the  particulate  to  soluble  form  followed  by  strong 
inhibition  of  the  soluble  form.  Also  hexokinase  from  rat 
liver  had  a  higher  affinity  for  ATP  generated  within  the "  50 
Figure  1.1.  Regulation  of  early  reactions  in  the  glyco- 
lytic  pathway  in  brain  and  erythrocytes  (after  Purich 
et  al.,  1973).  ". 
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mitochondrion  than  that  external  to  the  organelle  (cots 
et  al.,  1972;  Gots  and  Bessman,  1974). 
Pont  et  al.,  (1975)  interpreting  their  own  and  other 
results  pointed  out  that  "the  association  of  hexokinase 
with  mitochondrial  membranes  may  serve  to  control  glucose 
phosphorylation,  especially  in  muscle  and  brain;  the  local- 
ization  close  to  the  ATP-generating  system  would  efficient- 
ly  provide  ATP,  and  thus,  glucose  6-phosphate  in  sufficient 
amounts  to  ensuro  metabolism,  but  high  concentrations  of 
glucose  6-phosphate  or  ATP,  solubilize  hexokinase  and 
modify  its  kinetic  properties". 
Glucokinase  serves  a  specific  function.  It  is  not. 
inhibited  by  physiological  levels  of  glucose-6-phosphate 
and  thus  glucose  coming  from  the  portal  vein  (at  concentra- 
tions  near  the  Km  for  this  isoenzyme)  is  readily  phosphor- 
-ylated  for  glycogen  synthesis  (Newsholme  and  Start,  1973)" 
0 ""-.,. 
__/. 
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SECTION  2 
Purifications 
Extens_ve  work  has  been  done  in  this  Laboratory  on 
the  purification  and  physicochemical  study  of  human 
erythrocyte  enzymes  as  glucose  6-phosphate  dehydrogenase 
(Cohen  and  Rosemeyer,  1969a,  1969b),  6-phosphogluconate 
-dehydrogenase  (Pearse  and  Rosemeyer,  1974a,  1'974b)  and 
glutathione  roductase  (Worthington  and  Rosemeyer,  1974, 
1975,1976). 
The  aim  of  the  present  research  was  the  purification 
and  physicochemical  study  of  human  erythrocyte  hexokinase. 
Because  of  the  problems  involved  in  the  purification-of 
the  erythrocyte  enzyme  (Chapter  3),  exploratory.  small  scale 
purifications  were  tried  with  relatively  easily  available 
human  tissues  as  placenta  (Chapter  4)  and  heart  that  con- 
tained  HK  I.  The  latter  tissue  proved  more  favourable 
and  so  a  big  scale  purification  procedure  was  devised  for, 
hexokinase  from  this  tissue  (Chapter  5). 53 
CHAPTER  2 
Materials  and  methods. 
(a)  Human  tissues 
Blood,  out-dated  for  transfusion,  was  obtained  from 
the  Blood  Bank.  It  had  normally  been  stored  for  at  least 
three  weeks  at  0-  4+°C  in  acid/citrate/dextrose. 
Term  placentas  were  obtained  after  delivery  and 
stored  at  -25°C. 
Hearts  were  obtained  from  autopsy  and  stored  at  -25°C, 
for  one  week  to  one  month  till  the  desired  amount  of  tissue 
for  a  purification  was  collected. 
(b)  Buffers 
The  following  buffers  were  used  in  the  purification 
and  further  additions  to  these  are  indicated  at  the  appro- 
priate  stages.  Analytical  grade  reagents  were  used  where 
available  and  pH  was  measured  at  room  temperature. 
Potassium  phosphate  pH  =  8.0f  I=0.1  containing: 
0.34  gel  'U12P04 
5.66  g/l  K2lIP04 " 
54 
Potassium  phosphate  pH  =  7.5,  I=0.02  containing: 
0.27  g/l  KH2PO4 
"  1.04  g/l  K2HPO4 
Potassium  phosphate  pH  =  7.0,  I=0.1  containing: 
2.74  g/l  KII2PO4 
4.63  g/1  K2HPO4 
Potassium  phosphate  pH  =  6.59  I=0.05  containing: 
3.29  g/1  KH2PO4 
1.50  g/1  K2HPO4 
Potassium  phosphate  pH  =  6.5,  I=0.1  containing: 
6.04  g/1  KH2PO4 
3.23  g/1  K2HPO4 
Potassium  acetate  pIi  =  5.8,  I=0.05  containing: 
4.91  g/1  CH3COOK 
0.213  ml/l  CH3COOH 
Potassium  acetate  pH  =  5.8,  I'=  0.025  +  0.125  M  KC1- 
'  containing:  2.45  g/l  CH3COOK 
0.112  ml/l  CH3COOH 
9.32  g/l  KCl 
Potassium  acetate  pH  =  5.6,  I_0.1  +  0.2  M  MgC12 
containing:  9.81  g/l  C4  3 
COOK 
0.257  mi/l  CI13000H 
110..  6  g/1  MgC12.61120 55 
20  mM  Triethanolamine-HU  pH  -  7.0  +  5%  glycerol 
containing:  2.65  ml/1  Triethanolamine 
_.. 
50  mil  glycerol 
v 
All  buffers  contained  0.1%  (v)  2-mercap'toethanol, 
1  mM  K2EDTA  and  10  mM  glucose  unless  otherwise  stated. 
Solubilization  experiments  were  also  performed  in  the 
absence  of  these  substances. 
(c)  Preparation  of  resins 
1.  DEAE  -  Sephadex  A-50 
This  anion  exchanger  had  a  particle  size  of  40-120  µm. 
The  resin  was  left  to  swell  for  two  days  at  room  temp- 
erature  in  the  appropriate  initial  buffer.  It  was  washed 
with  several  volumes  of  the  same  buffer  by  filtering  the 
suspension  on  a  Buchner  funnel  and  resuspending  the  cake. 
in  fresh  buffer.  After  each  washing  the  pH  of  the  suspen- 
sion  was  adjusted  to  that  of  the  buffer.  The  resin  was 
considered  to  be  equilibrated  when  the  pH  and  conductivity 
of  the  eluate  was  the  same  as  the  applied  buffer. 
2.  CM  -  Sephadex  C-50 
This  cation  exchanger  had  a  particle  size  of  40=120,  µm. 
The  resin  was  swelled  and  equilibrated  in  the  same  way  as 
the  Sephadex  A-50. 
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3.  P-11  cellulose 
This  cation  exchanger  was  a  fibrous  cellulose  phos- 
phate  resin.  It  was  swelled  and  equilibrated  in  the  same 
way  as  the  Sephadex  C-50  with  one  addition.  Since  phospho- 
cellulose  had  a  brownish  colour  and  the  buffer  used  for 
swelling  was  becoming  coloured,  the  suspension  was  washed 
on  a  Buchner  funnel  with  several  volumes  of  the  same 
buffer  containing  1M  KC1  until  the  eluate  was  colourless. 
Subsequent  washing  of  the  resin  with  above  buffer  alone 
-removed  the  salt.  In  this  way  impurities  were  removed 
that  otherwise  would  contaminate  the  fractions  during  the 
elution. 
4.  Sephadex  G-200 
This  resin  used  for  gel  filtration  had  particle  size 
of  40-120  gm.  It  was  allowed  to  swell  in  the  buffer  used 
for  gel  filtration  for  three  days  and  was  poured  into  the 
column  at  room  temperature  under  atmospheric  pressure. 
The  column  was  transferred  in  a  cold  room  with  a  temperature* 
of  0-  4°C  and  was  allowed  to  stand  for  3  to  4  weeks  before 
use,  to  enable  the  resin  to  settle  and  allow  for  complete 
equilibration.  This  gave  better  and  more  reproducible 
results  as  was  found  previously  in  this  laboratory  (P. 
Cohen  Ph.  D.  Thesis,  1969).  The  same  column  was  used  sev- 
eral  times  until  the  flow  rate  was-reduced  substantially. 57 
After  each  use  the  column  was  washed  with  buffer  containing 
w 
0.02%  (v)  sodium  azide  as  antibacterial  agent.  Before  use 
the  column  was  washed  with  fresh  buffer  for  two  days  to  re- 
_move 
the  sodium  azide.  " 
"5.  "  Sepharose  4B  with  immobilized  glucosamine 
This  affinity  resin  was  prepared  using  Sepharose  4B 
as  supporting  matrix,  6-aminohexanoic  acid  as  spacer  arm 
and  cx-D-glucosamine  as  ligand.  It  was  prepared  in  three 
steps  according  to  the  method  of  Cuatrecasas  (1970)  with 
slight  modifications.  A  scheme  for  the  reactions  involved 
in  this  synthesis  is  given  in  Figure  2.1. 
(i)  Activation  of  Sepharose  4B  by  the  cyanogen 
bromide  method. 
One  volume  of  settled  Sepharose  4B  was  mixed  with 
equal  volume  of  water.  In  the  suspension  cyänogen  bromide 
was  dissolved  to  a  final  concentration  of  65  mg  per  ml  of 
settled  Sepharose  4B.  The  reaction  temperature  was  kept 
at  20  -  25°C  by  the  addition  of  crushed  ice  and  continuous 
stirring.  The  pH  was  maintained  at  11.0  with  the  addition 
of  5N  NaOH.  After  15  minutes  the  reaction  was  complete  as 
judged  by  the  constancy  of  pH.  The  suspension  was  filtered 
and  quickly  washed  with  15  volumes  of  chilled  0.1  M  sodium 
carbonate  buffer  pH  =  10.0.  Free  cyanide  ions  were  treated 
with  excess  of  sodium  hypochlorite  for  several  hours  before I 
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(i)  Activation  of  Sepharose  with  Br-CN. 
OH  0 
OH 
BrCN 
6 
Q\C-NH 
(ii)  Coupling  of  6-aminohexanoic  acid  to  activated  Sepharose. 
-C-N-CH2  - 
IOHCH2_HCHiCHrCO0 
NH. 
OH 
v00 
10ýC=NH 
+  H2N-CF  CHýCH2CH2CH-COO-  ý"°ý 
0 
C"N-CH2  CH2  2C14-  CH2  CHI-000- 
O-C-NH-CHF  C  HICH2-CKTCKTC  00- 
0 
OH 
(iii)  Coupling  of  glucosamine  to  Sepharose-N-6-aminohexanoic 
acid  by  a  carbodiimide  promoted  reaction. 
---NH-CHiCH2  CH2  CH2  CH2  COO- 
+NH  +  ---NH-CH2  CHI  CH2  CH'  CH2  C-O-ý 
RI-N-CQN-R2  0  NH 
R2 
_\" 
CH2OH 
C0 
OH 
HO  OH 
HO  OH 
NH2  1---NH-CH1CH-cH-CH-CH-C-NH 
U0 
Figure  2.1.  Reactions  involved  in  the  synthesis  of 
Sepharose-N-(6-aminohetianoyl)-2-amino-2-deox-Ny- 
D-glucopyranose. ýý 
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the  disposal  of  washings. 
(ii)  Coupling  of  6-aminohexanoic  acid  to  the  activ- 
ated  Sepharose  4B. 
The  activated  Sepharose  4B  cake  was  immediately  sus- 
--pended 
in  two  volumes  of  0.1  M  sodium  carbonate  buffer 
pH  =  10.0  containing  1.7  mmoles  of  6-aminohexanoic  acid 
per  ml  of  settled  Sepharose  4B.  The  suspension  was  left 
overnight  under  continuous  stirring  at  4°C.  Subsequently 
it  was  filtered  and  washed  successively  with  10  volumes  of 
water,  7  volumes  of  1M  KC1  in  water  and  15  volumes  of 
water. 
(iii)  Coupling  of  a-D-glucosamine  to  Sepharose-N-6- 
aminohexanoic  acid. 
The  resin  was  suspended  in  two  volumes  of  water  con- 
taining  70  µmoles  of  1-ethyl-3(3-dimethylaminopropyl) 
carbodiimide  hydrochloride  and  0.4  mmoles  of  a-D-glucos- 
amine  hydrochloride  per  ml  of  settled  Sepharöse.  The 
reaction  lasted  for  3  hours  with  continuous  stirring  at 
room  temperature  while  the  pH  was  maintained  at  4.75.  The 
suspension  was  filtered'and  the  resin  was  successively 
washed  with  7  volumes  of  water,  7  volumes  of  2M  KC1  in 
water  and  7  volumes  of  the  appropriate  buffer  for  the 
affinity  chromatography. 
For  storage  at  4°C,  sodium  azide  was  added  as  anti- 6o 
w 
bacterial  agent  to  a  final'  concentration  of  0.02%  (v)  to 
the  suspension.  Before  use  the  resin  was  washed  with 
fresh  buffer  for  the  removal  of  sodium  azide.  After  use 
,..  -_. 
the  resin  was  washed  with  5  volumes  of  2M  KC1/6  M  Urea  in 
"r 
water  for  the  removal  of  any  firmly  bound  proteins  on  the 
resin,  as  reported  by  Holroyde  et  al.  (1976  a). 
6.  Sepharose  4B  with  immobilized  N6-  (6-aminohexyl)carb- 
amoylmethyll-ATP 
The  ATP  analogue  (Figure  2.2)  was  a  gift  from 
Dr--K.  Mosbach.  It's  synthesis  is  described  by  Lindberg  and 
Mosbach  (1975)  and  it's  coupling  to  Sepharose  4B  was  made 
according  to  this  reference  with  slight  modifications,  in 
two  steps. 
(i)  Activation  of  Sepharose-4B  by  the  cyanogen 
bromide  method. 
Equal  volumes  of  settled  Sepharose  and  water  were 
mixed  and  200  mg  of  cyanogen  bromide  per  ml  of  settled 
Sepharose  was  dissolved  in  the  suspension.  The  reaction 
temperature  was  kept  at  20  -  250C  and  the  pH  maintained  at 
11.0.  The  reaction  was  completed  in  15  minutes.  The  sus- 
pension  was  filtered  and  washed  quickly  with  0.1  M  carbon- 
ate  buffer  pH  =  8.4  on  a  Buchner  funnel.. "  61 
"HN-CH2  CH2  CH2  CH2.  CH2  CH2NH  C-CH2  NH 
N. 
.N  .OO0  A 
-0-  ý-  0-P-0-P 
0-  0-  0-  HN 
OH  OH 
Figure  2.2.  N6-[(6-aminohexyl)carbamoylmethyl1-ATP 
coupled  on  Sepharose  4B 
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(ii)  Coupling  of  N6-[(6-aminohexyl)carbamoylmethyl]- 
ATP  to  the  activated  Sephärose  4B. 
The  activated  resin  was  immediately  mixed  with  1.5 
volume  of  the  carbonate  buffer  containing  5  µmoles  of  the. 
- 
ATP-analogue  per  ml  of  settled  Sepharose  4B.  The  suspen- 
sion  was  left  for  24  hours  under  continuous  stirring  at 
4°C.  It  was  filtered  and  washed  successively  with  20  vol- 
umes  of  the  following  solvents:  water,  1M  NaC19  acetate 
buffer  pH  =  4.5,  I=0.1  and  water.  The  resin  was  mixed 
with  5  volumes  of  0.1  M  glycine  and  the  suspension  was  ad- 
justed  to  pH  =  9.5  with  1N  NaOH  and  stirred  overnight  at 
4°C  for  the  neutralization  of  still  uncoupled  carboxyl 
groups  on  the  resin.  It  was  further  washed  with  20  vol- 
umes  of  water,  1M  NaCl  and  the  appropriate  buffer  for 
chromatography.  Half  the  quantity-of  the  ATP  analogue  at 
the  most  must  have  reacted  as  seen  by  the  absorbance  at 
267  nm  of  the  reaction  medium  before,  and  after  coupling. 
ýd)  Enzyme  assay 
Hexokinase  was  assayed  in  a  Perkin-Elmer 
photometer  equipped  with  a  65  chart  recorder, 
"back  off"  control.  Assays  were  conducted  at 
temperature  controlled  cell  compartment.  The 
activity  was  measured  by  coupling  the  formati, 
124  spectro- 
fitted  with 
25°C  using  a 
hexokinase. 
on  of  glucose 63 
6-phosphate  to  the  reduction  of  NADP  to  NADPHin  the  pres- 
ence  of  glucose  6-phosphate  dehydrogenase.  It  was  assumed 
that  in  the  presence  of  NADP  all  the  glucose  6-phosphate 
was  converted  to  6-phosphogluconate.  The  formation  of 
NADPH  was  followed  by  continuous  recording  of  the  absorb- 
ance  at  340  nm  assuming  that  the  molar  extinction  coeff- 
icient  at  this  wavelength  for  NADPH  is  6.22  x  10-3  M-1cm-1 
(Horecker  and  Kornberg,  1948). 
For  the  measurements  of  hexokinase  activity  during 
the  purifications,  the-assay  solution  was  always  freshly 
prepared  and  contained: 
130  mM  TES  -  KOH  buffer  pH  -  7.2  (I  -  0.05) 
75  mM  KC1  - 
5  mM  glucose 
10  mM  MgCl 
2 
5  mm  ATP 
0.6  mm  NADP 
0.25  Units  G6PD 
ml 
Cuvettes  of  3  ml  capacity  and  1  cm  light  path  were 
used.  The  reaction  was  initiated  by  the  addition  of  10  - 
20  µl  of  the'  appropriate  dilution  of  the  enzyme  solution 
so  that  the  reaction  velocity  was  linear  for  at  least  10 
minutes.  In  all  assays  a  blank  cuvotte  was  inserted  in 
the  double  beam  spectrophotometer  containing  all  the  assay 64 
components  except  hexokinase,  thus  any  hexokinase  activity 
present  as  impurity  in  glucose  6-phosphate  dehydrogenase 
was  automatically  deducted. 
(e)  Units.  of  enzyme  activity 
A  unit  of  enzyme  activity  was  defined  as  the  amount  of 
enzyme  required  to  phosphorylate  1  µmole  of  glucose"to 
glucose  6-phosphate  per  minute  at  25°C,  under  the  assay 
conditions  routinely  used.  This  corresponds  to  1  µmole 
NADPH  produced  in  the  coupled  assay.  Specific  activity 
was  defined  as  units  per  mg  of  protein. 
(f)  Determination  of  protein  concentration 
The  protein  concentration  of  partially  purified 
samples  of  hexokinase  was  calculated  using  the  method  of 
Warburg  and  Christian  (1941),  from  the  absorbance  measure- 
ments  at  260  nm  and  280  nm  in  a1  cm  light  path  cuvette. 
Protein  concentration  =  1.55  x  O.  D280 
nm  -  0.76  x  O.  D260 
nm  (mg/ml) 
Absorbancies  were  measured  with  a  Perkin-Elmer  124  spectro- 
photometer,  using  1  cm  light  path  quartz  cells,  1.3  61  cap- 
acity.  This  method  assumes  that  a1  mg/ml  protein  sol- 
ution  has  unit  optical  density  at  280  nm  and  corrects  for 
any  contaminating  nucleotides.. F. 
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The  protein  concentration  of  haemolysate  was  assumed 
as  35  gr  per  100  ml  packed  erythrocytes. 
The  protein  concentration  of  the  purified  heart  en- 
zyme  was  estimated  from  synthetic  boundary  measurements  in 
the  ultracentrifuge  using  interference  optics  (Babul  and 
Stellwagen,  1969).  Assuming  a  constant  refractive  index 
for  proteins,  this  method,  when  compared  with  the  absorb- 
ance  of  the  enzyme  solution  at  280  nm,  gave  an  extinction 
coefficient,  E  280  nm 
for  a1  mg/ml  solution  of  0.6  (Chap- 
ter  9).  This  value  was  used  only  for  the  estimation  of 
protein  concentration  in  the  final  purification  step  of 
heart  hexokinase. 
(g)  Concentration  of  dilute  protein  solutions 
At  various  stages  during  the  purification  procedures 
it  was  necessary  to  concentrate  protein  solutions.  Two 
techniques  were  used  for  this  purpose. 
1.  Vacuum  dialysis 
For  small  volumes  of  protein  solution,  vacuum  dialysis 
was  used  for  concentration  purposes.  A  glass  reservoir  of 
It 
20  -  100  ml  capacity  was  filled  with  a  length  of 
g  /32 
Visking  tubing,  held  in  place  by  a  rubber  bung.  The  res- 
ervoir  and  tubing  were  filled  with  the  dilute  protein  sol- . 
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ution  and  placed  in  a  Buchner  flask  containing  buffer  to 
provide  concomitant  dialysis.  The  flask  was  evacuated  on 
a  water  pump  and  allowed  to  stand  at  4°C  with  simultaneous 
stirring  of  the  buffer. 
2.  Ammonium  Sulphate  precipitation 
For  large  volumes  of  protein  solution  it  was  found  to 
be  most  convenient  to  add  sufficient  solid  enzyme  grade 
ammonium  sulphate  to  precipitate  the  enzyme  and  other. 
proteins  precipitating  at  the  same  salt  concentration. 
.  --.  Thus  concentration  and  some  fractionation  was  achieved  at 
the  same  time. 
ýh)  Columns 
The  columns  used  for  chromatographic  experiments  were 
made  from  borosilicate  glass  Pyrex).  '  At  their  lower  end 
they  became  narrower  and  were  connected  with  polythene  tub- 
ing.  The  resin  was  retained  in  the  column  by  a  small  quant- 
ity  of  boiled  cotton  placed  at  the  lower  end  of  the  column. 
The  flow  of  buffer  was  under  gravity,  the  reservoirs  being 
10  -  20  cm  over  the  top  surface  of  the  resin.  Since  the, 
flow  rate  for  Sepharose  4B  under  gravity  was  very  fast,  a 
peristaltic  pump  was  used  for  slowing  down-the  flow. 67 
CHAPTER  3 
Erythrocyte  hexokinase. 
(a)  Introduction 
Human  erythrocytes  have  certain  advantages  for  the 
purification  of  hexokinase.  They  represent  virtually  a. 
single  cell  population  without  intracellular  organelles 
and  they  are  easily  separated  from  other  components  of 
blood.  The  problems  with  lipid  and  particulate  matter  are 
minimal  during  purification.  The  ionic  and  metabolite 
levels  within  the  erythrocyte  have  been  studied  in  detail. 
Haemoglobin  constituting  approximately  99%  of  the  cell  pro- 
tein  can  be  easily  removed  in  one  step  (Cohen  and  Rosemeyer 
1969a).  The  erythrocytes  are  easily  obtained  in  big  quant- 
ities  from  out-dated-transfusion  blood.  Complications 
arising  from  the  presence  of  soluble  and-particulate  bound 
"  hexokinase  are  absent  since  intracOllular  organelles  are 
missing  and  only  a  small  amount  of  hexokinase  (6%)  has 
been  found  associated  with  the  red  cell  ghosts  (Tillmann 
et  al,  1975). 
However,  in  contrast  to  the  importance  of  hexokinase 
in  the  metabolism  of  human  erythrocyte,  as  a  key  glycolytic 68 
enzyme  in  a  rather  simple  and  well  defined  human  cell, 
extensive  physicochemical  study  was  hindered  by  the  inabil- 
ity  to  isolate  the  enzyme  in  sufficient  quantity,  The 
best  previous  attempt  for  purifying  a  mammalian  erythro- 
cyte  hexokinase  was  that  of  Rijksen  and  Staal  (1976a)  from 
human  erythrocytes  that  led  to  rather  heterogeneous  mater- 
ial  with  a  yield-of  0.37  mg  and  a  specific  activity  of 
14  Units/mg  at  37°C.  One  of  the  major  difficulties  seems 
to  be  the  level  of  hexo1inase  activity  in  erythrocytes 
which  is  the  lowest  compared  with  the  rest  of  the  glyco- 
lytic  enzymes  (Newsholme  and  Start,  1973;  Chapman  et  al. 
1962;  Rapoport,  1968). 
The  initial  aim  of  this  project  was  to  develop  a  pur- 
ification  procedure  for  hexokinase  from  human  erythrocytes 
that  would  yield  sufficient  quantities  of  homogeneous 
material  in  order  to  undertake  physical  and  catalytic 
studies  of  the  enzyme.  In  order  to  overcome  the  limit- 
ation  of  low  hexokinase  activity  level,  the  present  research 
was  focussed  on  a  big  scale  purification  procedure  separat- 
ing  proteins  on  various  principles  with  the  best  possible 
efficiency.  This  line  of  investigation  unfortunately  did 
not  give  a  homogeneous  hexokinase  preparation  but  offered 
a  substantial  improvement  over  previous  reports  both  in 
yield  and  purity. 69 
(b)  Purification  procedure 
The  scheme  that  was  developed  for  the  purification  of 
hexok.  nase  from  human  erythrocytes  is  shown  diagrammatic- 
ally  in  Figure  3.1.  A  summary  of  the  purification  is  given 
in  Table  3,1.  Haemolysis  and  the  bulk  ion-exchange  steps 
were  carried  out  at  room  temperature  while  all  other  steps 
were  performed  at  4°C. 
Step  1.  Preparation  of  haemolysate. 
80  pints  of  blood  was  centrifuged  in  an  MSE  Mistral- 
6L  centrifuge  at  4°C  and  2,000  xg  for  10  min.  The  super- 
natant  plasma  and  buffy  coat  were  removed  by  suction.  Red 
cells  were  washed-three  times  with  equal  volumes  of 
0.91%  (v)  NaCl  +1  mM  K2EDTA  in  water  and  centrifuged  as 
previously.  The  cells  were  lysed  by  mild  shaking  with 
v 
equal  volumes  of  water  plus  5%  (v)  sulphur-free  toluene  in 
10  1  glass  bottles.  Lysis  was  complbte  after  20  minutes. 
The  lysate  was  centrifuged  at  2,000  xg  for  20  minutes  and 
the  upper  toluene  layer,  containing  most  of  the  cell  debris, 
was  sucked  off. 
Step  2.  '  Bulk  separation  on  DEAF  -  Sephadex  A-50. 
Half  of  the  above  haemolysate  was  diluted  with  water 
reducing  the  ionic  strength  from  0.15  in  the  erythrocyte 
to  0.05.  The  pH  of  this  solution  was  titrated  to  6.5  with 70 
Figure  3.1.  Purification  scheme  for  hexokinase  from  red 
cells 
Haemolysate 
DEAE-Sephadex  (Buchner) 
Phosphate  pH  =  6.5,  I=0.05 
Acetate  pH  =  5.8,  I=0.05  +  0.35  M  KCl' 
filtrate  eluate 
CM-Sophadex  (Buchner) 
Acetate  pH  =  5.8,  I=0.0125  +  0.0875  M  KC1 
Phosphate  pH  =  7.0,  I=0.1  +  0.3  M  KC1 
filtrate  eluate 
45-60%  saturated  ammonium  sulphate 
precipitate 
DEAE-Sephadex  (Column) 
Phosphate  pH  =  7.0,  I=0.1 
Gradient  0-Q.  3  M  KC1 
fractions 
P-11  Cellulose  (Column) 
Acetate  pH  =  5.8,  I=0.025  +  0.125  M  KC1 
Gradient  0-0.4  M  KC1. 
fractions 
G-200  Sephadex  (Column) 
Phosphate  pH  =  7.0,  I=0.1 
fractions 
40-55%  saturated  ammonium  sulphate 
precipitate 
Affinity  chromatography 
(Column) 
20  triM  Triethanolamine-HC1  pH  =  7.0 
Step-with  200  mM  glucose. 
fractions 
concentrate  at  4  mg/mi. .  71. 
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0.5  M  K2HPO4.  The  diluted-haemolysate  was  pumped  equally 
into  two  25  1  aspirators  and  allowed  to  flow  through  two 
24  cm  (i.  d.  )  Buchner  funnels,  each  containing  2  lt  of 
volume  of  DEAE-Sephadex  equilibrated  with  phosphate  buffer 
pH  =  6.5,  I=0.05.  A  constant  head  of  liquid  was  main- 
tained  on  the  funnel  by  a  level  control  (Pearce,  Ph.  D. 
Thesis,  1972)  and  the  filtrate  was  syphoned  away  without 
disturbing  the  funnel  and  the  resin.  The  flow  rate' 
through  each-Buchner  funnel  was  about  7  lt  per  hour.  Two 
thicknesses  of  Whatman  54  filter  paper  were  used  to  retain 
the  resin  and  one  was  placed  on  the  surface  as  an  anti- 
disturbance  disc.  The  resin  in  each  funnel  was  washed 
with  phosphate  buffer  pH  =  6.5,  I=0.05  until  the  filtrate 
was  colourless,  applying  mild  suction  after  the  last  wash. 
The  enzyme  was  eluted  with  acetate  buffer  pH  =  5.8, 
I=0.05  +  0.35  M  KC1,  using  2.5  lt  of  buffer  for  each 
Buchner  funnel,  the  resin  being  stirred  and  sucked  dry 
during  the  final  stages  of  the  elution.  The  eluate  was 
made  2  mM  in  6-aminohexanoic  acid  since  it  is  thought  to 
act  as  inhibitor  of  the  proteolytic  enzyme  plasmin  (Yoshida, 
1966).  The  solution  was  stored  at  4°C,  while  step  2  was 
repeated  during  the  next  day  on  the  second  half  of  the 
above  haemolysate.  A  total  of  300  g  of  DEAE-Sephadex"was 
used. / 
Step  3.  Bulk  separation  on  CM  -  Sephadex  C-50.73 
The  combined  eluates  from  the  DEAE-Sephadex  were  dilut- 
ed  with  water  to  decrease  the  ionic  strength  to  0.1.  The 
solution  was  titrated  to  pH=5.8  with  10%  acetic  acid.  It 
was  applied  as  before,  to  two  24  cm  Buchner  funnels  each 
containing  a  2.5  1  bed  volume  of  CM-Sephadex,  equilibrated 
with  acetate  buffer  pH=5.8,  I=0.0125  +  0.0875M  KC1.  The 
flow  rate  was  about  71  per  hour.  The  resin  was  washed 
with  10  lt  of  the  above  buffer  and  eluted  with  31  of 
phosphate  buffer  pH=7.0,  I=0.1  +  0.3M  KC1.  The  resin  was 
stirred  and  sucked  dry  in  the  final  stage  of  elution.  A 
total  of  150  g  of  CM-Sephadex  was  used. 
Step  4.  First  fractionation  with  ammonium  sulphate. 
To  each  1  of  eluate  277  g  of  ammonium  sulphate  were 
added  gradually  with  stirring-to  give  a  45%  saturation 
with  the  salt.  The  precipitate  was  allowed  to  form  on 
overnight  storage  at  4°C.  It  was  centrifuged  at  10,000  xg 
for  20  min  using  a  Sorvall  RC2-B  preparative  centrifuge. 
The  precipitate  was  discarded  and  the  supernatant  was  made 
60"%  saturated  in  ammonium  sulphate  by  addition  of  99  g  of 
the  salt  per  1.  The  precipitate  was  allowed  to  form  on 
storage  as  before.  The  suspension  was  centrifuged  as 
above.  The  supernatant  was  decanted  and  the  precipitate 
was  dissolved  in  a  small  volume  of  phosphate  buffer-pH=7.0, 
'I=0.1  and  dialysed  '  against  60  volumes  of  the  same  buffer'. 
The  dialysis  buffer  was  replaced  twice. 74 
Step  5.  Chromatography  on  DEAE  -  Sephadex  A-50 
Any  precipitate  remaining  after  dialysis  was  removed 
by  centrifugation  at  15,000  xg  for  10  minutes.  The  sol- 
ution  was  applied  to  a  30  x  2.5  cm  column  equilibrated 
with  phosphate  buffer  pH  =  7.0,  I=0.1.  A  linear  salt 
gradient  was  applied  using  two  identical  interconnected 
250  ml  vessels,  one  containing  the  above  phosphate  buffer;  - 
the  other  containing  the  phosphate  buffer  with  0.3  M  KC1 
added.  The  flow  rate  was  50  ml/hour  and  4  ml  fractions 
were  collected.  The  elution  profile  is  given  in  Figure  3.2. 
Fractions  were  pooled  as  shown  and  dialysed  against  25 
volumes  of  acetate  buffer  pH  =  5.8,  I=0.025  t  0.125  M  KC1 
with  three  changes  of  buffer. 
Step  6.  Chromatography  on  P-11  cellulose. 
Any  precipitate  remaining  after  dialysis  was  removed 
by  centrifugation  at  15,000  xg  for  10  minutes.  The  sol- 
ution  was  applied  to  a  30  x  2.5  cm  column.  The  resin  was 
equilibrated  with  acetate  buffer  pH  =  5.8,  I=0.025  + 
0.125  bi  KC1.  A  linear  salt  gradient  was  applied  using  two 
identical  interconnected  250  ml  vessels,  one  containing  the 
above  buffer  and  the  other  the  same  buffer  plus  0.4  M  KC1. 
The  flow  rate  was  70  ml/hour  and  4.5  ml'fractions  were 
collected.  The  elution  profile  is  given  in  Figure  3.3" 
Fractions  were  pooled  as  indicated  and  were  concentrated  to 75 
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Figure  3.2.  Elution  profile  from  DEAE-Sephadex  (Step 
(o-0)  Absorbance  at  280  nm;  (0--4)  Enzyme  activity. 
Fractions  of  4  ml  were  collected.  The  horizontal  line 
indicates  the  fractions  pooled  after  elution. ýý 
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Figure  3.3.  Elution  profile  from  P-11  cellulose  (Step  6) 
(C>--O)  Absorbance  at  280  nm;  (G-4)  Enzyme  activity. 
Fractions  of  4.5  ml  were  collected.  The  horizontal  line 
indicates  the  fractions  pooled  after  elution. 77 
2  ml  with  vacuum  dialysis  against  phosphate  buffer  pH  a  7.0, 
I-0.10 
Step  7.  Gel  filtration  on  Sephadex  G-200. 
The  dialysed  solution  was  centrifuged  at  15,000  xg 
for  10  minutes  to  remove  any  precipitate  and  was  applied 
to  a  150  x2  cm  column  of  Sephadex  G-200,  which  had  been 
equilibrated  with  phosphate  buffer  pH  =  7.0,  I=0.1.  The 
same  buffer  was  used  for  elution.  The  flow  rate  was  about 
7  ml/hour  and  4  ml  fractions  were  collected.  The  elution 
profile  is  shown  in  Figure  3.4.  Fractions  were  pooled  as 
indicated  and  concentrated  to  3  ml  with  vacuum  dialysis. 
_. 
Step  8.  Second  fractionation  with  ammonium  sulphate. 
The  concentrated  protein  solution  was  centrifuged  on 
-a  bench  centrifuge  for  10  minutes  to  remove  any  precipit- 
ate.  A  saturated  solution  of  ammonium  sulphate  was  added, 
dropwise  with  stirring,  to  give  a  faint  turbidity  which 
occurred  at  about  4O"%  saturation  with  ammonium  sulphate. 
After  leaving  the  suspension  for  3  hours  at  room  temper- 
ature,  it  was  centrifuged  as  above  and  the  precipitate  was 
discarded.  The  supernatant  was  made  55%  saturated  in 
ammonium  sulphate  in  the  same  way  as  before  and  left  for 
3  hours  at  room  temperature.  After  centrifugation  the 
precipitate  was  dissolved  in  4  ml  of  20  mM  Triethanolamine '78 
10  5 
E 
E  U) 
c  O.  $  4c 
OD  D 
N.  I 
""  0.6  I'3 
(D  u  cIt  C3, 
D0.4  412  a) 
oI1>, 
0,2 
1 
"1  C 
w 
0O 
20  40  60.80 
Fraction  number 
Figure  3.4+.  Elution  profile  from  gel-filtration  on  Sephadox 
G-200  (Step  7) 
(0-0)  Absorbance  at  280  nm;  (o--o)  Enzyme  activity. 
Fractions  of  4  nil  were  collected.  The  horizontal  line  ind- 
icates  the  fractions  pooled  after  elution. 
i . 
79 
buffer  pH  =  7.0  and  dialysed  against  1,000  volumes  of  the 
same  buffer  without  glucose  and  with  one-change. 
Step  9.  Affinity  chromatography. 
After  centrifugation  at  15,000  xg  for  10  minutes, 
the  sample  was  applied  to  a  column  18  x  2.8  cm  of  Sepharose 
4B  on  which  glucosamine  was  bound  with  the  aid  of  6-amino- 
hexanoic  acid  acting  as  spacer.  The  resin  was  equilibrated 
with  20  mM  Triethanolam.  nq-HU  buffer  pH  =  7.0  without 
glucose.  A  volume  of  125  ml  of  the  same  buffer  was  passed 
through  the  column  to  remove  proteins  not  bound  on  the 
resin.  With  the  subsequent  passage  of  2J0  ml  of  the  same 
buffer  plus  50  mM  KC1,  a  smaller  protein  peak  was  eluted. 
The  enzyme  was  eluted  specifically  with  buffer  containing 
200  mM  glucose.  The  flow  rate  was  adjusted  to  35  ml/hour 
with  a  peristaltic  pump  and  fractions  of  5.2  ml  were  coll- 
ected.  The  elution  profile  is  given  in  Figure  3.5.  The 
protein  content  of  the  fractions  with  hexokinase  activity 
was  very  low  and  could  not  be  detected  by  measuring  absorb- 
ance  at  280  nm.  Fractions  were  pooled  as  indicated  and 
concentrated  to  a  small  volume,  with  protein  concentration 
of  4  mg/ml,  by  vacuum  dialysis  against  phosphate  buffer 
pH  =  7.0,  I=0.1.  The  hexokinase  preparation  was  stored 
at  4°C  under  nitrogen. 80 
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(c)  Comments  on  the  purification  procedure 
'-ý  aý-", 
'ýý-. 
The  'cells  haemolised  represented  mainly  erythrocytes 
since  plasma  was  removed  by  successive  washings  of  the 
packed  red  cells  with  physiological  saline  and  leucocytes 
were  removed  by  sucking  off  the  buffy  coat  and  supernatant 
after  centrifugation  of  blood. 
. 
In  the  body,  erythrocytes  have  a  finite  life  span  of 
approximately  120  days  after  which  they  are  removed  from 
circulation  by  the  reticuloendothelial  system.  So  erythro- 
cytes  in  blood  represent  all  ages  from  0  to  120  days.  In 
the  out  of  date  transfusion  blood  used  in  this  purification 
the  youngest  cells  are  21  days  old.  It  has  been.  shown  that 
the  activity  of  some  enzymes  including  hexokinase  deterior- 
ated  with  senescence,  the  half-life  time  for  hexokinase 
being  21  days.  (Chapman  and  Schaumberg,  '  1967).  The  level. 
of  this  enzyme  in  mature  erythrocytes  represented  an  esti- 
mated  2-3%  (Rogers  et  al,  1975a)  or  a  measured  14% 
(Chapman 
and  Schaumberg,  1967)  of  the  ret'iculocyte  activ- 
ity  (young 
erythrocytes,  0-2  days  old  containing  reticulum 
and  thus  having  the  potential  to  synthesize  some  proteins). 
These  facts  explain  the  low  specific  activity  for  hexokin- 
ase  found  in  haemolysates  of  this  purification  e.  g.  9.0002 
units/mg  at  25°C.  This  is  near  the  values  found  in  haemo- 
lysates  by  other  investigators  e.  g.  0.00042  units/mg 
(assay  at  37°C)  by  Gerber  et  al.,  19711.  and  0.00047  units/mg 82 
-assay  at  37°C)  by  Rijksen  and  Staal,  1976a. 
The  following  experiment  suggested  that  significant 
amounts  of  particulate  hexokinase  were,  not  present.  Equal 
volumes  of  packed  erythrocytes  and  phosphate  buffer  pH=7.0, 
I-0.02  were  mixed  and  haemolysis  was  complete  in  30  min- 
utes  at  room  temperature  with  mild  agitation.  The  haemo- 
lysate  was  centrifuged  for  20-minutes  at  27,000  xg  and 
the  pellet  was  divided  and  suspended  with  one  volume  of 
water  and  one  volume  of  acetate  buffer  pH  =  5.6,  I=0.1 
"  containing  0.2  M  MgC12'respectively.  After  30  minutes 
incubation  at  4°C  the  suspensions  were  centrifuged  as 
above.  With  both  extraction  buffers,  the  enzyme  activity. 
found  in  the  supernatant  represented  3-4%  of  that  found 
in  the  supernatant  of  haemolysate.  A  second  extraction. 
of  the  pellet,  as  described  above,  did  not  yield  any  enzyme 
activity.  It  seems  that  there  is  no  firmly  bound  partic- 
ulate  hexokinase  and  that  the  small  activity  found  in  the 
first  extraction  represented  hexokinase  entrapped  in  the 
pellet. 
The  procedure  developed  for  the  purification  of 
erythrocyte  hexokinase  makes  use  of  differences  between 
the  enzyme  and  other  erythrocyte  proteins  on  such  prop- 
erties  as  positive  and  negative  charges,  solubility  in 
presence  of  salt,  molecular  size  and  specificity  for 
immobilized  glucosamine. "  83 
The  initial  DEAE-Sephadex  step  was  designed  for  the 
removal  of  haemoglobin  that  constituted  the  bulk  of  protein* 
(4  Kg)  present  in  the  haemolysate.  Although  protein  meas- 
urements  were  not  made  after  the  DEAE-Sephadex  step  because 
of  the  high  readings  at  260  nm,  only  11g  were  left  after 
the  subsequent  CM-Sephadex  (Buchner)  step. 
Both  the  initial  DEAF  and  CM-Sephadex  steps  were  per- 
formed  as  stepwise  arrangements  on  Buchner  funnels  for  the 
faster  removal  of  the  bulk  of  protein  and  for  ease  of 
handling  large  volumes-of  haemolysate  and  DEAF-Sephadex 
eluate.  These  volumes  would  be-difficult  to  dialyse  and 
1 
so  the  reduction  in  ionic  strength  was  achieved  by  dil- 
ution.  Effective  resolution  on  the  resins  -gras  obtained 
by  later  steps  in  the  preparation. 
In  the  presence  of  10  mM  glucose,  0.1%  (v/v)  2-merc- 
aptoetha.  nol  and  1  mM  EDTA,  25%  of  enzyme  activity  was  lost 
on  the  CM-Sephadex  step.  If  glucose  and  2-mercaptoethanol 
were  not  incorporated  in  the  buffers  the  loss  was  sharply 
increased  to  70%.  In  contrast  to  this,  the  absence  of 
glucose  and  2-mercaptoethanol  had  no'effect'in  the  recov- 
ery  from  the  initial  DEAE-Sephadex  step  (90%).  Glucose  is 
known  to  stabilize  mammalian  hexokinases  against  inactiv- 
ation  by  heat  and  proteolysis  (Grossbard  and  Schimke,  1966; 
Wilson,  1978)'  and  sulfhydryl  reagents  (Redkar  and  Kenkare, 
1975;  Chou  and  Wilson,  1974). 84 
The  fractionation  with  ammonium  sulphate  (Step  4) 
concentrated  the  protein  solution  for  subsequent  chromato- 
-graphy  and  gave  a  2.5  fold  purification. 
Hexokinase  behaved  as  a  single  peak  in  both  anion  (Step 
5)  and  cation  (Step  6)  column  chromatographic  steps.  On 
Whatman  P-11  cellulose  'the  hexokinase  activity  peak  was 
rather  broad.  Before  deciding  on  Whatman  P-11  cellulose 
as  the  best  cation  exchanger  this  resin  was  compared  with, 
CM-Sephadex*C-50  and  CM  Bio-Gel  A.  All  were  equilibrated 
with  acetate  buffer  pH  =  5.8,  I=0.01  containing  0.05  M 
KCl.  Hexokinase  was  eluted  with  a  500  ml  linear  salt  grad- 
ient  of  0-0.4  M  KCl.  In  all  three  experiments  a  single 
enzyme  peak  was  obtained  but  the  specific  activities  of  the 
recovered  hexokinase  were  1/3-for  the  CM-Sephadex  C-50  col- 
umn  and  2/3  for  the  CM  Bio-Gel  A  column  of  the  enzyme's 
specific  activity  from  the  Whatman  P-11  cellulose  column. 
The  recoveries  were  similar.  One  peak  of  activity  was 
also  obtained  with  the  anion  exchange  DEAF  Bio-Gel  A  with 
the  same  recovery  and  specific  activity  as  with  the  hexo- 
kinase  from  the  DEAE-Sephadex  A-50  column. 
The  effect  of  the  second  fractionation  with  ammonium 
sulphate  (Step  8)  on  purification  ranged  from  a  factor  of 
1  to  1.5  and  could  be  omitted. 
Sephadex  G-200  gel  filtration  and  the  affinity  chrom- 
atography  were  left  to  the  end  of  the  purification 85 
procedure  for  best  effect  i.  e.  enhanced  resolution  in  gel- 
filtration  and  less  non-specific  binding.  on  affinity  chrom-. 
atography.  The  gel  filtration  revealed  size  heterogeneity 
with  protein  species  mainly  of  bigger  size  than  that  of 
hexokinase.  The  affinity  step  was  the  most  effective, 
offering  a  ten-fold  purification  and  thus  raising  the 
purification  factor  from  17,000  to  170,000. 
(d)  Conclusions 
The  purification  procedure  developed  for  human  eryth- 
rocyte  hexokinase  contains  9  steps  and  lasts  for-less  than 
three  weeks.  Beginning  with  80  pints  of  blood,  3  mg  of 
protein  was  recovered  with  a  specific  activity  of  37  units/ 
mg.  The  overall  yield  was  rather  low  (12%)  and  the  over- 
all  purification  high  (170,000).  S 
From  experiments  reported  in  Chapter  8,  it  is  obvious 
that  the  material  is-still  impure.  From  evidence  as  the 
specific  activity  and  SDS  electrophoresis.  it  seems  that  a 
"2  to  3  fold  purification  is  still  needed  for  the  isolation 
of  the  enzyme.  Since  the  quantity  of  purified  protein  was 
small  and  the  obvious  purification  techniques  were  exhaust- 
ed,  no  attempt  for  further  purification  of  the  enzyme  was 
made. 
Two  previous  purifications  bf  mammalian  erythrocyte 
hexokinase  are  reported,  both  for  the  human  enzyme  (Table 86 
3.2).  An  improvement  was  made  over  the  best  of  them 
(Rijksen  and  Staal,  1976a)  for  the  following  reasons.  The 
procedure  was  scaled  up  for  dealing  from  approximately 
1  pints  of  blood  to  80  by  solving  technical  problems  in- 
volved  in  big  scale  laboratory  preparations.  Cation  ex- 
change  steps  were  added  for  the  removal  of  some  negative- 
ly  charged  proteins.  These  factors  resulted  in  3  mg  of 
protein  with  a  specific  activity  of  37  units/mg  (25°C)  com- 
pared  with  0.4  mg  of  protein  with  specific  activity  of  14 
units/mg  (37°a). 
This  preparation  suggests  that  the  low  hexokinase  act- 
ivity  in  haemolysates  is  due  to  low  levels  of  protein  - 
.  rather  than  a  low  specific  activity.  Further-purification 
would  be  required  for  sufficient  material  to  study  the 
physical  properties  of  erythrocyte-hexokinase.  Such 
attempts  would  demand  larger  amounts  of  starting  material 
and  some  improvement  in  the  recoveries  and  resolutions  for 
the  purification  steps. s 
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CHAPTER  4+ 
Placental  hexokinase. 
(a)  Introduction 
Placenta  was  used  as  a  readily  obtainable  tissue  of 
interest  as  a  source  of  human  foetal  material.  As  no 
other  attempted  isolation  of  hexokinase  from  such  a  source 
has  been  reported,  this  preliminary  isolation  is  mentioned 
although  it  was  only  carried  out  on  small-scale  pilot 
experiment. 
(b)  Purification  procedure 
The  scheme  used  for  the  partial  purification  of  hexo- 
kinase  from  human  term  placenta  is  shown  diagrammatically 
in  Figure  4.1.  A  summary  of  the  above  purification  is  giv- 
en  in  Table  4.1.  All  steps  were  carried  out  at  4°C. 
Step  1.  Solubilization  of  hexokinase 
One  placenta  was  left  to  thaw  out  at  4°C.  A  quantity 
of  50  gr  of  tissue  was  homogenised  with  two  volumes  of 
chilled  phosphate  buffer  pH  =  7.0,  I=0.02  in  a  Waring 
blender  for  four  20  second  intervals  at  full  speed.  The 89 
Figure  4.1.  Purification  scheme  for  hexokinase"from  term 
,  placenta 
Homogenate 
Solubilization 
Acetate  pH  =  5.6,  I=0.1  +  0.2  M  MgC12 
solution 
Dialysis 
Phosphate  pH  =  8.0,  I=0.1 
solution 
DEAE-Sephadex  (Column) 
Phosphate  pH  =  8.0,  I=0.1 
Gradient  0-0.4  M  KC1 
fractions 
P-11  cellulose  (Column) 
Acetate  pH  =  5.8,  I=0.025  +  0.125  M  KC1 
Gradient  0'-  0.4  M  KC1 
fractions 
Sephadex  G-200  (Column) 
Phosphate  pH  =  7.0,  I=0.1 
fractions 9o 
Table  4.1.  Summary  of  procedure  for  purification  of  hexokin- 
ase  from  term  placenta 
Step  Volume  Protein  Activity  Specific  Yield 
Activity 
ml  mg  Units  Units/mg  % 
. 
'I.  Solubilization  109  *  -.  39  -  100 
2.  Dialysis  109 
. 
1.01x103  34.5  0.034  89 
3.  DEAF-Sephadex  265  167  31.8  0.19  82 
4.  P-11  cellulose  111  14.3  21.5  1.5  55 
5.  Sephadex  G-200  59  1.9  16;  1  8.5  41 
*  The  extract  was  turbid  and  the  initial  estimate  of  protein 
concentration  was  unreliable. 91 
homogenate  was  centrifuged  for  20  minutes  at  35,000  x  g. 
The  supernatant  was  decanted  and.  the  pellet  was  mixed  with 
2  volumes  of  acetate  buffer  pH  =  5.6,  I=0.1  containing 
0.2  M  MgCl2  and  homogenised  as  before.  The  suspension  was 
left  to  stand  for-45  minutes  and  centrifuged  as  above. 
Step  2.  Dialysis. 
The  pellet  was  discarded  and.  the  supernatant  was  dial- 
=  ysed  against  30  volumes  of  phosphate  buffer  pH  =  8.0,1 
0.1  with  2  changes.  A  heavy  precipitate  was  formed,  that 
was  removed  by  centrifugation  at  10,000  xg  for  20  minutes. 
Steg  Chromatography  on  DEAE-Sephadex  A-50. 
The  supernatant  was  applied  to  a  21  x  2.5  cm  column 
equilibrated  with  phosphate  buffer  pH-8.0,1=0.1..  A  linear. 
salt  gradient  was  applied  using  two  identical  interconnected 
250  ml  vessels,  one  containing  the  phosphate  buffer  pH=8.0, 
I=0.1,  the  other  containing  the  same  buffer  plus  0.4  M  KCI. 
The  flow  rate  was  30  ml/hour  and  4.5  ml  fractions  were  coll- 
ected.  The  elution  profile  is  given.  in  Figure  4.2.  Fract- 
ions  were  pooled  as  shown  and  were  dialysed  against  25  vol- 
umes  of  acetate  buffer  pH-5.8,  I=0.025  containing  0.125  M 
KC1  with  one  change  of  buffer. 
Step  4.  Chromatography  on  P-11  Cellulose. 
The  dialysed  solution  was  centrifuged  at  159000x  g  for 
10  minutes  to  remove  any  precipitate  formed  during  dialysis 
and  was  applied  to  a  17x2.5  cm  column  equilibrated  with 
acetate  buffer  pH=5.8,  I=0.025#0.125  M  KCl.  A  linear  gradient 
was  applied  using  two  identical  interconnected  250  ml  vessels, 92 
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Figure  4.2.  Elution  profile  from  DEAE-Sephadex  (Step  3) 
(0-0)  Absorbance  at  280  nm;  (0-9i)  Enzyme  activity. 
Fractions  of  4.5  ml  were  collected.  The  horizontal  line 
indicates  the  fractions  pooled  after  elution. "  93 
one  containing  the  acetate  buffer  and  the  other  the  same 
buffer  plus-0.4  M  KC1.  The  flow  rate  was  50  ml/hour  and 
4.8  ml  fractions  were  collected.  The'elution  profile  is 
given  in  Figure  4.3.  Fractions  were  pooled  as  shown  and 
were  concentrated  by  vacuum  dialysis  to  1.6  ml  and  dial- 
ysed  against  500  volumes  of  phosphate  buffer  pH  -  7.0, 
I=0.1  with  one  change  of  buffer. 
Step  5.  Gel  filtration  on  Sephadex  G-200. 
The  dialysed  solution  was  centrifuged  at  15,000  xg 
for  10  minutes  to  remove  any  precipitate  formed  during 
dialysis  and  was  applied  to.  a  150  x2  cm  column.  of  Sephadex 
G-200  which  had  been  equilibrated  with  phosphate  buffer 
pH  =  7.0,  Io0.1.  The  same  buffer  was  used  for  elution. 
The  flow  rate  was  7  ml/hour  and  4  ml  fractions  were  coll- 
ected.  The  elution  profile  is  shown  in  Figure  4.4.  Frac- 
tions'were  pooled  as  indicated  and  concentrated  by  vacuum 
dialysis  to  a  small  volume. 
(c)  Comments  on  the  purification  procedure 
The  extraction  of  50  g  of  placental  tissue  with  phos- 
phate  buffer  pH  =  7.0,  I=0.02  gave  15  units  of  enzyme 
activity  in  the  supernatant.  Subsequent  two  extractions. 
with  acetate  buffer  p11  =  5.6,  I=0.1  with  0.2  M  MigC12 
gave  39  and  12  units  of  enzyme  activity  respectively. . 
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Figure  4.3.  Elution  profile  from  P-11  cellulose  (Step  4) 
(0-0)  Absorbance  at  280  nm;  (0---4)  Enzyme  activity. 
Fractions  of  4.8  ml  were  collected.  The  horizontal  line 
indicates  the  fractions  pooled  after  elution. 95 
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Figure  4.4.  Elution  profile  from  gel-filtration  on  Sephadex 
G-200  (Step 
(O-O)  Absorbance  a  t  280  nm;  (ß-"o)  Enzyme  activity. 
Fractions  of  4  ml  w  ere  collected.  The  horizontal  line  indi- 
cates  the  fractions  pooled  after  elution. 96 
This  is  an  indication  that  most  of  the  placental  hexokin- 
ase  is  of  the  particulate  form  and  that'an  increased  salt 
concentration  is  needed  for  its  extraction.  The  tissue  was 
not  perfused,  only  drained  of  blood,  but  the  contribution 
of  erythrocyte  hexokinase  should  be  minimal  because  of  its' 
low  specific  activity.  Placenta  under  the  conditions  men- 
tioned  is'at  least  six  times  richer  in  hexokinase'than 
erythrocytes  if  the  total  activity  recovered  as  above  is 
expressed  peng  fresh  tissue  and  compared  with  the  erythro- 
cyte  hexokinase  activity  expressed  per  g  of  haemoglobin. 
The-proportion  of  hexokinase  activity  found  in  tjie  super- 
natant  of  homogenate  as  compared  to  the  sum  of  'enzyme  act- 
ivity  extracted  with  MgCl2  is  within  the  range  of  20-30% 
of  hexokinase  activity  found  in  the  cytoplasmic  supernatant 
of  human  term  placentas  by  Gustke  and.  Kowalewski  (1975)" 
.  The  freezing  of  the  tissue  at  -25°C  and  thawing  possibly 
does  not  increase  the  soluble  activity  but  exposes  latent 
activity  (also  released  by  salts)  as  was,  found  to  be  the 
case  for  rat  brain  hexokinase  (Wilson,  "1967,1968;  Teichgräber 
and  Biesold,  1968). 
The  purification  procedure  followed  was  that  used  for 
the  purification  of  porcine  heart  hexokinase  on  a  large 
scale  by  Eastorby  and  O'Brien  (1973)  with  the  following 
minor  modifications.  The  P-11-cellulose  resin  was  equili- 
brated  with  acetate  buffer  pH  =  5.8,  I=0.025  containing "  97 
0.125  M  KC1  instead  of  phosphate  buffer  pH  I=0.05 
and  the  salt  gradient  was  0-0.3-M  KC1  instead  of  0-0.4  M 
KCl.  Also  the  G-200  Sephadex  resin  was  equilibrated  with 
phosphate  buffer  pH  -  7.0,  I=0.1  instead  of  phosphate 
buffer  pH  =  8.0,  I=0.1  and  the  gradient  volume  for  DEAE- 
Sephadex  chromatography  was  500  ml  instead  of  2  lt. 
All  three  chromatographic  steps  showed  a  purification 
factor  of  6  to  8.  The  low  specific  activity  of  the  dial- 
ysed  extract  indicate  that  placenta  is  a  poor  tissue  for 
providing  pure  material,  using  the  above  procedure. 
ýdý  Conclusions 
Hexokinase  was  purified  at  least  200-fold  from  human 
placenta  with  5  steps  in  9  days  to.  a  specific  activity  of 
. 
8.5  units/mg.  The  only  previous  report  for  purification  of 
hexokinase  from  placenta  is  a  15-fold  purification  from 
human  term  placenta  by  Gustke  (1975). 
No  further  purification  of  hexokinase  was  pursued 
from  this  tissue  since  hexokinase  from  heart  purified  with 
the  same  small  scale  procedure  gave  a  better  final  specific 
activity  of  20  units/mg  and  thus  the  investigation  was 
transferred  to  the  heart  enzyme 
(Chapter  5). ""/"-" 
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CHAPTER  5 
Heart  hexokinase. 
(a)"  Introduction 
Cardiac  muscle  is  a  tissue  richer  in  hexokinase  than 
erythrocytes.  Although  it  contains  less  hexokinase  than 
brain,  heart  has  a  high  percentage  of  soluble  enzyme 
(Wilson  and  Feigner,  1977)  and  it  is  a  tissue  that  is 
easily  disrupted  and  has  a  low  lipid  content.  From  pre- 
vious  reports  human  heart  should  contain  only  one  iso- 
enzyme,  HKI  (Neumann  at  al.,  1974;  Rogers  at  al.,  1975b)" 
Easterby  and  O'Brien  (1973)  obtained  pure  enzyme 
from  porcine  hearts,  in  sufficient  quantity  for  physico- 
chemical  studies.  The  only  previous  purification  of  hexo- 
kinase  from  human  heart  did  not  give  material  of  high 
purity  in  sufficient  yield  (Neumann  et  al.,  19711)"" 
With  the  purification  procedure  presented  here,  25  mg 
of  well  characterized  protein  was  recovered  from  1.15  Kg 
of  human  heart  tissue. 
(b)  Purification  procedure 
The  scheme  that  was  developed-for  the  purification 
of  hexokinase  from  human  heart  is  shown  diagrammatically 99 
in  Figure  5.1.  A  summary  of  the.  above  purification  is 
given  in  Table  5.1.  All  steps  were  carried  out  at  4°C 
except  the  bulk  separation  on  DEAE-Sephadex. 
Step  1.  Preparation  of  homogenate. 
Refrigerated  hearts  were  left  to  thaw  at  40C.  Adj- 
acent  fat  and  connective  tissue  was  removed.  The  muscle 
was  cut  into  small  pieces  and  minced.  A  quantity  of 
1.15  Kg  of  minced  tissue  was  homogenised  with  three  vol- 
umes  of  chilled  phosphate  buffer  pH  =  7.5,  I=0.02  in  a 
Waring  blender  for  four  20  second  intervals  in  full  speed. 
The  homogenate  was  centrifuged  in  a  Sorvall  RC2-B  prepar- 
. 
ative  centrifuge  for  15  minutes  at  6,000  x  g..  The  pellet 
was  extracted  once  more  with  three  volumes  of  the  same 
buffer  and  centrifuged  as  above.  The  supernatants  of  both 
-extractions  were  pooled  and  passed  through  glass  wool  to 
remove  floating  lipid. 
Step  2.  Bulk  separation  on  DEAE  -  Sephadex  A-50. 
The-pH  of  the  protein  solution  was  about  6.0  and  was 
titrated  to  6.5  with  0.5  M  K2HPO4.  The  solution  was  div- 
ided  into  two  halves  and  allowed  to  flow  under  gravity 
through  two  24  cm  Buchner  funnels,  each  containing  a.  2  lt' 
bed  volume  of  DEAF-Sephadex  equilibrated  with  phosphate 
buffer  pH-=  6.5,1  =  0.05.  The  flow  rate  through  each "  100 
Figure  5.1.  Purification  scheme  for  hexokinase  from  heart 
Homogenate 
" 
DEAE-Sephadex  (Buchner) 
Phosphate  pH  -  6.5,  I=0.05 
Phosphate  pH  =  6.5,  I=0.1  +  0.3  M  KC1 
filtrate  eluate 
45-65%  saturated  ammonium  sulphate 
precipitate  - 
DEAE-Sephadex  (Column) 
Phosphate  pH  =  7.0,  I-0.1 
Gradient  0-0.3  M  KC1 
fractions 
P-11  cellulose  (Column) 
Acetate  pH  =  5.8,  I=0.025  +  0.125  M  KC1 
Gradient  0-0.4  M  KC1 
fractions 
Affinity  chromatography  (Column) 
20  mM  Triethanolamine-HC1  pH  -  7.0 
00  Step  with  200  mM  glucose. 
fractions 
"  Concentrate  at  8  mg/ml. 
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Buchner  funnel  was  about  5.  litres-per  hour.  The  resin  in 
each  funnel  was  washed  with  the  above  buffer  until  the 
:  filtrate  was  colourless,  applying  mild-suction  during  the 
final  washes.  The  enzyme  was  eluted-with  phosphate  buffer 
pH  =  6.5,  I=0.1  plus  0.3  M'KC1  using  2.5  lt*of  buffer 
for  each  Buchner  funnel,  the  resin  being  stirred  and  sucked 
dry  during  the  final  stages  of  elution.  The  total  weight 
of  dry  resin  used  was  150  g.  - 
Step  3.  Fractionation  with  ammonium-sulfate. 
To  each  litre  of  eluate  277  g  of  ammonium  sulfate 
were  added  to  give  a.  45/  saturation  with  the  salt.  The 
precipitate  was  allowed  to  form  on  overnight  storage. 
The  suspension  of  the  45%  saturated  ammonium  sulfate  was 
centrifuted  at  10,000  xg  for  20  minutes  using  a  Sorvall 
RC2-B  centrifuge.  The  precipitate  was  discarded  and  the 
supernatant  was  made  65/  saturated  in  ammonium  sulfate  by 
the  addition  of  134  g  of  salt  per  '1  of  solution.  The 
precipitate  was  allowed  to  form  on  storage  and  the  suspense 
ion  was-centrifuged  as  above.  The  supernatant  was  discard- 
ed  and  the  precipitate  was  dissolved  in  phosphate  buffer 
pH  =  7.0,  I_0.1  and  dialysed  against  60  volumes  of  the 
same  buffer.  The  dialysis  buffer  was  replaced  once.  - 
Step  4.  Chromatography  on  DEAF  -  Sephadex  A-50. 
Any  precipitate  remaining  after  dialysis  was  removed 
k "  103 
'  by  centrifugation  at  15,000  xg  for  10  minutes.  The  sol- 
ution  was  applied  to  a  30  x  2.7  cm  column  equilibrated 
with  phosphate  buffer  pH  =  7.0,  I=0.1.  A  linear  salt 
gradient  was  applied  using  two  identical  interconnected 
250  ml  vessels,  one  containing  the  phosphate  buffer 
pH  =  7.0,  I=0.1,  the  other  containing  the  same  buffer 
plus  0.3  M  KC1.  The  flow  rate  was  30  ml/hour  and  5  ml 
fractions  were  collected.  The  elution  profile  is  given  in 
Figure  5.2.  Fractions  were  pooled  as'shown  and  were  dial- 
ysed  against  60  volumes  of  acetate  buffer  pH  -  5.8,  I- 
0.15  with  two  changes. 
Step  5.  Chromatography  on  P-11  cellulose. 
The  dialysed  solution  was  centrifuged  at  15,000  xg 
for  10  minutes  to  remove  any  precipitate  formed  during 
dialysis  and  was  applied  to  a  30  x  2.7  cm  column  equili- 
brated  with  acetate  buffer  pH  =  5.8,  I=0.025  +  0.125  M 
KC1.  A  linear  gradient  was  applied  using  two  identical 
interconnected  250  ml  vessels,  one  containing  the  above 
acetate  buffer  and  the  second  containing  the  same  buffer 
plus  0.4.  M  KC1.  The  flow  rate  was  50  ml/hour  and  5  ml 
fractions  were  collected.  The  elution  profile  is  given  in 
Figure  5.3.  Fractions  were  pooled  as  shown  and  were.  conc- 
entrated  with  vacuum  dialysis  to  10  ml  and  dialysed  against 
300  volumes  of  20  mM  Triethanolamine-HC1  buffer  pH  =  7.0, lo4 
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Figure  5.2.  Elution  profile  from  DEAE-Sephadex  (Step  4) 
(o-o)  Absorbance  at  280  nm;  (0"-.  )  Enzyme  activity. 
Fractions  of  5  ml  were  collected.  The  horizontal  line  indi- 
cates  the  fractions  pooled  after  elution. ý' 
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Figure  5.3.  Elution  profile  from  P-11  cellulose  (Step  5) 
(0-0)  Absorbance  at  280  nm;  (a-G)  'Enzyme  activity. 
Fractions  of  5  ml  were  collected.  The  horizontal  line 
indicates  the  fractions  pooled  after  elution. 
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without  glucose.  The  dialysis  buffer  was  replaced  once. 
Step  6.  Affinity  chromatography. 
The  dialysed  solution  was  centrifuged  at  15,000  xg 
for  10  minutes  to  remove  any  precipitate  and  the  solution 
was  applied  to  a  19  x  2.6  cm  affinity  column  containing 
immobilised  glucosamine  on  Sepharose  4B.  The  resin  was 
equilibrated  with  20  mM  Triethanolamine-HC1  buffer  pH 
7.0.  A  volume  of  125  ml  of  the  same  buffer  was  used  to 
wash  out  proteins  not  bound  on  the  resin.  The  subsequent 
passage  of  160  ml  of  the  same  buffer  containing  50  mM  KC1 
J 
released  a  protein  peak.  Finally  the  hexokinase  activity. 
peak  was  eluted  with  the  previous  buffer  containing  200  mM 
.  glucose.  The  elution  profile  is'given  in  Figure  5.4.  The 
flow  rate  was  adjusted  to  35  ml/hour  with  a  peristaltic 
pump  and  4.6  ml  fractions  were  collected.  Fractions  of 
hexokinase  activity  were  pooled  as  shown  and  were  conc-_ 
entrated  with  vacuum  dialysis  to  a  small  volume  with  a 
protein  concentration  of  about  8  mg/ml  and  dialysed  against 
300  volumes  of  phosphate  buffer  pH.  =  7.0;  I=0.1.  The 
enzyme  was  stored  at  0-4°C  under  nitrogen. 
(c)  Comments  on  affinity  chromatography 
The  affinity  'of  an  enzyme  to  a  ligand  is  altered  upon 
the  immobilization  of  the  latter.  Reasons  for  this  change 
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Figure  5.4.  Elution  profile  from  the  affinity  chromato- 
graphy  (Step  6) 
(0-0)  Absorbance  at  280  nm;  (e-O)  Enzyme  activity. 
Fractions  of  4.6  ml  were  collected.  The  horizontal  line 
indicates  the  fractions  pooled  after  elution. 
A:  20  mM  Triethanolamine-HC1  buffer  pH  7.0 
B:  Buffer  A  with  50  mM  KC1  added 
C:  Buffer  B  with  200  mM  glucose  added. 108 
are  the  chemical  modification  of  the  ligand  for  its  binding 
on  the  insoluble  matrix  and  its'  steric  availability  to 
the  enzyme.  Other  factors  affecting  the  affinity  are  dir- 
@ttly  related  to  the  ligand  and  enzyme  stich  as:  the  temp- 
iDrature  (Harvey  at  al.,  1974b),  the  pH  (Lowe  et  al., 
1974a),  the  ionic  strength  and  hydrophobicity  of  the  liquid 
phase  (Lowe  and'Mosbach,  1975).  the  geometry  of  the  column, 
the  input  flow  rate  of  the  enzyme  solution  (Lowe  et  al., 
1974b),  and  the  concentration  of  the  immobilized  ligand  in 
the  resin  (Harvey  et  al.,  1974a;  Holroyde  et  al.,  1976a). 
The  response  of  hexokinase  from  various  sources  to 
immobilized  mucleotide  and  glucose  derivatives  is  summar- 
ized  in  Table  5.2.  Glucosamine,  is  phosphorylated  by 
brain  hexokinase  while  N-acetylglucosamine  is  not  phospho- 
rylated  and  acts  as  a  competitive  inhibitor  of  this  enzyme 
with  respect  to  glucose  (Harpur  and  Qüastel,  1949; 
Bachelard  et  al.,.  1971).  The  derivative  N-(6-Aminohexan- 
oyl)-2-amino-2-deoxy-D-glucopyranose  was  found  to  be  a 
competitive  i  hibitor  of  rat  liver  glucokinase  versus  gluc- 
ose  (Ki  =  0.75  MM)  by  Holroyde  et  al.  9(19764.  Glucosamine 
bound  directly  to  Sepharose  had  no  affinity  for  liver 
glucokinase  (Holroyde  et  al.,  1976a).  However  the  inter- 
position'of  a  six  carbon  spacer  arm  promoted  binding  of 
both  rat  liver  glucokinase  (Holroyde  et  al.,  1976b)  and 
rat  skeletal  muscle  HK  II  (Holroyde  and  Trayer,  1976),  and 
so  allowed  the  isolation  of  these  two  enzymes. VIO 
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A  resin  prepared  by  coupling-glucosamine  to  activated 
CH-Sepharose  4B  (Sepharose  4B  with  a  six-carbon  spacer 
-arm) 
helped  in  the  purification  of  human  erythrocyte  hexo- 
kinase  by  retardation  of  hexokinase  activity  towards  the 
bulk  of  the  proteins  of  the  enzyme  sample  applied  (Rijksen 
and  Staal,  1976x). 
Trayer  et  al.  (1974)  comment  that  hexokinase  (with 
low  Km  for  glucose)  from  rat  liver.  binds  to  immobilized 
N6-(6-aminohexyl)-ADP,  and  not  to  immobilized  8-(6-amino- 
hexyl)-amino-ADP.  In  contrast,  glucokinase  binds  to  both 
nucleotides 
(Trayer  et  al.,  1974).  This  suggests  that  the 
binding  of  hexokinase  to  these  nucleotides  is  weak  and  dep- 
ends  on  the  mode  of  attachment  to  the  matrix. 
Interaction  of  human  heart  and  erythrocyte  hexokinase  with 
immobilized  glucosamine  - 
The  preparation  of  an  affinity  resin  using  Sepharose 
1+B,  6-aminohexanoic  acid"(as  spacer)  and  glucosamine  (as 
the  ligand)  is  described  in  Chapter  2.  Pilot  experiments 
were  performed  by  using  small  columns  (10  x  0.8  cm)  equili- 
brated  with  20  mM  Triethanolamine-11C1  buffer  pH  =  7.0  con- 
taining  7.5  mM  MgC121  1  mM  EDTA,  0.1%  (v/v)  2-mercaptoeth- 
anol,  5°;  (v/v)  glycerol  and  50  mM  KC1  at  4°C.  The  flow 
rate  was  kept  constant  at  1.0  ml/hour.  About  1.5  units  of 
purified  heart  hexokinase  in  1  ml  of  the  above  buffer  was 
S. "0 
.  111 
applied  on  a  column,  No  activity  passed  through  in  5  bed 
volumes  of  washing  solution.  Application  of  a  60  ml  linear 
gradient  0-0.3  M  KC1  eluted  a  single  peak  corresponding  to 
a  KC1  concentration  of  150  M.  Leaking  of  enzyme  activity 
began  at  100  mM  KC1.  Alternatively  hexokinase  was  eluted 
with  a  pulse  of  200  mM  glucose;  The  latter  method  of  elution 
was  adopted  for  its  better  recovery  and  for  its  specificity. 
Non  specific  binding  was  tested  by  using  resin  coupled 
to  6-aminohexanoic  acid  alone  (without  further  attachment 
of  glucosamine).  The  conditions  of  the  experiment  perform- 
ed  on  this  resin  were  as  those  used  for  the  normal  affin- 
ity,  step  for  the  purification  of  heart  hexokinase,  and  the 
hexokinase  preparation  used  was  that  recovered  from  the  pre-' 
ceding  step.  This  control-resin  did  not  retain  any  hexokin- 
ase  activity  and  no  improvement  of  the  specific  activity 
was  obtained. 
The  affinity  resin  interacts  specifically  with  both 
the  heart  and  the  erythrocyte  enzyme,  as  can  be  seen  from 
the  facts  that  both  enzymes  bind  on  the  resin,  are  eluted 
with  glucose  and  that  at  least  one  of  them  (heart)  does 
not  interact  with  the  matrix  and  the  spacer.  However  this 
resin  lacks  chemical  characterization,  as  compared  with 
resin  prepared  by  Holroyde  et  al.  (1976a),  that  is  by 
coupling  of  pre-synthesized  N-(6-Aminohexanoyl)-2-amino-2- 
deoxy-D-glucopyranose  to  activated  Sepharose  4B.  However 
the  relatively  complicated  and  time  consuming  presynthesis 112 
of  the  glucosamine  derivative  was-avoided  with  the  present 
method. 
The  effectiveness  of  the  resin  diminished  consider- 
ably  after  one  year  of  storage  at  4°C  with  sodium  azide, 
as  seen  from  the  fact  that  hexokinase  was  eluted  as  a  retarded 
peak  as  compared  to  the  main  protein  peak,  without  the 
pulse  of  glucose.  This  deteriorated  resin  behaved  as  the 
affinity  resin  reported  by  Rijksen  and  Staal  (1976a)  for 
the  purification  of  erythrocyte  hexokinase.  The  most 
possible  explanation  is  that  the  decrease  of  the  affinity 
of  the  enzyme  for  the  resin  was  caused  by  a  decrease  of 
the  concentration  of  the  ligand  bound  to  the  resin. 
Sepharose  4B  with  immobilized  N6-[(6-Aminohexanoyl)carba- 
moylmethyl]ATP 
The  preparation  of  this  resin  is  described  in  Chapter 
2.  Small  columns  of  10  x  0.8  cm  were  equilibrated  with 
50  mM  Tri-HC1  buffer  pH  =  8.1  containing  10  mM  MgC12, 
1  mM  EDTA  and  0.1%  (v/v)  2-mercaptoethanol.  Chromatography 
was  performed  at  room  temperature  with  a  constant  flow 
rate  of  15  ml  per  hour.  Samples  of  2-5  units  of  purified 
heart  and  commercial  yeast  hexokinase  in  2-10  ml  of  the 
above  buffer  were  applied  to  the  column.  Both  hexok.  nases 
passed  through  with  15  and  4+0%  recoveries.  for  the  heart 
and  the  yeast  enzyme  respectively.  Pulses  with  10  mM 113 
MgCl2  plus  5  mM  ATP  or  1M  KC1  did  not  elute  any  more  act- 
ivity.  Yeast  hexokinase  was  tested  since  it  was  reported 
by  Lindberg  and  Mosbach  (1975)  that  it  dephosphorylated 
this  immobilized  ATP  analogue  in  the  presence  of  Mgz+  and 
glucose.  The  very  low  recovery  of  heart  hexokinase  may 
be  explained  by  its'  instability  in  the  absence  of  glucose 
at  room  temperature. 
Several  explanations  for  the  non-binding  of  heart 
hexokinase  niay  be  given: 
(i)  The  enzyme.  has  no  affinity  for  this  ATP  anal- 
ogue  because  of  the  modification  of  the  ATP  molecule  for 
immobilization,  or  its,  lower  availability  to  the 
.  enzyme 
on  attachment  to  the  resin; 
(ii)  The  enzyme  has  small  affinity  for  this  ATP 
analogue  so  that  a  low  concentration  of  the  analogue  in 
-the  resin  may  exclude  binding.  This  is  likely  as  the 
estimated  maximum  concentration  of  the  ATP-analogue  on  the 
resin  is  in  the  range  of  the  K  for  the  true  substrate 
m 
(MgATP)  ; 
(iii) 
"The  reaction  mechanism  of  heart  hexokinase  is  an  ord- 
ered  one,  with  glucose  binding  first.  Against  this  view 
is  the  fact  that  some  investigators  have  proposed  a  rapid 
equilibrium  random  mechanism  for  mammalian  hexokinases 
(Bachelard  et  al.,  1971;  Gerber  et  al.,  1974),  while 
Toews  (1966)  has-proposed  an  ordered  sequential  mechanism 114 
but  with  ATP  binding  first. 
(d)  Other  comments  on  the  purification  procedure 
A  small  scale  purification  was  tried  for  heart  hexo- 
kinase  with  exactly  the  same  procedure  as  described  in 
Chapter  4+  for  placental  hexokinase.  The  specific  activity 
after  Step  2  (dialysis)  was  more  than  two-fold  higher  and 
so  was  the  specific  activity  of  the  purified  2  mg  of 
protein  after  Step  5  (gel  filtration)  i.  e.  20  units/mg  as 
compared  with  8.6  units/mg  from  placenta.  In  this  proced- 
ure  the  extraction  was  in  acetate  buffer  pH  =  5.6,  I= 
0.1  +  0.2  M  MgC12ý  The  subsequent  chromatographic  step 
requires  dilution  of  this  buffer.  This  involves  excessive- 
ly  large  volumes  when  using  large  amounts  of  tissue.  Ex- 
. 
traction  with  phosphate  buffer  pH  _  7.5,  Z=0.02  (in  the 
method  adopted)  gave  the  same  specific  activity  for  hexo- 
kinase  (2.65  units/g  tissue)  as  the  acetate  buffer  with 
MgC12  (2.2  units/g  tissue).  The  extract  with  phosphate` 
buffer  required  no  further  dilution  for  chromatography. 
If  in  the  procedure  summarised  in  Figure  5.1.,  gel 
filtration  ('Sephadex  G-200)  was  used  instead  of  the  affin- 
ity  chromatography  step,  a  specific  activity  of  47  units/ 
mg  was  obtained  (A280. 
ß= 
10).  If  gel  filtration  was 
used  after  the  affinity  chromatography  step,  one  peak  of .1  15 
enzyme  activity  was  observed  coinciding  with  the-sole 
protein  poak  (Chapter  9)  and  no  increase"  in  the  specific 
activity  was  obtained.  Thus  the  gel-filtration  step  was 
judged  to  be  unnecessary.  ý"""" 
One  poak  of  enzyme  activity  was  found  from  DEAE-Seph- 
adex  A-50  and  Whatman  P-11  cellulose  chromatographic  steps. 
However  a  trace  of  activity  at  the  leading  edge  was  con- 
sistently  found  on  P-11  cellulose.  -  Chromatographic  frac- 
tions  assayed  with'glucose  concentrations  of  0.5  mM  and 
100  mM  respectively  did  not  reveal  the  coexistence  of  the 
HK-III  or  HK  IV  with  the  reported  HK  I'for  human  heart. 
(e)  Solubilisation  of  particulate  hexokinase 
In  order  to  test  the  effect  of  pH  and  salts  on  the 
solubilisation  of  particulate  hexokinase,  the  following 
experiments  were  performed.  Human  heart  tissue  stored  at 
-450C  was  thawed,  chopped  and  minced.  A  quantity  of  the 
minced  tissue  was  homogenised  with  3  volumes  of  chilled 
phosphate  buffer  pH  =  7.5,  I=0.02  in  a  MSE  Atomix  blender 
for  three,  20  second  intervals  at  full.  speed.  The  homogen- 
ate  was  centrifuged  at  40,000  xg  for  30  minutes  in  a 
Sorvall  RC2-B  centrifuge.  The  supernatant  was  decanted 
and  the  pellet  was  kept  overnight  on  ice.  Quantities  of 
2g  were  dispersed  in  6  ml  of  the  various  buffers  used  for .  116 
the  sol;  Ubilization  experiments.  The  dispersion  was  facil- 
itated  by  agitation  using  a  Whirlmixer  (Fisons)  for  1  min- 
ute.  Arter  2  hours  of  incubation  on  ice  the  homogenates 
were  C  !  ltrifuged  as  above  and  the  supernatants  were  assayed 
for  enAyme  activity. 
Tho  effect  of  buffered  solutions  of  I-0.1  at-pH 
values 
-from 
5.4-to  7.9  is  shown  in  Figure  5.5.  The  solub- 
ilisation  of  particulate  hexokinase  was  unexpectedly  inc- 
Teased  by  increasing  pH,  reaching  a  plateau  at  approximate- 
ly  pH  a  7.0.  Previous-  investigations  for  porcine  heart 
hexokiniAso  by  Hernandez  and  Crane  (1966)  and  by  Easterby 
and  O'I1ijen  (1973)  showed  an  inverse  relation  i.  e.  dec- 
rease  Of'  solubilisation  by  increasing  the  pH  in  the  range 
of  5  to  9  and  5.6  to  7.1  respectively.  The  use  of  fresh 
tissue  : Iii  these  reports  may  account  for  the  difference 
from  thm,  present  results  on  stored  material. 
III  accordance  with  both  reports  the  solubilisation 
increasod  with  increasing  concentration  of  KC1  and  the 
effect  Was  more  pronounced  at  lower  pH  values  (Easterby 
and  O'Bi  ion,  1973).  Results  are  shown  in  Figure  5.6.  The 
effect  cif  salt  concentration  seems  to  be  that  of  ionic 
strength  rather  than  of  the  actual  concentration  of  ions 
since  XGl  (monovalent 
cation)  and  MgCl2  (divalent  cation) 
on  an  ionic  strength  basis  had  similar  solubilising  effects 
(Figuro;  i  5.69  (a)  and  (b)  respectively). "  117 
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Figure  5.5.  Effect  of  pH  on  the  solubilisation  of  hexo- 
kinase  _ 
Solubilisation  is  shown  as  a  percentage,  of  the  maximum 
obtainable  with  phosphate  buffer  pH  =  5.99  I-=  0.1  plus 
0.4  M  KCl. 
Acetate  buffer  was  used  for  p11  =  5.4,  the  rest  were  phosphate 
buffers.  The  ionic  strength  of  all  buffers  was'0.1. . 118 
-100 
PH  PH 
80  7.4 
7.9 
C 
60  6.4 
0 
C3 
0  5.9 
n 
75 
O 
(a)  (  b) 
5.4  5.4 
000.1 
02  Q3  0.4  0.5  0  0.1  Q2  Q3  0.4  0.5 
Ionic  strength 
Figure  5.6.  Effect  of  ionic  strength  at  various  pH  values 
on  the  solubili.  sation  of  hexokinase 
Solubilisation  is  shown  as  a  percentage  of  the  maximum 
obtainable  with  phosphate  buffer  pH  =  5.9,  I=0.1  plus 
0.4  M  Kcl. 
All  buffers  used  had  I=0.1.  Higher  values  of  I  were 
"  obtained  by  the  addition  of  KC1  (a)  and  MgC12  (b). 
The  following  buffers  were  used:  acetate,  pH  =  5.4; 
phosphate,  pH  =  5.9;  phosphate,  pH  =  6.4;  phosphate, 
pH  =  7.9;  Tris-HCl,  PH  =  7.4. 119 
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The  purification  procedure  developed  for  human  heart 
hexokinase  contains  6  steps  and  takes  12  days.  Beginning 
with  1.15  Kg  of  minced  tissue,  25  mg  of  protein  was  puri- 
fied  with-a  specific  activity  of  58  units/mg.  The  overall 
purification  was  1,700  fold  and  the  overall  yield  was  47%. 
Reported  purifications  of  mammalian  low  Km  hexokinases 
are  summarized  in  Table  5.3.  However  only  the  purifications 
of  porcine  heart  hexokinase  by  Easterby  and  O'Brien  (1973) 
and  that  of  rat  brain  hexokinase  by  Chou  and  Wilson  (1972) 
are  supported  by  solid  evidence  of  homogeneity. 
One  previous  purification  of  human  heart  hexokinase 
'has  been  reported-by  Neumann  et  al.  (1974).  That  purifi- 
cation  procedure  had  certain  disadvantages.  The  overall 
yield  was  very  low  (2.5%)  so  that  an  initial  quantity  of 
8  Kg  of  heart  tissue  had  to  be  processed  over  7  steps  (the 
first  three  of  them  repeated  four  times)  for  the  prepar- 
ation  of  10  mg  of  purified  protein.  The  material  was 
tested  for  purity  only  with  immunoelectrophoresis  and  show- 
ed  only  one  precipitation  arc.  The  comparatively  high 
specific  activity  (71  units/mg)  of  the  purified  material 
should  be  ascribed  mainly  to  the  higher  pH  of  the  assay 
solution  used  and  to  a  lesser  extent  to  the  lower  ionic 
strength.  Both  of  these  factors  affect  the  maximum  veloc- 
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ity  of  the  hexokinase  reaction  as  shown  in  Chapter  6.  A 
sample  assayed  according  to  this  assay  method  (Neumann 
et  al.,  1974')  had  a  70%  greater  activity  than  the  assay 
method  used  in  the  present  work  (Chapter  2).  A  correspond- 
. 
ing  assay  according  to  the  method  of  Easterby  and  O'Brien 
(1973)  gave  an  activity  value  120%  higher  than  in  the 
present  work. 
The  homogeneity  of  the  purified  hexokinase  described 
in  this  Chapter  is  discussed  in  Chapter  9. SECTION  3  123 
'Enzyme  activity 
CHAPTER  6 
Kinetics  of  human  heart  hexokinase. 
(a)  Measurement  of  enzyme  activity 
The  kinetics  of  the  coupled  assay  for  hexokinase  in 
the  presence  of  G6PD  have  been  studied  extensively 
(Easterby,  1973;  Storer  and  Cornish-Bowden,  1974)"  By 
using  excess  of  G6PD  (0.5  units  per  ml  of  assay  solution) 
the  transition  time  was  kept  small  (calculated  to  be  less 
than  10  seconds)  and  the  steady  state  of  glucose  6-phos- 
phate  0.2  µM,  calculated  according  to  Easterby  (1973),  was 
much  lower  than  the  reported  Ki  of  glucose  6-phosphate 
versus  glucose  (77  µM)  for  human  placental  hexokinase 
-(Gustke,  1975). 
Reaction  velocities  were  calculated  from  the  change 
in  absorbance  at  340  nm  measured  by  a  Perkin-Elmer  124 
spectrophotometer  connected  to  a  64  chart  recorder.  All 
measurements  were  performed  at  25°C  by  circulating  water 
to  the  cuvette  holder  from  a  waterbath.  Cuvettes  of  1  cm 
light-path  and  3  ml  capacity  were  used.  Initiation  of  the 
hexokinase  reaction  was  made  by  the  addition,  of  20  µl  of 
a  diluted  (glucose  free)  sample'of  purified  hexokinase. ""/:. 
. 
12 
(b)  The  effect  of  pH  on  activity 
The  ionic  strength  of  the  buffers  used  was  kept  con- 
stant  since,  as  shown  later,  hexokinase  activity  decreases 
with  increasing  ionic  strength.  The  reaction  mixture  con- 
tained  100  mM  glucose,  5  mM  ATP,  10  mM  MgCl2,0.6  mM  NADP 
and  0.5  units/ml  G6PD  in  the  appropriate  buffers  of  0.05 
ionic  strength. 
The  profile  of  hexokinase  activity  over  a  p11-range 
from  4.5  to  8.8  is  shown  in  Figure  6.1.  The  activity  inc- 
reased  gradually  from  pH  =  4.5  to  pH  =  7.7.  Above  this  pH 
the  activity  remained  constant  up  to  the  tested  pH  =  8.8. 
This  profile  is  in  accordance  with  pH  values  for  max- 
imal  activity  reported  for  mammalian  hexokinases  (Table  6.1). 
(c)  The  effect  of  salts  on  activity 
The  assay  solution  used  contained  100  mri  glucose, 
5  mM  ATP,  10  mM  MgC12,0.6  mM  NADP  end  0.5  units/ml  G6PD 
in  Tris-HC1  buffer  pa  =  8.0,  I=0.01. 
The  effect  of  various  concentrations  of  the  salts, 
KC1,  NaCl,  NH4C1,  K2HPO4  and  the  base  Tris  is  shown  in 
Figures  6.2  and  6.3.  The  pH  of  the  assay  solution  varied 
little  because  of  the  addition  of  salts,  i.  e.  between  8.0 
and  8.3  (well  inside  the  p11  optimum). 
All  salts  studied  showed  a  similar  effect  of  decreas- 
ing  the  maximal  hexokinase  activity  with  increasing  ionic 
0 125 
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Figure  6.1.  The  dependence  of  heart  hexokinase  activity 
on  pH,  using  buffers  of  1=0.05. 126 
,. 
Table  6.1.  pH  optima  of  Vmax  for  low  Km  mammalian  hexo- 
kinases 
Tissue  pH  Reference 
Human  erythrocytes  7.0-8.4  Rijksen  and  Staal 
(1976a) 
Human  erythrocytes  8.1  Chapman  et  al., 
Calf  heart  8.0-9.0  Sols  and  Crane 
(1954) 
Dog  heart  8.0-9.0  Mayer  et  al., 
(1966) 
Rat  tissues  (HK  I  to  HK  III)  7.8-8.8  Grossbard  and 
Schimke  (1966) 
Schimke  and 
Grossbard  (1968) 
Ritt  liver  (HK  I  to  HK  III)  8.0-9.0'  Gonzalez  et  al., 
(1967). 127 
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Figure  6.2.  The  effect  of  KC1  and  NaCl  on  the  activity 
of  heart  hexokinase  at  pH  =  8.0  in  a  low  ionic  strength 
Tris-HC1  buffer 
An  activity  of  100%  was  taken  as  that  in  Tris-HC1  buffer, 
ionic  strength  0.01. 
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Figure  6.3.  The  effect  of  salts  on  the  activity  of  heart 
hexokinase  at  pH  =  8.0  in  a  low  ionic  strength  Tris-HCl 
buffer 
An  activity  of  100%  was  taken  as  that  in  Tris-HC1  buffer, 
ionic  strength  0.01. . 129 
strength.  A  similar  effect  is  reported  for  rat  skeletal 
muscle  hexokinase  (Weiser  et  al.,  1970).  " 
(d)  Kinetic  constants  for  glucose  and  MgATP2-  -  s""  - 
. 
For  the  measurements  of  Michaelis  constants  for  gluc-, 
ose  and  MgATP2-,  assay  solutions  were  prepared  containing 
0.6  mM  NADP  and  0.5  units/ml  G6PD  in  TES-KOH  buffer 
pH  =  7.0,1  =  0.065. 
Glucose  concentration  was  varied  from  20  to  100  µM, 
MgATP2  concentration  was  varied  from  0.2  to  1.0  mM  by 
the  addition  of  calculated  amounts  of  MgCl2  and  ATP.  The. 
concentration  of  Mg2+  ions  was  held  cönstant  at  2  mM. 
Under  the  above  conditions  the  rest  of  the  ion 
species  originating  from  Mg2+  and  ATP4-  varies  as  follows: 
[ATP4-]  from  5  to  25  µM, 
[ATP113-]  from  3  to  15  µM  and 
[ATPHMg  ]  from  3  to  16  µM. 
Calculations  were.  based  on  the  following  association 
and  dissociation  constants: 130 
'  (i)  Mg  2+ 
+  ATP4  "C.  - 
1Ký  MgATP2-,  K1  =4x  104  M-1  ' 
--. 
(ii)  Mg 
2+ 
+  ATPH3_ 
K2 
MgHATP_,  K2  =  5.8`x  102  M-1 
K 
(iii)  ATPH3 
3--ý 
ATP4  +H  K3  =  8.1  x  10-8  M 
(iv)  ATPHMg 
4 
ATPMg2  +  H+,  K4  =  .6x 
10-6  M. 
reported  by  Phillips  et  äl.  (1966). 
The  reasons  for  keeping  the  Mg2+  ion  concentration 
constant  and  the  ATP4  ion  concentration  at  low  levels  was 
that  it  has  been  reported  by  Rijksen  and  Staal  (1976b)- 
for  human  erythrocyte  hexokinase  that  both  ions  competit- 
ively  inhibit  the  enzyme  against  MgATP2  ,  with  inhibition 
constants  of  16  -  18  mM  and  1.6  mM  respectively.  Gerber- 
et  al.  (1974)  found  that  uncomplexed"Mg2+  up  to  4  mM  activ- 
ated  human  erythrocyte"hexokinase  two  fold  and  inhibited 
it  at  higher  concentrations. 
The  hexokinase  reaction  was  initiated  by  the  addition 
of  20  µl  of  purified  hexokinase  solution  to  a3  ml  assay- 
cuvette.  The  hexokinase  solution  had  been  previously  dial- 
ysed  against  the  assay  buffer  (TES-KOII  P11  =  7.0,  I=0.065) 
"  containing  1  mM  EDTA  and  0.1%  (v/v)  2-mercaptoethandl  for 
the  removal  of  glucose. 
Whereas  under  saturation  of  hexokinase  with  substrates, ,  r.  .S 
131. 
the  change  in  absorbance  at  340  nm-was  linear  with  time  at 
pH  =  7.2  and  8.0,  an  anomalous  situation  occurred  over 
the  pH  range  of  7:  0  to  8.2  with  suboptimal  concentrations 
of  glucose  and  MgATP2  .  The  velocity  decreased  with  time 
during  the  first  ten  minutes  tested,  after  the  initiation 
of-the  hexokinase  reaction,  and  at  a  greater  rate  during 
the  first  five  minutes. 
The  non-linearity  of  the  reaction  decreased  by  inc- 
reasing  glucose  concentrations  from  20  to  100  µM  at  pH  =7 
and  8  while  MgATP2  concentration  had  no  effect  at  pH  =7 
(Figure  6.4),  increased  the  non-linearity  at  pH  =  8. 
Non-linearity  increased  by  increasing  the  pH  of  the  assay 
solution  over  the  pH  range  of  7.0  to  8.0  in  the  presence  of 
20 
.M  glucose  and  1  mM  MgATP2-.  Additionally  the  pH  opti- 
mum  shifted  to  lower  pH'value  (Figure  6.5). 
Possible  explanations  for  the  decrease  of  enzyme 
velocity  with  time  may  be  thermal  inactivation  at  low 
levels  of  enzyme  stabilizer,  glucose,  or  proteolytic  in- 
activation  of  the  enzyme  although  the  latter  possibility 
is  remote  when  using  material  of  high  purity.  Glucose  is 
reported  to  have  a  protective  effect  over  heat  inactiv- 
ation  for  HK  I  from  rat  brain  (Grossbard  and  Schimke,  1966), 
human  term  placenta  (Gustke,  1975)  and.  human  erythrocytes 
(Rijksen  and  Staal,  1976a)  and  over  proteolytic  inactiv- 
ation  of  HK  I  from  rat  brain  (Grossbard  and  Schinike,  1966). 0.12 
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Figure  6.4.  Recordings  of  hexokinase  reaction  a  minst 
time  at  different  glucose  and  MgATP2  concentrations 
v0_2  ws_10  :  Ratio  of  relative'velocitios  at  first  two 
and  last  two  minutes  of  hexokinase  reaction  of  ton*  minutes. 
The  assay  solution  was  TES-KOH  pH  =  7.0v  I=0.065  *contain- 
ing  0.6  mLI  NADP  and  0.5  units/ml  G6PD. 
0 133... 
Figure  6.5.  Correlation  of  pH  and  non-linearity  of  rec- 
.i_.  ording  of  hexokinase  against  time 
The  assay  solutions  were  TES-KOH,  I-0.05  containing  5 
1  mM  MgATPZ-,  20  µM  glucose,  0.6.  mM  NADP  and  0.5  units 
ml  G6PD. 
- 
(A)  :  Change  in  absorbance  at  340  run  during  *the  first 
10  minutes  of  the  hexokinase  reaction  at  pH  -  7.0 
and  8.0. 
(B)  :  Relative  velocity  at  the  first  two  (O)  and  last 
two  (A)  minutes  of  the  hexokinase  reaction  for 
ten  minutes  between  pH  =  7.0  and  8.0. 
(Cý  Ratio  of  relative  velocities  at  first  -two  and  last  ; 
`  two  minutes  of  hexokinase  reaction  of  ten  minutes 
between  pH  -  7.0  and  8.0. 134 
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For  the  above  reasons  pH  =  7.0  was  chosen  for  kinetic 
measurements.  Also  velocities  were  calculated  from  the 
fifth  to  tenth  minute  after  the  initiation  of  the  reaction 
because  by  that  time  the  change  in  absorbance  at  340  nm 
was-approximately  linear.  However  because.  of  the  lack  of 
linearity  even  at  100  pM  glucose  the  results  presented 
below  should  be  considered  on  a  qualitative  rather  than  a. 
quantitative  basis. 
The  calculation  of  kinetic  constants  at,  suboptimal 
substrate  concentration  was  based  on  the  following  equation, 
according  to  Alberty  (1953). 
V 
=1+ 
KA+  KG  + 
K_  . 
[A]  [G]  [Al[G] 
where  A  and  G  represent  MgATP2  and  glucose  respectively. 
When  MgATP2-  concentration  is  varied  the  ordinate 
intercept  and  slope.  are 
Intercept-==  (<+ 
KAGl 
V  [G] 
Slope. 
l  (+  KG 
`  [GJ .ý 
.  136 
Similarly  when  glucose  concentration  is  varied: 
Intercept  + 
Kni  (KG 
V  [A1 
slope  KA) 
V"  [A]  . 
In  all  cases  linear  regression  with  the  least  squares' 
method  was  made. 
Results  are  presented  in  Figures  6.6v  6.7  and  6.8 
6.9.  Under  the  assay  conditions  used,  the  Km  for  glucose 
was  found  equal  to  51  µM  and  for  MgATP2  equal  to  0.32  mM. 
These  values  are  in  accordance  with  tlose  reported  for 
HK  I  from  rat  brain  by  Grossbard  and  Schimke  (1966),  (47 
pM  and  0.42  mM  respectively)  and  for  human  erythrocyte 
hexokinase  by  Rijksen  and  Staal  (1976a)  (64  µM  and  0.50  mM 
respectively).  However  they  differ  from  those  reported  by 
Neumann  et  al.  (1974)  (98  µM  and  1.4  -.  1.6  mm  respectively) 
for  the  human  heart  enzyme. 
The  lines  of  diagrams  6.6  and  6.8  do  not  intercept 
on  the  abscissa  axis.  The  experiments  were  done  in  a 
buffer  of  low  ionic  strength  (0.0'65).  At  the  higher 
levels  of  MgATP  there  is  an  increase  in  ionic  strength 
(by  0.02  approximately)  which  would  decrease  the  activity. 
An  increase  in  the  activity  at  the  higher  levels  of 
2 
MgATP-  would  shift  the  data  towards  a  common  intercept  on '137 
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Figure  6.6.  Relation  between  velocity  and  glucose  conc- 
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Figure  6.8.  Relation  between  velocity  and  MgATP2  conc- 
entration  at  20,40,60  and  100  J.  M  glucose  . 
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Figure  6.9.  Plots  of  the  slope  and  the  ordinate  intercept 
versus  the  reciprocal  of  glucose  concentration  from  Fig- 
ure  6.8. 141 
the  x-axis. 
By  calculation  KA.  KG  was  found  to  be  greater  than  KAG 
by  a  factor  of  2.  This  means  that  the  two  Michaelis 
-"=-  constants,  KA  and  KG,  are  not  mutually  independent.  How- 
ever  the  non-linearity  of  the  hexokinase  reaction  does  not 
allow  conclusive  interpretation  of  the  experimental  find- 
ings. 
A  summary  of  the  reported  Michaelis  constants  for 
glucose  and*MgATP2-  of  hexokinase  from  human  tissues  and 
porcine  heart  is  presented  in  Table  6.2. 142 
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Physical  properties 
CHAPTER  7 
Materials  and  methods. 
ýa)  Starch  gel  electrophoresis 
Starch  gel  electrophoresis  was  performed  according  to 
the  method  of  Smithies  (1955). 
Buffers. 
(i)  Tris-EDTA-borate  buffer  'pH 
=  8.6,  containing 
109  gIl  Tris,  5.84  g/l  EDTA  and  30.9  gIl  boric  acid 
(Rosemeyer  and  Huehns,  1967).  This  stock  buffer  was 
diluted  20  fold  for  the  preparation  of  gel  and  8  fold  for 
the  electrode  vessels. 
(ii)  Tris-EDTA-borate-Mg  buffered  solution.  It  was 
prepared  by  adding  0.025M  MgCl2  to  buffer  (i).  This  stock 
buffer  was  diluted  10  fold  for  the  preparation  of  gel  and 
8  fold  for  the  electrode  vessels  (Rogers  et  al.,  1975b). 
(iii)  Potassium  phosphate  buffer  pH  =  7.0,  I=0.1  con- 
taining  2.74  g/l  K1I2PO4  and  4.63  g/l  K2HP04.  This  stock 
buffer  was  diluted  with  water  to  I=0.02  for  the  prep- 
aration  of  gel  and  0.06  for  the.,  electrode  vessels.  EDTA 
was  added  to  both  dilutions  to  a  final  concentration  of "  145 
1  mM. 
(iv)  Potassium  phosphate  buffer  pH  =  6.0,  I=0.1  con- 
taining  9.75  g/l  KH2P04  and  1.65  g/l  K2HP04.  This  stock 
buffer  was  diluted  with  water  to  I=0.02  for  the  prep- 
aration  of  gel  and  0.06  for  the  electrode  vessels.  EDTA 
was  added  to  both  dilutions  to  a  final  concentration  of 
1  MM. 
Preparation  of  gel. 
The  gel  was  prepared  by  mixing  36  g  of  hydrolysed 
starch  with  300  ml  of  the  appropriate  buffer  in  a  round 
bottomed  flask.  The  slurry  was  heated  gently  until  it 
became  viscous  and  clear.  The  gel  was  degassed  on  a 
water  pump  and  poured  into  Perspex  trays  22  cm  long,  13  cm 
wide  and  0.8  cm  deep.  The  gel  was  allowed  to  set  at  room 
,  temperature  and  finally  cooled  at  4°C  for  one  hour. 
Electrophoresis. 
The  protein  samples  were  soaked  into  small  strips  of 
Whatman  No.  3  filter  paper  (1.3  x  0.5  cm)  and  inserted 
into  a  vertical  cut  in  the  gel  about  7  cm  from  one  end. 
Filter  paper  wicks  were  used  to  connect  the  gel  to  the 
electrode-vessels.  The  surface  of  the  gel  was  covered 
with  a  thin  sheet  of  polythene  to  prevent  evaporation. 
Electrophoresis  was  carried  out  at  4°C.  With  the  Tris- 146 
EDTA-borate  system  a  constant  voltage  of  480  V  was  applied 
for  5  hours  while  with  the  Tris-EDTA-borate-Mg  system  a 
constant  voltage  of  200  V  was  applied  for  22  hours.  With 
the  potassium  phosphate  buffer  systems  a  constant  current 
of  50  mA  was  applied  for  5  hours. 
Stain  for  hexokinase  activity  and  protein.  Preservation  of 
gels 
After  electrophoresis,  gels  were  sliced  into  three 
horizontal  sections.  The  thin  middle  section  was  stained 
for  protein  and  the  lower  cut  surface  was  stained  for 
enzyme  activity. 
_ 
Hexokinase  activity  was  developed  by  pouring  20  ml  of 
the  staining  solution  described  for  polyacrylamide  gels  and 
incubating  the  system  at  room  temperature  for  about  2  hour 
in  the  dark. 
For  the  staining  of  proteins  the  gels  wore  overlaid 
with  a  1%  (w/v)  solution  of  naphthalene  black  in  methanol- 
acetic  acid-water  (5:  1.4,  v/v/v).  The  stain  was  allowed 
to  soak  into  the  gel  for  about  5  minutes  and  the  back- 
ground  stain  removed  by  repeated  washings  with  the  same 
solvent  for  1-2  days. 
The  gels  were  preserved  in  methanol-acetic  acid-water 
(5:  1.4,  v/v/v). 147 
(b)  Cellulose  acetate  electrophoresis 
Buffers. 
(i)  Tris-citrate  buffer  pH  =  8.6,  containing  9.2  g/l 
Tris  and  1.05  gIl  citric  acid. 
(ii)  Borate-NaOH  buffer  pH  =  8.6,  containing  92.75  g/l 
boric  acid  and  0.3  moles/1  NaOH. 
Electrophoresis 
Sepharose  III  cellulose  polyacetate  electrophoresis 
strips(15.2  cm  long  and  2.5  cm  wide  were  impregnated  with 
Tris-citrate  buffer  pH  =  8.6  by  floating  them  onto  the 
surface  of  the  buffer  and  subsequently  immersing-them  for 
at  least  10  minutes.  The  strips  were  blotted  between  2 
pieces  of  blotting  paper  avoiding  excess  drying  (indic- 
ated  by-the  appearance  of  white  spots)  and  placed  on  the 
shoulder  pieces  of  a  Shandon  Cellulose  Acetate  Electro- 
phoresis  tank.  For  wicks  double  thickness  of  Whatman 
paper  No  1  was  used.  The  electrode  vessels  contained 
borate-NaOH  buffer  pH  =  8.6.  A  small  quantity  of  protein 
sample  (5-10  µi)  was  applied  with  a  micropipette  as  an  even 
streak  about  2  cm  from  the  cathode  wick.  The  electro- 
phoresis  was  completed  in  50  minutes  at  a  constant  volt- 
of  250  V.  age er 
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Stain  for  hexokinase  activity  and  protein.  Preserv- 
ation  of  strips. 
Hexokiriase  activity  was  visualised  by  immersion  in 
the  same  staining  solution  described  for  polyacrylamide 
. 
gels,  for  5  minutes  at  room  temperature  in  the  dark. 
For  the  protein  stain,  the  strips  were  immersed  in 
a  1%  (w/v)  solution  of  naphthalene  black  in  methanol- 
acetic  acid-water  (5:  1:  4,  v/v/v)  for  5  minutes.  The  back- 
ground  stain  was  rapidly  removed  by  repeated  washings  in 
the  same  solvent. 
. 
The  developed  strips  were  preserved  in  a  methanol- 
acetic  acid-water  (5:  1:  4,  v/v/v)  solution.  A  gradual 
fading  of  formazan  bands  occurred  with  time. 
(c)  Polyacrylamide  gel  electrophoresis 
Disc  electrophoresis  was  performed  in  5  and  7.5% 
polyacrylamide  gels  using  modifications  of  the  methods  of 
Ornstein  (1964)  and  Davies  (1964). 
Buffers. 
(i)  Tris-HC1  buffer  pH  =  6.7,  containing  0.45  moles/i 
-HC1  and  50  g/1  Trist  titrated  to  pIi  =  6.7  with  additional 
Tris. 1l9 
(ii)  Tris-HC1  buffer  pH  8.9,  containing  0.48  moles/1 
HC1-and  366  g/i  Tris,  titrated  to  pH  8.9  with  additional 
Tris. 
(iii)  Tris-glycine  buffer  pH  -  8.5,  containing  3  g/1 
Tris  and  14.4  g/l  glycine,  titrated  with  additional  Tris. 
(iv)  Acrylamide  solution  containing  30%  (w/v)  acryl- 
amide  and  0.8%  (w/v)  bis-acrylamide. 
(v)  Samp]  e  buffer  containing  2  ml  glycerol,  0.5  ml  0.1% 
(w/v)  bromophenol  blue,  0.1  ml  Tris-HCl  buffer  pH  =  6.7 
(buffer  (i))  and  7.5  ml  water. 
Preparation  of  gel. 
The  gel  solution  was  prepared  by  adding  4.2  or  6.2  ml 
of  acrylamide  solution  to  give  a  final  concentration  of 
.  acrylamide  of  5  and  7.5%  (w/v)  respectively,  3.1  ml  Tris- 
HC1  buffer  pH  -  8.9,10  µl  of  Tetraethylene  methylene 
diamine  (TEMED)  and  water  up  to  the  volume  of  25  ml.  The 
solution  was  degassed  in  an  aspirator  connected  on  a  water 
pump.  Polymerization  was  initiated  by  the  addition  of  50 
or  250  µl  of  a  10%  (w/v)  freshly  prepared  ammonium  per- 
sulphate  solution  in  water,  depending  on  whether  a  slow 
(within  30  minutes)  or  a  fast  (within  8  minutes)  polymer- 
isation  was  required..  The  fast  polymerisation  was  prefer- 
red  when  G6PD  was  incorporated  in  the  gel  solution  because 150 
it  was  shown  that  this  enzyme  is  rapidly  inactivated  by 
the  acrylamide  and  bisacrylamide  monomers  Harrison,  197Z).  - 
The  concentration  of  G6PD  in  the  gel  solution  was  0.56 
units/ml.  Immediately  after  the  addition  of  ammonium  per- 
,  sulphate  the  gel  solution  was  poured  into  glass  tubes 
7.5  x  0.5  cm  and  overlaid  with  water. 
Electrophoresis. 
After  the  completion  of  polymerization,  the  tubes  were, 
inserted  into  a  Shandon  disc  electrophoresis  assembly  and 
the  electrode  compartments  filled  with  Tris-glycine  buffer 
pH  =  8.5.  A  small  volume,  root  more  than  50  µl,  of  protein 
solution  was  applied  with  a  micropipette  on  the  tubes. 
This  protein  solution  was  prepared  by  mixing  equal  volumes 
of  the  protein  sample  and  the  sample  buffer.  Electro- 
phoresis  was'carried  out  at  4+°C  with  a  constant  current  of 
2  mA  per  tube.  It  was  completed  when  the  bromophenol  blue 
marker  band  reached  0.5  cm  from  the  anode  end  of  the  tubes. 
"  Stain  for  hexokinase  activity'. 
Each  gel  was  incubated  in  a  test  tube  containing  the 
following  staining  solution,  at  room  temperature  and  in 
the  dark. _,  151 
Tris-HC1  buffer  pH  -  8.0,  'I  =  0.05  containing 
5  mM  ATP 
10  mm  MgCl 
2 
100  mM  glucose 
0.6  "  mM  NADP 
0.5  units/ml  G6PD 
0.5  mg/ml  PMS 
0.5  mg/ml  MTT 
If  G6PD  was  incorporated  in  the  gel,  staining  was  per- 
formed  as  above  except  that  this  enzyme  was  omitted  from 
the  staining  solution.  Brown  bands  were  developed  in  the 
areas  of  hexokinase  activity  due  to  the  formation  of  insol-. 
uble  formazan  by  the  following  set  of  reactions. 
ATP  Glucose 
Methyl-dihydro- 
ADP  -6-P  NADP  phenozonium  ion  MTT 
x 
6-PGI.  NADPH  PM 
*S 
Formozon 
Protein  stain. 
The  gels  were  stained  for  protein  by  incubation  in  a 
0.2%  (w/v)  solution  of  Coomassie  Brilliant  Blue  R  in 
methanol-acetic  acid-water  (25:  7:  68,  v/v/v)  for  12  hours. / 
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The  background  stain  was  removed  by  repeated  washing  in 
the  same  solvent.  Gels  stained  for  protein  did  not  contain 
G6PD  since  this  enzyme  produced  a  background  protein  stain. 
Preservation  of  gels. 
Gels  stained  for  hexokinase  activity  and  for  protein 
were  kept  in  methanol-acetic  acid-water  (25:  7:  68,  v/v/v) 
solution.  However  hexokinase  activity  bands  faded  with  time. 
(d)  SDS  polyacrylamide  electrophoresis 
One  of  the  most  critical  tests  of  protein  homogeneity 
is  the  polyacrylamide  gel  electrophoresis  in  the  presence 
of  the  anionic  detergent,  sodium  dodecyl  sulphate  (SDS). 
This  method  is  normally  used  for  determining  the  subunit 
composition  of  a  protein,  but  by  loading  a  large  protein 
sample  onto  the  gel  the  presence  of  small  amounts  of 
impurities  may  be  detected.  It  has  been  also  shown  that 
the  separation  of  proteins  by  SDS  electrophoresis  is  dep- 
endent  on  the  molecular  weight  of  their  polypeptide  chains 
(Shapiro  et  al.,  1967)  so  that  when  the  electrophoretic 
mobilities  of  polypeptide  chains  were  plotted  against  the 
logarithms  of  their  molecular  weights  a  smooth  curve  was 
obtained.  Certain  factors  have  been  found  to  produce 
artifacts,  e.  g.  lipid  and  carbohydrate  attached  to  pro- 153 
teins,  or  incomplete  binding  of  SDS  to  proteins. 
SDS  polyacrylamide  gel  electrophoresing  was  performed 
using  a  system  based  on  the  methods  of  Weber  and  Osborne 
(1969)  and  Laemmli  (1970)  using  5  and  10%  (w/v)  polyacryl- 
amide  gels. 
Buffers. 
They  were  the  same  as  for  the  normal  polyacrylamide 
gel  electrophoresis  with  the  following  modifications: 
i)  The  electrode  buffer,  Tris-glycine  pH  =  8.5 
contained  also  0.1%  (w/v)  SDS. 
ii)  The  sample  buffer  contained  also  2.5iö  (w/v) 
SDS  and  2%  (v/v)  2-mercaptoethanol. 
f 
Preparation  of  gel. 
. 
The  gel  solution  was  prepared  by  adding  4.2  or  8.4  ml 
of  acrylamide  solution  to  give  a  final  concentration  of 
acrylamide  monomer  5  and  10%  (w/v)  respectively,  3.1  ml 
Tris-HC1  buffer  pH  =  8.9,0.5  ml  of  a  5%  (w/v)  SDS  sol- 
ution  in  water,  10  }1l  TEMED,  and  water  up  to  a  volume  of 
25  ml.  The  gel  solution  was  degassed  before  the  addition 
of  SDS,  and  polymerization  was  initiated  by  the  addition 
of  50  µi  of  a  freshly  prepared  10%  (w/v)  solution  of 
ammonium  persulphate  in  water.  The  gels  were  poured  in. 
glass  tubes  12  x  0.5  cm  and  overlaid  with  a  small  volume 
I .  r. 
X54 
of  0.1%  (w/v)  solution  of  SDS  in  water.  After  30  minutes 
polymerization  was  complete. 
Preparation  of  protein  samples  and  electrophoresis. 
Equal  volumes  of  protein  solution  and  sample  buffer 
were  mixed  in  narrow  tubes  (2  min  diameter)  and  boiled  in 
a  water  bath  for  5  minutes  to  reduce  the  protein  fully. 
The  surface  of  the  gels  was  flushed  with  electrode 
buffer  and  the  tubes  assembled  in  a  Shandon  disc  electro- 
phoretic  apparatus.  Up  to  20  }bl  of  reduced  protein  sample 
was  applied  to  the  surface  of  the  gel.  '  Electrophoresis  was 
carried  out  at  room  temperature  with  a  constant  current  of 
2  mA  per  tube,  until  the  bromophenol  blue  marker  band 
reached  1  cm  from  the  anode  end  of  the  tubes. 
Staining  of  gels  for  proteins.  glyco  and  lipoproteins. 
Preservation  of  gels. 
After  electrophoresis  the  gels  were  -immersed  in  a 
15%  (w/v)  solution  of  trichloroacetic  acid  in  water  for  2 
hours  to  precipitate  the  proteins. 
(i)  General  orotein'stain 
Gels  were  stained  with  Coomassie  brilliant  blue  R 
as  described  for  normal  polyacrylamide  gels.  The  ab'sorp- 
tion  profile  of  the  gels  at  265  nm  was  recorded  with  a 
Joyce  Loebl  u.  v.  scanner  connected  to  a  Bryans  27000  chart 155 
recorder. 
(ii)  Stain  for  glycoproteins 
For  the  detection  of  glycoproteins,  gels  were  stained 
according  to  the  method  of  Zacharius  et  al.,  (1969).  The 
gels  were  rinsed  lightly  with  water  and  were  immersed  in 
a  1%  (w/v)  solution  of  periodic.  acid  in  3/  (v/v)  acetic 
acid  in  water  for  50  minutes.  They  were  thoroughly  washed 
with  several  changes  of  water  and  shaking  for  24  hours  for 
the  complete  removal  of  I03  ions.  The  gels  were  trans- 
-__ 
(erred  to  test  tubes  containing  the  fuchsin-sulphite  stain 
prepared  as  described  below  and  kept  in  the  darkýfor  50 
minutes.  Afterwards  the  gels  were  washed  with  freshly  pre- 
pared  0.5%  (w/v)  metabisulphite.  solution  in  water. 
The  fuchsin-sulphite  stain  was  prepared  as  follows: 
1g  of  basic  fuchsin  was  dissolved  in  100  ml  of  boil- 
ing  water.  The  solution  was  cooled  to  60°C  and  2g 
of  potassium  metabisulphite  was  added.  Subsequently 
20  ml  of  1N  HC1  solution  was  added  slowly.  The  sol- 
ution  was  left  overnight  in  a  stoppered  flask.  The 
solution  was  decolourized  with  charcoal  and  filtered. 
(iii)  Stain  for  lipoproteins 
For  the  detection  of  lipoproteins,  gels  were  stained 
according  to  the  method  of  Craven  and  Basford  (1974).  The 156, 
gels  were  immersed  in  a  Sudan  black  B  solution  and  left 
overnight.  The  sudan  black  B  solution  was  prepared  by 
mixing  10  ml'  of  a  saturated  solution  of  sudan  black  B  in 
-.  ethanol,  4  ml  glycerol,  6  ml  water  and  1  ml  acetic  acid. 
Background  stain  was  removed  by  soaking  in  a  glycerol- 
water-acetic  acid  solution  (4:  16:  1,  v/v/v). 
(e)  Analytical  gel  filtration 
Analytical  gel  filtration  can  be  used  as  an  indication 
of  size  homogeneity  and  for  initial  estimation  of  molecular 
weight,  diffusion  coefficient  and  Stokes'  radius. 
'(i)  As  an  indication  of  homogeneity 
By  heavily  loading  a  long  Sephadex  G-200  column  with 
a  protein  sample  and  studying  the  elution  profile,  an  indi- 
cation  of  the  solute  homogeneity  with  respect  to  size  can 
be  obtained  if  the  enzyme  activity  peak  coincides  with  the 
protein  peak  and  the  specific  activity  is-constant  through- 
out  it.  However  neither  the  resolution  nor  the  sensitiv- 
ity  of  absorbance  at  280  nm  are  clear  indications  of  homo- 
geneity. 
(ii)  Initial  estimation  of  molecular  weight 
Gel  filtration  on  Sephadex  0-200  was  used  by  Andrews 
(1964,1965)  as  a  comparative  method  giving  estimates  of -  157 
the  molecular  weight  of  proteins.  The  elution  volume  of 
the  protein  was  related  to  the  logarithm-of  molecular  weight. 
The  relationship  was  found  to  hold  for  many  of  the  proteins 
studied,  although  certain  exceptions  were  noted,  especially 
for  those  proteins  with  a  highly  asymmetrical  shape,  or 
those  with  a  high  proportion  of  carbohydrate. 
(iii)  Initial  estimation  of  diffusion  coefficient  and 
Stokers  radius 
The  elution  of  proteins  through  dextran  polymers  may 
be  considered  as  a  function  of  the  Stokers  radius  of  the 
molecule  (Ackers,  1964;  Siegel  and  Monty,  1966).  The 
Stokers  radius  may  be  related  to  the  diffusion  coefficient 
of  a  molecule  using  the  Stoke's-Einstein  law  for  the  free 
diffusion  of  spherical  particles  D= 
6nTr 
Thus  the 
elution  of  a  protein  may  be  related  to  its'  diffusion 
coefficient.  Experimentally  a  smooth  relationship  was 
found  to  hold  for  many  proteins  when  their  elution  volume 
was  plotted  against  the  reciprocal  of  diffusion  coeffic- 
ients  (Andrews,  1965)-. 
ýiv)  Conditions  for  analytical  gel  filtration 
Sephadex  G-200  columns  were  poured  as  described  in 
Chapter  2.  For  the  purpose  of  checking  homogeneity  the 
column  had  dimensions  of  150  x2  cm  and  the  flow  rate  was 
8  ml/hour.  For  estimation  of  molecular  weight  and  diffu- 
sion  coefficient,  the  column  had  dimensions  1110  x1  cm  and "  158 
the  flow  rate  was  7  ml/hour.  Samples  with  the  markers  and 
hexokinase  were  run  separately.  Both  types  of  gel-filt- 
ration  experiments  were  performed  at  4°C.  Phosphate 
buffer  pH  =  7.0,  I=0.1  containing  10  mM  glucose,  1  mM 
. 
K2EDTA  and  0.1%  (v/v)  2-mercaptoethanol  was.  used  both  for 
dialysis  of  the  samples  chromatographed  and  for  their  - 
elution  from  the  columns. 
(f)  Sedimentation  velocity 
Sedimentation  velocity  experiments  were  performed 
using  a  Beckman  Spinco  model  E,  analytical  ultracentrifuge, 
equipped  with  an  RTIC  unit.  All  experiments  were  carried 
out  at  10°C.  A  standard  A  -D  rotor  (maximum  speed  59,780 
r.  p.  m.  )  was  used  and  the  radial  co-ordinates  defined  by 
the  counterbalance  reference  edges.  Ilford  rapid  ortho- 
metallic  plates  were  used  with  the  schlieren  optical  sys- 
tem  and  the  plates  measured  with  a  twin  coordinate  trav- 
elling  microscope. 
"  All  sedimentation  velocity  experiments  were  performed 
at  59,780  r.  p.  m.  Standard  cells  fitted  with  sapphire 
windows  and  12  mm  Kel.  F  centerpieces  of  40  sector  angle 
were  routinely  used.  The  cells  were  filled  with  0.6.  -  0.7 
ml  of  protein  solution,  normal].  ),  about  5  mg/ml. 
Sedimentation  coefficients  were  measured  by  taking 159 
photographs  at  equal  time  intervals,  after  the  schlieren 
peak  had  spearated  from  the  meniscus. 
The  sedimentation  coefficient  is  defined  by  the 
equation  s=2  02r  and  the  integrated  form  was  used  to 
wr  dt 
obtain  s 
2 
log10r  = 
sw  t+ 
constant 
2.303 
where  s  ik  the  sedimentation  coefficient 
r  is  the  radial  distance 
w  is  the  rotor  speed  in  radians/s 
t  is  the  time  interval  between  measured  position  of  r 
By  plotting  log10r  against  t,  a  straight  line  should 
be  obtained  for  a  system  of  a  single  discrete  protein 
entity,  the  slope  of  which  is  proportional  to  s.  A  least 
mean  squares  procedure  was  used  to  determine  the  slope  of 
the  graph. 
The  observed  sedimentation  coefficient  obtained  for 
the  temperature  and  solvent  conditions  of  the  centrifug- 
ation  was  corrected  to  the  standard  s20. 
w 
values  using 
the  equation 
ý1  t,  alb  (1-0020W  20W  s20w  '-  sobs 
X12  \ý1w  (1-vp)t.  b 
wt 160 
where  11  bt  is  the  viscosity  of  buffer  at  temperature  t 
pW.  2Q  is  the  density  of  water  at,  20°C 
is  the  partial  specific  volume  of  the  protein 
The  viscosities  and  densities  of  solvents  were  taken 
from  International  Critical  Tables.  The  ionic  strength 
was  generally  0.1  or  greater  to  minimize  charge  effects. 
(g)  Boundary  formation  and  the  measurement  of  diffusion 
coefficient 
For  the  determination  of  protein  concentrations, 
artificial  boundaries  between  solvent  and  protein  sol- 
ution  were  formed-using  a  double  sector,  synthetic  bound- 
ary  centerpiece.  Two  scribe  lines  at  the  top  and  middle 
of  one  face  of  the  centerpiece  allowed  passage  of  solvent 
from  one  sector  to  the  other,  with  the  concurrent  dis- 
placement  of  air.  0.15  ml  of  the  ptotein  solution  was' 
placed  in  one  sector  and  0.45  ml  of  the  corresponding 
buffer,  against  which  the  protein  solution  had  been  dial- 
ysed,  was  placed  in  the  other  sector.  The  rotor  speed  was 
gradually  increased  and  the  boundary  seen  to  'form  at 
1,000  rpm  until  the  excess  buffer  had  layered  on  top  of 
the  protein  solution.  The  rotor  was  stabilized  at  6,995 
r.  pm.  At  this  speed  it  was  thought  that  negligible  sedi- 
mentation  would  occur  during  the  diffusion  experiments. s  ",  wi 
161 
"  For  the  boundary  forming  experiments,  two  sets  of 
photographs.  were  taken  at  various  phase-plate  angles,  allow- 
ing  the  boundary  to  diffuse  between  each  set.  For  the  diff- 
usion  experiment  photographs  were  taken  at  a  constant  time 
interval  and  fixed  phase  plate  angle. 
The  protein  concentration  was  estimated  from  the 
boundary  forming  experiment  by  trapezoidal  integration  of 
the  schlieren  peak. 
The  diffusion  coefficient  was  calculated  from  the 
"  equation 
1A2 
D=-  (1 
) 
. 
(1 
-  w2st)"  (Schachman,  1959) 
4TCtH 
where  A  is  the  peak  area,  calculated  by  trapezoidal 
integration 
H  is  the  peak's  height 
t  is  the  time  interval  from  the  start  of  the 
experiment. 
At  the  low  speed  employed  for  the  diffusion  experiments 
the  term  w2  st  is  negligible. 
Values  of  (A/H)2/21L  were  plotted  against  t  and  the 
slope  of  the  line  calculated  by  the  least  mean  squares 
method. 
The  observed  diffusion  coefficient  for  the  protein  at 162 
the  temperature  and  solvent  conditions  of  the  experiment 
was  corrected  to  a  D20. 
w  value  using  the  equation 
93  020. 
w  -  D0bs: 
2T 
,  `fit  . 
(2b  b 
20/w  \.  w  It 
whepe  T  is  the  absolute  temperature 
'lbt  is  the  viscosity  of  buffer  at  temperature  t 
'lw20  is  the  viscosity  of  water  at  20°C. 
(h)  Sedimentation  equilibrium 
Sedimentation  equilibrium  experiments  were  performed 
according  to  the  method  of  Van  Holde  and  Baldwin  (1958), 
using  Schlieren  optics  and  solution  columns  of  3  mm.  Cells 
fitted  with  Epon-Aluminium  double  sector  centerpieces 
(12  mm,  2°  sector  angle)  and  sapphire  windows  were  used. 
One  sector  was  loaded  with  0.11  ml  of  protein  solution, 
the  other  with  0.13  ml  of  corresponding  buffer. 
The  speed  of  centrifugation  was  selected'to  give  a 
value  of  0.9  for  aq  defined.  as  a=RT2 
Mr  W2  (1-0p)  '  (b2-a2) 
where  a  and  b  are  the  radial  positions  at  the  top  and 
bottom  of  the  protein  solution.  This  value  of  a  is  equiv- 
alent  to  selecting  a  speed  to  obtain  a  value  of  3  for  the 
ratio  Cb/Ca  where  Ca  and  Cb  are  the  protein  concentrations 
at  the  top  and  bottom  of  the  protein  solution. .  163 
.  The  minimum  length  of  time  for  the  equilibrium  experi- 
ment  was  determined  using  the  equation:  - 
--  --  (b 
-  a) 
z 
D 
where  p(a)  is  a  complex  function  of  a  and  of  the  differ- 
ence  in  protein.  concentration  between  the  top  and  the 
bottom  of  the  solution  column.  This  equation  defines  a 
condition  in  which  (Cb'-'Ca)  is  within  0.1%  of  the  cönc- 
-entration  difference  expected  at  equilibrium.  (This  error 
is  much  less  than  the  limits  of  resolution  of  the  measure- 
ments).  F(a)  converges  rapidly  to  a  value  of.  0.68  for 
values  of  a)0.6. 
The  basic  flow  equation  in  the  sedimentation  equil- 
ibrium  experiments  derived  by  substituting  the  Svedburg 
equation  in  the  Lamm  (1929)  equation-is 
1  dc 
_  2AM  (Equation  1) 
rcdr 
where  A=  w2i1-üp) 
2RT 
C  is  the  protein  concentration 
r  is  the  distance  from  the  centre  of  rotation  of 
the  centrifuge  rotor 
dc  is  the  corresponding  concentration  gradient  Er 
M  is  the  molecular  weight F-  - 
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The  initial  concentration  C  was  obtained  from  bound- 
0 
ary  forming  experiments.  The  meniscal  concentration  Ca 
was  obtained  by  double  integration: 
br 
dr  a 
aa2 
The  mean  value  of  the  weight  average  molecular  weight 
-across  the  cell,  Mw,  was  calculatod  by  the  following 
equation: 
_ 
(cb-Ca)  1  MW 
CO  A(b2-  a2) 
The  mean  value  for  the  "Z  average"  molecular  weight 
across  the  solution  column,  Mz,  was  calculated  from  the 
following  equation: 
1  dcl  (1  dC}  (Fýr, 
a  r  crlb-  1  MZ 
cb-  ca  2A 
Heterogeneity  of  preparations  was.  detected  by: 
(i)  the  ratio 
ýlz 
which  is  unity  when  one  molecular 
species  is  present. 
(ii)  From  the  integrated  form  of  equation  1, 
Incr  InCQ+AM(r2-a2)  ,a  plot  of  In  Cr  versus  r2 
should  give  a  straight  line  for  homogeneous  material. 
The  slope  of  this  line  would  be  Mw . 165 
(iii  From  equation  1,  a  plot  of 
r.  de 
versus  (Cr 
-  Ca) 
should  give  a  straight  line  for  homogeneous 
material.  The  slope  of  this  line  would,  be'Mz. 
(iv)  From  equation  1.  the  molecular  weight  at  various 
points  in  the  solution  is  Mw(r)  _ 
37C 
1  dc 
dr' 
This  value  should  be  constant  throughout  the  sol- 
ution  column  for  homogeneous  material.  The  values 
may  be  summed  across  the  column  to  give  a  mean 
value  Mw(r). 
(i)  Sucrose  gradient  ultracentrifugation 
Sucrose,  gradient  preparative  ultracentrifugation  was 
performed  according  to  the  method  of  Martin  and  Ames 
(1961)  for  the  estimation  of  the  sedimentation  coefficient 
of  hexokinase  by  interpolation  between'markers  of  known 
values  of  s20. 
w'  - 
A  Beckman  L2-65B  preparative  ultracentrifuge  with  a 
swinging  bucket  rotor  (SW40  Ti)  was  used.  Polycarbonate 
tubes  (9.5  x  1.4  cm)  of  14  ml  capacity  were  slowly  filled 
from  the  outlet'of  a  gradient  mixer.  The  mixer  consisted 
of  two  equal  cylindrical  chambers  built  in  a  block  of 
perspex  glass,  interconnected  at  the  bottom  with  a  stop- 
cock.  One  chamber  contained  a  20%  (w/v)  sucrose  solution 
in'phosphate  buffer  pH  =  7.0,  I=0.1  plus  10  mM  glucose, 
1  mM  EDTA  and  0.1%  (v/v)  2-mercaptoethanol.  The  other 166 
contained  a  5%  (w/v)  sucrose  solution  in  the  same  buffer, 
.  ý,  The  latter  chamber  served  also  for  the  mixing  of  the  grad- 
ient  with  the  help  of  a.  spinning  platinum  loop.  Polythene 
tubing  was  attached  with  the  bottom  of  this  chamber  with 
a.  glass  micropipette  on  its'  other  end.  The  outflow  of 
the  gradient  to  the  bottom  of  the  tubes  was  adjusted  with 
a  screw  clamp.  In  this  way  the  gradient  was  inverted  in 
the  tubes  and  the  final  sucrose  concentration  at  the  top 
and  bottom  of  the  tubes  was  5  and  20$  respectively.  The 
tubes  were  left  for  some  hours  to  stand  at  4°C  before  the 
application  of  0.5  ml  samples  containing  hexokinase  and  the 
markers  previously  dialysed  against  the  above  buffer.  The 
samples  were  layered  at  the  top  of  the  gradient  with  a 
micropipette  and  the  tubes  were  centrifuged  for  16  hours  at 
40,000  r.  p.  m.  at  4°C.  Fractions  were-collected  by  fixing 
each  tube  in  a  cylindrical  chamber  having  two  outlets-at 
its'  bottom  and  top.  -  A  hole  was  punched  to  the  tube  from 
the  bottom  outlet  of  the  chamber  and  50%"(w/v)  sucrose 
"  solution  in  the  buffer  was  pumped  in  with  a  peristaltic 
pump.  The  gradient  was  thus  forced  upwards  and  flowed 
out  from  the  top  of  the  chamber.  Equal  fractions  of  16 
drops  (0.5  ml)  were  collected  and  analysed. .ý 
...  ý  .. 
167 
CHAPTER  8' 
Erythrocyte  hexokinase 
(a)  Electrophoresis 
Electrophoretic  studies  of  adult  human  erythrocyte 
hexokinase  isoenzymes  are  conflicting  showing,  on  starch 
gels,  7  bands  (Eaton  et  al.,  1966),  or  HK  I  and  HK  III 
(Holmes  et  al.,  1967;  Holmes  et  al.,  1968;  Schröter  and 
Tillman,  1968;  Neumann  et  al.,  1974),  or  HK  I,  HK  II  and 
HK  III  (Malone  et  al.,  1968),  or  a  double  HK  I  band  and 
HK  III  (Kaplan  and  Beutler,  1968),  or 
'a 
triple  HK  I  band 
and  HK  III  (Rijksen  et  al.,  1977),  or  double  bands  for 
both  HK  I  and  HK  II  (Rogers  et  al.,  1975b).  On  agarose 
gel  electrophoresis  4  bands  were  observed  (Altay  et  al., 
1970)- 
A  common  feature  is  the  persistence  of  HK  I  in  all 
investigation  mentioned  above.  Also  in  almost  all  cases 
HK  I  band(s)  represented  most  of  the  enzyme  activity  of 
the  samples.  Inconsistencies  in  number  and  isoenzyme 
types  presumably  arise  from  differences  in  experimental 
conditions  and  criteria  for  characterizing  isoenzymes. 
ý1)  Starch  gel  electrophoresis 
The  purified  erythrocyte  hexokinase  was  electrophor- . 168 
esed  on  starch  gel  under  conditions  described  in  Chapter 
7.  With  the  Tris-EDTA-borate  buffer  pH  =  8.69  after  a 
5  hour  electrophoresis,  a  single  anodal  band  was  stained 
for  activity  with  mobility  slightly  slower  than  that  of 
CO-haemoglobin  used  as  marker.  However  after  electro- 
phoresing  with  the  Tris-EDTA-borate-Mg  buffer,  pH  = 
8.6,  for  22  hours  at  lower  voltage,  four  hexokinase  bands 
of  almost  equal  staining  intensity.  were  revealed  with 
relative  mobilities  to  haemoglobin  equal  to  0.9,0.75, 
0.65  and  0.53.  These  values  were  almost  identical  to 
those  found  by  Rogers  et  al.  (1975b)  for  fresh  haemolys- 
ates'under  the  same  electrophoretic  conditions.  It  is 
difficult  to-explain  the  different  patterns  on  electro- 
phoresis  in  Tris-EDTA-borate  and  Tris-EDTA-borate-Mg 
buffers.  The  additional  bands  could  arise  from  variation 
in  bound  ions,  or  possibly  different-conformations  of 
the  enzyme.  According  to  Rogers  et  al.  (1975b)  the  multi- 
banded  pattern  of  low  Km  hexokinases  in  several  human 
tissues  may  have  arisen  as  a  result  of  secondary  modific- 
ations  of  the  "primary"  isoenzyme,  where  the  "primary" 
isoenzyme  is  usually  the  least  anodal  band  of  a  multi- 
banded  complex. 
With  the  phosphate  buffer  solution  of  pH  =  7.0 
one  band  of  activity  was  revealed  throughout  the  purific- 
ation  procedure  moving  1.2  cm  towards  the  anode,  whereas 169 
CO-haemoglobin  moved  0.45  cm  towards  the  cathode. 
The  isoelectric  point  for  erythrocyte  hexokinase  was 
found  as  6,  as  enzyme  activity  was  observed  only  in  the 
origin  after  electrophoresis  with  phosphate  buffer  system 
pH  =  6.0.  Easterby  and  O'Brien  (1973)  reported  the  same 
value  for  porcine  heart  hexokinase  by  the  same  method. 
The  isoelectric  point  of  rat  brain  hexokinase  was  found  to 
be  between  6  and  6.5  by  isoelectric  focussing  (Chou  and  Wilson, 
1972)"Rijksen  and  Staal  (1976a).  by  isoelectric  focussing  of 
the  purified  human  erythrocyte  enzyme  found  a  major  protein 
band  with  the  rather  low  value  of  pH  =  4.7.  However  the 
band.  shown  may  represent  a  major  impurity  of  their  prep- 
aration. 
(2)  Polyacrylamide  gel  electrophoresis 
Electrophoresis  of  the  purified  erythrocyte  hexokinase 
with  5  and  7.5%  normal  polyacrylamide  gels  (as  described 
'in  Chapter  7)  with  a  protein  loading  of  2  µg  per  tube  re- 
vealed  one  band  of  hexokinase  activity,  stained  with  G6PD 
either  in  the  staining  solution  or  in  the  gel.  By  increas- 
"  ing  the  protein  loading  to  50  µg  per  tube,  one  major  and 
one  faster  minor  protein  band  was  revealed  after  staining 
for  protein  or  scanned  at  265  nm  (Figure  8.1).  Hexokinase 
activity  was  still  represented  by  one  band  coinciding  to 
the  central  area  of  the  major  protein  band. 
Incubating  the  hexokinase  sample  for  24  hours  in 
Tris-HC1  buffer  pH  =  8.0,  I=0.01  plus  0.1  M  KC19 
1  mri  glucose  6-phosphate,  0.1ö  (v/v)  2-mercaptocthanol i 
.C 
Figure  8.1.  Scanning  trace  of  265  nm  of  7.5%  normal 
polyacrylamide  gel  after  electrophoresis  of  purified 
erythrocyte  hexokinase 
0:  Origin;  M:  bromophenol  blue  band  after  electrophoresis 
anode,  cathode. 171 
and  1  mM  EDTA,  prior  to  electrophoresis,  did  not  alter  the 
protein  or  activity  pattern  obtained  on  electrophoresis  on 
7.5%  polyacrylamide. 
(b)  Molecular  size 
(1)  Molecular  weight  and  diffusion  coefficient  (D 
20.  w) 
by 
analytical  gel  filtration 
A  sample  of  7  units  of  purified  erythrocyte  hexo- 
,. 
kinase  in  0.5  ml  of  buffer  was  applied  to  a  Sephadex  G-200 
column  calibrated  with  the  protein  markers  shown  in  Table 
"  9.1.  '  Fractions  of  1.4  ml  were  collected.  The  relation 
between  the  logarithm  of  the  molecular  weight  of  markers 
and  their  elution  volume  is  shown  in  Figure  9.3.  The 
relation  between  the  reciprocal  of  the  diffusion.  coeffic- 
ientsof  the  markers  and  their  elution  volume  is  shown  in 
Figure  9.4.  The  molecular  weight  was  estimated  as  108,500 
and  the  D20. 
w 
as  50  µm2/s.  The  diffusion  coefficient  corres- 
ponds  to  a  Stokes  radius  of  42.5  A° 
The  molecular  weight  of  purified  human  erythrocyte 
hexokinase  was  found  t6  be  higher  (132,000)  by  gel  filt- 
ration  on  Sephadex  G-200  and  Ultrogel  AcA  44  by  Rijksen 
and  Staal(1976a).  The  molecular  weight  of  the  same  -enzyme 
in  haemolysates  was  found,  by  gel  filtration  on  Sephadex. 
G-200,  to  be  in  the  same  range  i.  e.  103,900  and  107,700 1  72 
for  HK  I  and  HK  II  respectively  by  Rogers  et  al.  (1975b). 
(2)  S20. 
j1 
value  by  preparative  ultracentrifugation 
The  sample  applied  to  sucrose  density  gradient  prep- 
arative  ultracentrifugation  contained  5  units.  of  purified 
erythrocyte  hexokinase,  2.5  mg"of  horse  heart  cytochrome  C 
and  120  units  of  rabbit  muscle  lactate  dehydrogenase.  The 
concentration  of  cytochrome  c  was  measured  by  absorbance 
at  550  nm.  The  activity  of  lactate  dehydrogenase  was 
assayed  by  the  change  of  absorbance  at  340  nm  after  adding 
20  91  of  each  fraction  in  3  ml  of  0.1M  sodium  phosphate 
buffer  pH  =-7.4  containing  0.58  mM  NADH"and  1.8  mM  sodium' 
pyruvate.  The  sucrose  concentration  of  the  fractions  was 
measured  by  a  Bellingham  &  Stanley  Ltd  (London)  refracto- 
meter.  ' 
"  By  plotting  s20. 
w 
values  versus  the  sucrose  concentra- 
tion  at  the  peak  of  each  protein  (Figure  8.2)  an  s 
" 
20.  w 
value  of  6.1  was  found  for  erythrocyte  hexokinase  assuming 
s  20.  w 
values  of  2.1  S  for  cytochrome  c  (Atlas  and  Farber, 
1956)  and  7.6  S 
. 
for  lactate  dehydrogenase  (Jaenicke  and 
Snof,  1968). 
(3)  Sedimentation  velocity  patterns.  Effect  of  glucose 
6-phosphate 
The  sedimentation  velocity  profile  of  purified  erythro- 173 
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(A)  (B) 
Figure  8.3.  The  effect  of  glucose  6-  phosphate  on  the 
sedimentation  pattern  of  purified  ery  throcyte  hexokinase 
(A)  The  buffer  was  phosphate  p11  =  7.0,  I=0.1  containing 
10  mM  glucose,  1  mM  EDTA  and  0.1;  %  (v/v)  2-mercapto- 
ethanol. 
(B)  The  buffer  was  Tris-HCl  pH  =  8.0,  I=0.01  containing 
0.1  N  KC1,1  mri  EDTA,  0.1%  (ý%r/v)  : 2-mercaptootlianol 
and  1  mmM  glucose  6-phosphate. 
The  protein  concentration  Wa.  s  it  mij/ml.  Photographs 
were  taken  90  minutes  after  reaching  the  speed  of  59,780 
rpm  at  a  schlieren  plate  angle  of  (  )45o(13)40o.  The  temp- 
0 
erature  was  10  C. ý,: 
475 
cyte  hexokinase  in  Figure  8.3  (A)  showed  a  single  symmetri- 
cal  peak  with  a  faster  moving  trace.  The  s20. 
w 
value  of 
the  major  peak  was  5.45  S.  Although  this  value  can  not  be 
referred  to  hexokinase  since  the  sample  was  not  pure,  it 
is  interesting  that  the  value  found  is  very  near  to  that 
of  heart  hexokinase  (5.5  S)  under  the  same  buffer  cond- 
itions.  However  the  value  of  6.1  S  found  by  preparative 
ultracentrifugation  is  much  higher. 
If  the  above  sample  of  erythrocyte  hexokinase  was 
dialysed  against  the  buffer  containing  1  mM  glucose  6- 
phosphate,  for  24  hours,  molecular  species  of  higher  size 
were  observed  (Figure  8.3  B),  evidently  produced  by  aggreg- 
ation.  Thus  the  erythrocyte  enzyme  appears  to  aggregate 
in  the  presence  of  glucose  6-phosphate  as  found  for  the 
enzyme  from  heart  (Chapter  9). 
(4)  SDS-polyacrylamide  gel  electrophoresis 
50  µg  of  purified  erythrocyte  hexokinaso  were  sub- 
jected  to  electrophoresis  on  5%  SDS-polyacrylamide  gel 
(Figure  8.4,  A), 
The  appearance  of'multiple  bands  with  protein  stain 
shows  the  heterogeneity  of  the  sample,  in  accordance  with 
the  low  specific  activity  of  the  purified  material. 
The  slow  main  band  has  an  identical  relative  mobility 
as  the  slower  band  observed  for  the  purified  heart  hexo- 
kinase  on  electrophoresis  under  the  same  conditions  (Fig- 176 
to 
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(A)  (B) 
Figure  8.4.  5ö  SDS-polyacryl.  amide  Tel  electrophoresis  of 
erythrocyte  and  heart  hexokinase 
(A)  50  ug  per  tube  purified  erythrocyte  hexokinase 
(B)  40  µg  per  tube  purified  heart  hexokinase 
A  piece  of  wire  marks  the  position  of  bromophenol  blue 
band  after  the  electrophoresis.  Staining  was  for  proteins. 177 
ure  8.4,  B).  The  results  suggest  that  the  slow  main  band 
in  the  erythrocyte  sample  represents  hexokinase. 
a 
-I " 
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CHAPTER  9* 
Heart  hexokinase  ' 
(a)'  Electrophoresis 
Electrophoretic  investigations  on  mammalian  heart 
tissues  have  shown  the  presence  of  hexokinase  type  I  only, 
for  man  (Neumann  et  al.,  1974;  Ritter  et  al.,  1974;  Kamel 
and  Schwarzfischer,  1975;  Rogers  et  al.,  1975b),  for  yellow 
baboon  (Papio  cynocephalus),  for  green  monkey 
(Cercopithecus  aethiops)  (Ritter  et  al.,  1974).  and  for  pig 
(Easterby  and  O'Brien,  1973).  Besides  HK  I,  traces  of 
HK  II  and  HK  III  were  observed  for  guinea  pig  heart 
. 
(Faulkner  and  Jones,  1976).  However  for-rat  heart,  by 
DEAE-cellulose  chromatography,  HK  I  was  found  to  represent 
only  35%  of  the  total  soluble  hexokinase,  the  rest  char- 
acterized  as  HK  II  (Katzen  et  al.,  1970). 
Electrophoretic  results  shown  below  suggest  the 
presence  of  one  isoenzyme,  presumably  type  I,  in  human 
heart  as  well  as  the  electrophoretic  homogeneity  of  the 
purified  enzyme. 
(1)  Starch  gel  electrophoresis 
Small  paper-strips  were  moistened  with  a  purified 
heart  hexokinase  solution  containing  9  mg  of  protein  per "0 
X79 
ml  of  solution.  A  single  anodal  band  was  stained  with 
protein  stain  under  the  electrophoretic  conditions  shown 
in  Table  9.1. 
In  every  electrophoretic  experiment  there  was  a 
coincidence  of  activity  and  protein  stain.  However,  the 
activity  stain  was  too  diffuse  to  be  a  reliable  criterion 
of  purity.  The  fact  that  a  diffuse  band  of  activity  was 
observed  only  on  starch  gels  but  not,  on  cellulose  acetate 
strips  or  polyacrylamide  gels  may  indicate  a  possible 
interaction  of  purified  hexokinase  with  starch  gel. 
One  anodal  band  of  hexokinase,  1.3  cm  from  the  origin, 
was  also  observed  by  Neumann  et  al.,  (1974)  with  20  MM 
barbital-HC1  buffer,  pH  =  8.6,  after  a5  hours  electrophor- 
esis  at  250  V.  Rogers  et  al.,  (1975b),  found  in  homogen-' 
ates  of  human  heart,  two  bands  of  HK  I.  wi  th  the  Tris-EDTA- 
'borate-Mg  buffer  system,  pH  =  8.6.  However,  with  the  same 
electrophoretic  conditions  two  bands  were  also  observed 
with  a  heart  extract  in  this  project,  but  only  one  band  was 
obtained  with  the  purified  material. 
(2)  Cellulose  acetate  electrophoresis 
With  heavy  protein  loading  (45  µg  of  purified  heart 
hexokinase  per  cellulose  acetate  strip)  a"single  protein 
band  was  observed  coinciding  with  the  enzyme  activity 
band  (Figure  9.1).  This  band  moved  about  5  cm  towards  the 180 
Table  9.1.  Starch  gel  electro  phoresis'of  heart  hexokin- 
ase  .. 
Distance  from  origin  (cm). 
Buffer  system  Hexokinase  CO-Hemoglobin  Time  Electric 
(hours)  field 
Tris-EDTA-  +2.8  +5.4  5  480  V 
Borate  pH  =  8.6 
Tris-EDTA-  +1.3  +5.5  20  "85  V 
Borate-Mg 
pH  =  8.6 
Potassium  +0.35  -0.25  5  50  mA 
phosphate 
PH  =  7.0 
+ý  -;  indicate  movement  towards  the  anode  or  cathode. 181 
(A)  (B) 
(-F) 
1(0) 
Figure  9.1.  Electro  phoresis  of  45  lip  of  heart  hexoki.  na:  -e 
on  cellulose  acetate  strips  at  p}I  =  8.6 
A  Strip  stained  for  protein. 
13  Strip  stained  for  hexokinase  activity. 
Origin,  anode,  cathode. "  182 
anode  under  the  present  experimental  conditions  (Chapter  7). 
Controls.  omitting  ATP  from  the  staining  solution,  were 
negative. 
(3)  Polyacrylamide  gel  electrophoresis. 
The  electrophoretic  profile  of  heart  hexokinase  with 
7.5%  normal  polyacrylamide  gel  electrophoresis  is  shown  in 
Figure  9.2. 
Either  with  low  protein  loading  (5  µg/tube)  for  better 
resolution  or  with  heavy  protein  loading  (40  µg/tube)  for 
detecting  minor  protein  components  and  enzyme  bands  with 
J 
low  hexokinase  activity,  a  single  band  stained  for  hexo- 
kinase  activity  was  observed  corresponding  to  the  single 
band  stained  for  protein.  The  same  profile  was  also  ob- 
served  with  5%  polyacrylamide  gels,  except  that  the  hexo- 
kinase  band  travelled  double  the  distance  from  the  origin 
and  was  broader. 
No  difference  was  observed  in  the  electrophoretic 
" 
profile  with  either  of  the  staining  methods  for  hexokinase 
activity  i.  e.  incorporation  of  G6PD  into.  the  gel  or  into 
the  staining  solution.  However  the  former  method  appeared 
more  sensitive  and  gave  staining  in  depth  whereas  the 
latter  stained  a  faint  ring  outside  the  gel  because  G6PD 
could  not  diffuse  into  the  gel.  Controls  omitting  ATP  from 
the  staining  solution,  were  negative. Ii 
ýr 
,ý 
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(A)  (B)  (C)  (D) 
Figure  9.2.  Electrophoresis  of  heart  hexokinase  on  7.5`,  ö 
normal  polyacrylamide  gel 
A  and  B  40  µg  of  protein  loaded  per  tuba. 
C  and  D5  µg  of  protein  loaded  per  tube. 
A  and  D  stained  for  hexokinase  activity  with  G6PD 
incorporated  into  the  gel. 
B  and  C  stained  for  protein. 
Pieces  of  wire  mark  the  position  of  bromophonol  blue  band 
after  the  electrophoresis. "r. 
184 
(4)  Electrophoresis  as 
'a 
criterion  of  purity 
Electrophoresis  with  heavy  protein'loading  may  reveal' 
the 
'presence 
of  small  quantities  of  impurities  differing 
mainly  in  charge  from  the  protein  of  interest. 
Starch  gel  electrophoresis  with  paper-strips  impreg- 
nated  with  a9  mg/ml  solution  of  purified  heart  hexokinase, 
or  cellulose  acetate  electrophoresis  with  45  µg  of  protein 
per  strip,  or  polyacrylamide  gel  electrophoresis  with  40  µg 
per  gel  showed  consistently  a  single  protein  band.  This 
indicates  the  electrophoretic  homogeneity  of  the  sample. 
(b)  Molecular  Size 
(1)  Initial  estimation  of  molecular  weight  and  diffusion 
coefficient,  D20. 
w, 
by  analytical  gel  filtration 
"A  sample  of  0.5  ml,  was  applied  on  a  Sephadex  G-200 
column,  containing  the  following  markers:  15  mg/ml  y- 
globulins,  15  units/ml  lactate  dehydrogenase,  40  mg/ml  ser- 
um  albumin,  20  mg/ml  ovalbumin  and  3  mg/ml  blue  dextran. 
Molecular  weights  and  diffusion  coefficients  of  the  protein 
markers,  derived  from  gel  filtration  experiments  are  given 
in  Table  9.2.  Blue  dextran  was  used  for  the  estimation  of 
the  void  volume.  The  concentration  of  ovalbumin,  serum 
albumin  and.  'Y-globulin  in  the  fractions  was  measured  by 
the  absorbance  at  280  nm.  The  concentration  of  blue- 185 
Table  9.2.  Protein  markers  for  gel  filtration 
Molecular  Diffusion 
Protein  Source  weight  Coefficient  Reference 
3 
x  10  (D 
0 
) 
2  .w 
µm2s 
y-Globulins  Bovine  205  41  Andrews, 
(1965) 
Lactate  Pig  147.  -  -Determann' 
dehydrogenase  heart  and  Mattner, 
(1969) 
Albumin  Bovine  67  59  Andrews, 
serum  (1965) 
Ovalbumin  Egg  41  78  Andrews, 
(1965). '"  186 
dextran  was  measured  by  the  absorbance  at  620  nm  and  the 
activity_of-lactate  dehydrogenase  by  the-assay  method  used 
after  sucrose  gradient  centrifugation'(Chapter.  8). 
A  sample  of  0.5  ml  containing  20  units/ml  of  purified 
heart  hexokinase  was  chromatographed  and  fractions  of 
1.6  ml  were  collected. 
The  relation  between  the  logarithm  of  the  molecular 
weight  of  markers  and  their  elution  volume  is  shown  in 
Figure.  9.3.  The  relation  between  the  reciprocal  of  the 
diffusion  coefficients  of  the  markers  and  their  elution 
volume  is  shown  in  Figure  9.4+.  'By  linear  regression  the 
molecular  weight  was  found  equal  to  106,000  and'the  diff- 
usion  coefficient  (D20  )  equal  to  51  µm2/s.  The  latter 
rw 
value  corresponds  to  a  Stokes  radius  of  42  A°. 
Neumann  et  al.  (1974)  reported  an  apparent  molecular 
.  weight  for  purified  heart  hexokinase  by  gel-filtration  on 
Sephadex  G-200  of  11.1,000  which  is  in  approximate  agreement 
with  the  present  results.  - 
(2)  Gel  filtration  as  a  criterion  of  purity 
A  sample  of  1.4  ml  of  purified  heart  hexokinase  with 
a  protein  concentration  of  18  mg/ml  was  applied  on  a 
Sephadex-G-200  column.  The  elution  profile  is  shown  in 
Figure  9.5.  "Fractions  of  4  ml  were  collected. 
Within  the  sensitivity  of  the  measurement  of  absorb- 187 
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Figure  9.3.  Empirical  method  for  ebtimating  the  molecular 
weight  of  hexokinase.  from  heart  and  erythrocyte 
Plot  of  Log10  molecular  weight  against  elution  volume  for 
standard  proteins  on  a  Sephadex  G-200  column. .,.  ý. 
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Figure  9.4+.  Diffusion  coefficient  for  erythrocyte  and 
heart  hexokinase  from  gel-filtration 
Plot  of  J/D20. 
W 
versus  elution  volume  for  standard  proteins 
after  gel  filtration  on  Sephadex  G-200. 189 
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Figure  9.5.  Elution  profile  from  gel-filtration  on 
Sephadex  G-200  of  purified  heart  hexokinase 
(0--0)  Absorbance  at  280  nm;  (A----A)  Enzyme  activity. 
Fractions  of  4  ml  were  collected. J90 
'`ý_ýa.. 
ance  at  280  nm  a  single  protein  peak  was  found  coinciding 
with  the  enzyme  activity.  The  specific  activity  was  con- 
stant  in  the  fractions  tested,  except  at  both  edges  of 
the  peak  where  protein  measurements  were  low  and  thus  un- 
reliable.  Within  the  limits  of  resolution  of  this  method 
the  sample  appears  homogeneous  with  respect  to  size. 
(3)  Estimation  of  molecular  weight  by  SDS-polyacrylamide 
electrophoresis 
Figure  9.6.  shows 
.5 
and  10%  SDS-polyacrylamide  gel  el- 
ectropherograms  of  purified  heart  hexokinase  with  protein 
loading  of  6  µg/gel.  For  the  estimation  of  the  molecular' 
weight  of  hexokinase  the  5%  polyacrylamide  gel  was  prefer- 
red  for  its  better  resolution  and  thus  more  accurate  est- 
imation  of  molecular  weight. 
The  protein  markers  myosin,  ß-galactosidase,  phosphor- 
ylase  a,  bovine  serum  albumin,  pyruvate  kinase  and  oval- 
bumin  were  run  separately.  The  molecular  weights  assumed 
for  the  markers  are  shown  in  Table  9.3.  Graphs  of  the  log- 
arithm  of  molecular  weights  of  the  markers  against  their 
relative  mobility  for  5  and  10%  SDS-polyacrylamide  gels  are 
shown  in  Figures  9.7.  and  9.8.  respectively. 
With  linear  regression  the  two  bands  were  found  to 
correspond  to  molecular  weights  of  124,000  and  109,000  at 
5%*polyacrylamide  concentration.  The  two  bands  thus 191 
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(A)  (B) 
Figure  9.6.  SDS-j,.  )lvacrvla-nide  e1  ectro1)1  ,  I''  is  of  6  11 
heart  hexokinase 
(A)  (Y,  10  SDS-PAGE 
(B)  5j%o  SDS-PAGE 192 
Table  9.3.  Protein  markers  for  SDS-poly  acrylamide  electro- 
phoresis 
Molecular 
Protein  Source 
i  h  03 
Reference 
we  g  tx1 
Myosin  Rabbit  220  Woods  et  al., 
muscle 
(1963) 
,  . 
Slayter 
and  Lowey,  (1967), 
Ullmann  et  al., 
(1968). 
ß-Galactosidase  E.  coli  130  Seery  et  al., 
(1967),  Ullmann 
et  al.,  (1968) 
Phosphorylase  a  Rabbit  100  Cohen  et  al., 
(1971) 
muscle 
Albumin  Bovine  68  Tanford  et  al., 
(1967) 
serum 
"  Pyruvate  kinase  Rabbit  57  Steinmetz  and 
muscle 
Deal,  (1966) 
Ovalbumin  Egg  43  Castellino  and 
Barker,  (1968). 5.4 
5.2 
"1- 
3 
G 
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5.  U  Pnospnoryiase  a 
0 
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0 
o  Serum  albumin 
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o  Pyruvate  kinase 
Ovalbumin 
4.6 
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Relative  mobility 
Figure  9.7.  Graph  of  the  logarithm  of  molecular  weight 
against  relative  mobility  for  the  standard  proteins  on 
SDS-polvacrylamß-de  gel  electrophoresis 
Full  circles  represent  the  two  bands  of  the  heart  hexo- 
kinase  sample. 194 
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Figure  9.8.  Grap  h  of  lop  molecular  weight  against  relat- 
ive  mobilit  y  for  the  standard  proteins  on  10%  SDS-poly- 
acrylamide  gel  electrophoresis 
Full  circle  s  represent  the  two'bands  of  the  heart  hexo- 
kinase  sample. 195 
"  differed  by  159000,  With  10%  polyä.  crylamide  concentration 
however,  both  bands-corresponded  to  smaller  molgcular 
weights  (Table  9.4). 
The  observation  of  two  bands  instead  of  the  expected 
one,  is  difficutl  to  interpret.  It  is  generally  accepted 
that  low  Km  mammalian  hexokinases  (HK  I  and  HK  ii)  are  mono- 
meric  with  a  molecular  weight  of  approximately  100,000  as 
measured  under  denaturing  conditions  (Easterby,  1971;  Chou 
and  Wilson,  1972;  Easterby  and  O'Brien,  1973;  Holroyde  and 
Trayer,  1976). 
" 
However,  some  divergencies  to  this  pattern  have  been 
'reported.  Easterby  (1971)  observed  with  porcine  heart  hexo- 
kinase  two  bands  corresponding  to  molecular  weights  of 
92,000  and  100,000  after  SDS-polyacrylamide  electrophoresis.. 
These  bands  were  reduced  to  one  band  of  97,000  molecular 
weight  if  the  enzyme  was  heat-treated  (to  100°C  for  5  min 
prior  to  dialysis  against  SDS-containing  buffer.  Craven  and 
"Basford  (1974)  reported  that  rat  brain  hexokinase  solubil- 
ised  by  glucose  6-phosphate  and  purified  by  DEAE-cellulose 
chromatography  showed,  on"SDS-polyacrylamide  gel  electro- 
phoresis,  a  major  band  of  130,000  and  a  minor  band  of 
100,000  molecular  weight  when  the  enzyme  was  treated  at 
450C  with  1%  (w/v)  SDS  and  0.2%  (v/v)  2-mercaptoethanol. 
However  if  the  same  sample  was  pretreated  with  2;  ö  (v/v) 
2-mercaptoethanol  for  30  minutes  in  boiling  water  before 
the  addition  of  1%  (w/v)  SDS,  a:  peptide  of  45,000 "  196 
Table  9.4.  Estimation  of  molecular  wei  ght  of  heart  hexo- 
kinase  by  SDS-polyacrylamide  electrophoresis 
Large  Small  'Acrylamide 
Difference 
component  component  concentration 
(M.  wtx103)  (M.  wtx103)  (  M.  wtx103) 
124  1o9  15  5 
124  110  14  5 
125  108  17  5 
117  98  19  10 197 
appeared  suggested  as  a  subunit_öf  hexokinase. 
Monakhov  et  al.,  (1975)  showed  that  four  isoenzymes  of 
soluble  human  gastric  mucosa  hexokinase  purified  by  poly- 
acrylamide  gel  electrophoresis  had  molecular  weights  ran  g- 
ing  from  112,000  to  125,000  as  found  by  density  gradient 
preparative  ultracentrifugation.  Treatment  of  each  iso- 
enzyme  with  1%  SDS  and  boiling  for  3  minutes  led  to  the 
appearance  of  two  intense  bands  on  SDS-polyacrylamide  gel 
electrophor.  sis  corresponding  to  molecular  weights  of 
60,000  and  96,000,  whereas  if  8M 
,  urea  was  added  on  top  of 
SDS  only  one  band  of  60,000  molecular  weight  appeared. 
The  two  bands  of  purified  human  heart  hexokinase 
.  shown  in  Figure  9,9  may  represent  either  two'hexokinase 
molecules  differing  in  size,  or  hexokinase  and  a  major 
impurity.  If  both  bands  represent'  hexokinase,  the  smaller 
one  could  be  a  degraded  form  of  the  other.  Alternatively 
the  larger  species  could  include  a  non-protein  moiety  such 
as  lipid  or  carbohydrate. 
Moreover  one  can  not  exclude  the  creation  of  artifacts 
during  the  preparation  of  samples  and  electrophoresis. 
Partial  denaturation  of  a  protein  molecule  may  lead  to  in- 
complete  binding  of  SDS  to  it  and  thus  to  electrophoretic 
mobility  similar  to  a  higher  protein  species.  Ammonium 
persulphate  used  for  the  initiation  of  polymerization  of 
the  gelling  solution  is  reported  to  produce  artifacts  with 198 
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Figure  9.9.5%j  SDS-polyacrylamide  electrophoresis  of  45  t_t 
of  heart  hexokinase 
(A)  Staining  for  proteins. 
(B)  Scanning  at  265  nm.  Origin  (O)  and  position  of 
bromophenol  blue  band  (M). "  199 
normal  polyacrylamide  electrophoresis  (Mitchell,  1967; 
Shapiro  et  al.,  1967;  Brewer,  1967;  Schyns,  -1968). 
Pringle  (1970)  reported  that  proteolysis  of  yeast 
hexokinase  in  the  presence  of  sodium  dodecylsulphate  was 
avoided  by  phenylmethyl  sulphonylfluoride  (PMSF),  an 
irreversible  serine  protease  inhibitor  (Schulze  et  al., 
1967).  Similar  results  were  presented  for  the  same  enzyme 
by  Easterby  and  Rosemeyer  (1972). 
Certain  modifications  in  the  electrophoretic  proced- 
ure  were  tried  in  order  to  investigate  the  nature  of  the 
two  bands  on  SDS-polyacrylamide"electrophoresis 
1 
(i)  Prerun  of  gels  for  2  hours  with  a  constant 
current  of  2  mA/tube. 
(ii)  Photopolymerizätion  of  gelling  solution  with 
µg/ml'riboflavin. 
(iii)  Blockage  of  sulfhydryl  groups  of  the  sample 
with  iodoacetamide  before  boiling  with  the 
sample  buffer. 
(iv)  Addition  of  20  mM  PMSF  solution  in  95%  ethanol 
to  the  sample,  to  a  final  concentration  of 
1-2  mM,  prior  to  the  boiling  with  the  sample 
buffer. 
(v)  Addition  of  PMSF  to  the  homogenate  of  heart 
tissue  (Step  1  of  the  respective  purification ,.  - 
200 
procedure)  to  a  final  concentration  of  1-2  mM. 
(vi)  Dialysis  of  the  sample  against  the  sample 
buffer  for  24  hours  after  its  boiling  with  the 
same  buffer. 
(vii)  Addition  of  8M  urea  to  the  sample  buffer. 
None-of  these  modifications  gave  achange  in  the  two 
band  pattern.  Also  stain  for  glycoproteins  was  negative 
while  stain  for  lipoproteins  stained  only  a  narrow  band 
at  the  bromophenol  blue-band  position. 
It  is  difficult  to  imagine  that  one  of  the  two  bands 
is  an  impurity  since  it  must  have  followed  closely  hexo- 
kinase  in  all  purification  steps  and  also  has  an  affinity 
for  glucosamine  bound  on  Sepharose.  Interestingly  the 
larger  component  corresponded  to  the  main  band  seen  for 
erythrocyte  hexokinase  on  SDS-polyacrylamide  Gel  (Chapter 
8).  The  possible  heterogeneity  of  hexokinase  owing  to 
attached  lipid  or  carbonhydrate  was  ruled  out  with  appropri- 
ate  stains. 
No  half  size  subunits  were  observed  with  the  purified 
human  heart  hexolcinasein  contrast  to  reports  by  Craven 
and  Basford  (1974)  for  rat  brain  hexokinase  and  Monakhov 
et  al.,  (1975)  for  human  gastric  mucosa  hexokinase.  The 
findings  of  those  authors  should  be  interpreted  with  cau- 
tion  since  experiments  were  performed  with  impure  hexo- 
kinase  samples. 20  1 
(Li)  SDS-polyacrylamide  electrophoresis  as  a  criterion  of 
purity 
"  Heavy  loading  of  SDS-polyacrylamide  gels  (45  mg'of 
protein  per  tube)  revealed  two  major  bands  "  and  .a  minor  one 
at  the  position  of  the  bromophenol  blue  band,  marked  by  a 
piece  of  wire,  as  seen  in  Figure'9.9(A).  In  Figure  9.9(B) 
the  spectrophotometric  tracing  of  absorbance  at  265  nm  is 
shown. 
"  The  denatured  sample  of  purified  heart  hexokinase  con- 
tained  as  discussed  above,  two  protein  components.  The 
spectrophotometric  trace  shows  that  the  components  are 
present  in  approximately  equal  amounts  in  this  preparation. 
In  other  preparations  the  amount  of  large  component  ranged 
from  25%  to  55%  of  the  total  protein. 
(5)  Estimation  of  partial  specific  volume, 
The  partial  specific  volume  of-heart  hexokinase  was 
calculated  from  density  measurements  performed  with.  the 
Anton  Paar  K.  G.  (Austria)  digital  precision  density  meter 
DMA  02D.  The  principle  of  this  apparatus  is  based  on  the 
mechanical  escillator  technique  described  by.  Kratky  et  al. 
(1973)" 
For  the  density  difference  of  two  samples  the  follow- 
ing  equation  holds: "  202 
d1  -  d2  K(T12  -  T22) 
where  dj,  d2  are  the  densities  of  two  samples 
K  is  the  constant  of  the'  apparatus 
and  T1,  T2  are  the  respective  times  for.  104  full 
periods  of  the  vibrator  (displayed  in 
the  apparatus  in  units  of  10  µs)  for 
the  two  samples.  ti 
Measurements  were  made  at  10°C  with  a  barometric 
pressure  of  767.65  mm  of  mercury  column  (at  24°C).  The 
density  of  dry  air  was  assumed  to  be  0.001260  g/ml  and. 
that  for  water  0.999700  g/ml  at  10°C..  The  solution  of 
hexokinase  had  a  protein  concentration  of  8.96  mg/ml  in 
phosphate  buffer  pH  =  7.0,  I=0.1  containing  0.2  M  KC11 
10  mM  glucose,  1  mM  EDTA  and  0.1%  (v/v)  2-mercaptoethanol. 
The  protein  concentration  was  estimated  from  refracto- 
metric  measurements  as  mentioned  below. 
From  measurements  of  T  for  dry  air  and  water,  K  was 
found  equal  to  3.250388.10-14  g/ml  x  s2.  From  measure- 
ments  of  T  for  the  water-buffer  and  water-protein  solu- 
tions,  the  densities  of  buffer  and  protein  solutions  were 
found  to  be  1.016202  and  1.018536  g/ml  respectively..  A 
summary  of  T  measurements  is-presented  in  Table  9.5. 203 
Table  9.5. 
Material  T  (10-5sec)  ''  S.  D.  S.  E.  n 
Dry  air  5532018.5  1.91  0.96  4 
Water  7830759.25  1.71  0,85  4 
Buffer  7863108.5  4.80  2.40  4 
Hexokinase  solution  7867672.83  9.45  3.86  6 
..  rt 
x 
-- 
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The  partial  specific  volume  was  calculated  from  the 
following  equation: 
(c)  d2  -  d1) 
d1  c 
where  'U(c)  is  the  partial  specific  volume  measured  at 
a  single  solute  concentration 
d1  is  the  density  of  the  solvent  in  g/ml 
d2  is  the  density  of  the  solution  in  g/ml 
and  c  is  the  concentration  of  protein  in  g/ml. 
Thus  the  partial  specific.  volume  was  found  equal  to 
0.728  ml/g  under  the  above  conditions. 
The  partial  specific  volumes  of  rat  brain  and  porcine 
heart  hexokinases  calculated  from  their  amino  acid  compos- 
iticn  were  found  to  be  higher  i.  e.  -0.74 
(Chou  and  Wilson, 
1972)  and  0.737  ml/g  (Easterby,  1971)  respectively. 
(6)  Estimation  of  the  extinction  coefficient  E 
1%, 
280 
1cm 
nm 
The  refractive  index  for  hexokinase  was  assumed  to  be 
1.6,  a  value  typical  for  non-haem  proteins.  Proteins  with 
a  refractive  index  of  about  1.6  have  been  reported  to  cause 
an  average  displacement  of  4.1  fringes/mg/ml  in  a  refracto- 
meter 
(Babul  and  Stellwagen,  1969).  Thus  by  measuring  the 
number  of  fringes  crossed  in  traversing  a  protein-solvent 205 
boundary,  the  concentration  of  a  protein  solution  may  be 
determined. 
A  Spinco  model  E  ultracentrifuge  equipped  with 
Rayleigh  interference  optics  was  used-as  a  refractometer. 
A  sample  approximately  5  mg/ml  of  'the  enzyme  was  dialysed 
exhaustively  against  phosphate  buffer  pH  =  7.0,  I=0.1 
containing  0.2  M  KC19  10  mM  glucose,  1  mM  EDTA  and  0.1% 
(v/v)  2-mercaptoethanol.  A  boundary  was  formed  between 
the  protein  solution  and  the  dialysis  buffer  as  described 
in  Chapter  7.  The  boundary  was  allowed  to  diffuse  at 
"  6,995  r.  p.  m.  at  10  oC 
and  interference  photographs  were 
taken  over  a  period  of  90  minutes. 
The  fringe  displacement  was  measured  using  a  twin 
co-ordinate  travelling  microscope  and  by'counting  the 
fringes  crossed  from  solvent  to  solution.  The  hexokinase 
..  concentration  was  calculated  using  the  value  of  4.1 
fringes  displaced  for  each  mg  of  protein  per  ml  of  solution. 
The  absorbance  of  the  hexokinase  solution  at  280  nm  was 
measured  prior  to  the  ultracentrifuge  experiment,  using  a 
Perkin-Elmer  124  double-beam  spectrophotometer  and  1  cm 
light-path  cuvettes. 
The  absorbance  at  280  nm  combined  with  the  protein 
concentration  obtained  by  the  fringe  displacement  in  the 
ultracentrifuge,  gave  an  extinction  coefficient, 
E1%' 
1  cm 
--  6.0.  This  value  was  then  used  for  subsequent  280  nm 206 
"  measurement  of  protein  concentration  of  heart  hexokinase 
using  theabsorption  at  280  rim. 
Extinction  coefficients  reported.  for  mammalian  hexo- 
kinases  are  summarized  in  Table  9.6..  These  values  although 
determined  by  various  methods  of  protein'  estimation,  vary 
only  from  5.1  for  brain  hexokinase  to  6.0  for  the  porcine 
heart  enzyme.  The  higher  value'of  7.62  reported  by 
Neumann  et  al.  (1974)  may  be  caused  by  impurities  in  their 
preparation. 
The  low  absorbance  at  280  nm  is  compatible  with  the 
relatively  low  content  of  aromatic  amino.  acids  as  shown- 
by  amino  acid  composition  studies  of  rat  brain  (.  Chou  and-- 
Wilson,  1972)  and  porcine  heart  hexokinase  (Easterby  and 
O'Brien,  1973). 
(7)  Estimation  of  sedimentation  coefficient,  s20. 
w' 
under 
various  buffer  conditions 
In  Table  9.7  results  of  sedimentation  velocity  ultra- 
centrifugations  are  presented  under  various  conditions  of 
pH,  ionic  strength  and  protein  concentration. 
At  pH  =  7.0  no  significant  alteration  of  sediment- 
ation  coefficient  was  observed  by  doubling  the  protein  conc- 
entration  from  4  to  9  mg/ml. 
The  increase  of  ionic  strength  at  pH  =  7.0  from  0.1 
to  2.1  resulted  in  a  decrease  of  the  sedimentation  coeff- .  x::  <......  - 
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Table  9.6.  Extinction  0  coefficients,  E 
280  1  cm, 
of  mammal- 
run 
ian  hexokinases, 
Source  E1%, 
1  cm  Method  of  protein  Reference  280  nm  measurement 
Human  heart  7.62  Biuret  Neumann  at  al., 
(1974) 
Porcine. 
_6.0 
Refractometric  Easterby  and 
heart  O'Brien  (1973) 
Rat  brain  5.53  Lowry  Schwartz  and 
Basford  (1967) 
Rat'brain  5.1  Turbidimetric  Chou  and 
Wilson  (1972) 
Bovine  5;  5.  Lowry  Redkar  and 
brain  Kenkare  (1972) 
Human  heart  6.0.  Refractometric  Present  results. 
r ýý 
"" 
ý) 
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Table  9.7.  Effect  of  pH  and  ionic  strength  on  the  sediment- 
ation  coefficient 
Protein 
Correction  s20.  w 
PH  Buffer  concentration  factor  (to 
(m  ml)  nearest 
o.  o5)S. 
7,0,  Phosphate  1=0.1  4  1.340  5.50 
7.0  Phosphate  I=0.1  8  1.340  5.50 
7.0  Phosphate  1=0.1  9  1.340  5.50 
7  .0  Phosphate  1=0.1+0,2M  KC1  IQ  1.361  5.1.5 
7.0  Phosphate  I=0.1+2  M  KC1  5  1.735  4.80 
6.0  Acetate  I=0.1+0.2  M  KC1  6.5  1.416  5.85 
8.0  Tris-HC1  I=0.01+0.2  M  KC1  6.5  1.324  5.30 
All  solutions  contained  10  mM  glucose,  1"mM  EDTA  and  0.  1% 
'(v/v)  2-mercaptoethanol.  Expe  riments'  were  performed  at 
° 
'10C. "u 
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j-. 
ient  from  5.5  to  4.8.  If.  a  dissociation  to  subunits  was 
occurring,  a  much  greater  decrease  of  s  should  be  ex-  20.  w 
pected.  So  it  is  more  likely  that  at  high  salt  cöncentra- 
tion  the  protein  is  preferentially  hydrated,  causing  an 
increase  in  the  partial  specific  volume  (Ti)  for  the  pro- 
tein.  Since  no  allowance  is  made  for  this  change  of  v, 
the  sedimentation  coefficient  appears  to  be  low.  This 
phenomenon  has  been  reported  to  occur  to  other  proteins, 
for  instance  serum  albumin  and  aldolase  (Reisler  and 
Eisenberg,  1969). 
`  The  lowering  of  H  from  gp7.0  to  6.0  resulted  in  an 
increase  of  sedimentation  coefficient  from  5.15  to  5.85  at 
total  ionic  strength  of  0.3.  Since  the  schlieren  peak  at 
pH  =6  was  a  single  symmetrical  one,  this  increase  can  be 
either  the  result  of  a  conformational  change  of  the  hexo- 
kinase  molecule  or  of  a  rapid  equilibrium  between  monomer 
and  polymer(s).  - 
(8)  Sedimentation  velocity  pattern  as  a  criterion  of 
purity 
Sedimentation  relbcity  experiments  are-a  useful  guide 
to  the  purity  öf  an  enzyme  preparation,  although  small 
amounts  of  impurities  would  not  be  visible  using  this 
technique. 
Sedimentation  experiments  on  the  enzyme  in  buffers 'ý 
._ý 
ýk 
210 
containing  10  mM  glucose,  1  mM  EDTA  and  0.1%  (v/v)  2- 
mercaptoethanol  at  10°C,  performed  as  described  in  Chapter 
7,  showed  single,  symmetrical  boudaries  over  a  range  of  pH 
and  ionic  strength.  Figure  9.10  shows  a  typical  sediment- 
ation  pattern  obtained  in  phosphate  buffer  at  pH  =  7.0, 
I=0.1. 
... 
The  purified  heart  hexokinase  sample  appears  homogen- 
eous  within  the  resolution  and  sensitivity  limits  of  this 
type.  of  experiment. 
(9)  Estimation  of  diffusion  coefficient,  D20. 
w 
Measurements  of  the  D20. 
w 
by  observing  the  diffusion- 
of  a  boundary  in  a  low  gravitational  field  in  the  ultra- 
centrifuge,  gave  a  value  of  47  9m 
2/s 
using  two  different 
buffer  conditions  (Table  9.8). 
The  graphical  analysis  of  the  diffusion  data  for  the 
experiment  in  phosphate  buffer  pH  =  7.0,  I=0.1  is  shown 
in  Figure  9.11. 
The  D20*w  found  in  ultracentrifuge  is  slightly  lower 
than  the  value  found  by  gel  filtration  (51  }im2/s).  With 
D20. 
w 
equal  to  47  µm2/s,  the  calculated  Stokes  radius  is 
°  45  A. 
(10)  Estimation  of  molecular  weight  by  the  combined  sedi- 
mentation  coefficient  and  diffusion  coefficient  yalue5. -1 
-211 
Figure  9.10.  Sedimentation  pattern  of  purified  heart 
hexokinase 
The  protein  was  8  mg/ml  in  potassium  phosphate  buffer 
pH  =  7.0,  I=0.1  containing  10  mM  glucose,  1  mM  EDTA  and 
0.11,  -,  0 
(v/v)  2-mercaptoothanol.  'Migration  is  frone  left-  to 
right.  The  photograph  was  taken  90  min  after  reaching  a 
speed  of  59,780  rev/min.  Temperature  was  10°C.  The 
schlieren  plate  angle  was  55°. 212 
. 
Table  9.8.  Estimation  of  diffusion  coefficient,  D20. 
w' 
of  heart  hexokinase  by  boundary  forming  experiments 
Protein 
PH  Buffer  concentration 
Correction  D22 
(m  ml) 
factor  (inn  Is) 
7.0  Phosphate,  I=0.1  8  1.365  47 
8.  O'  Tris-HC1,  I.  =0.01+0.2M  KC1,8  -1-333  47 
Buffers  contained  10  mM  glucose,  1  mM  EDTA  and  0.1%  (v/v) 
2-mercaptoethanol.  Experiments  were  performed'at"10C.  ° 213 
3.5r 
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Figure  9.11.  Analysis  of  the  diffusion  data  for  hexokinase 
in  phosphate  buffer  pH  =  7.0,  I-0.1 
The  square  of  the  ratio  of  the  area  of  the  schlieren  peak 
to  itst  height,  over  2TL,  is  plotted  against  time.  Centri- 
fugation  was  performed  at  6,995  r"p"m.  "  and'  at  10°C. 214 
Assymetry  of  the  hexokinase  molecule 
Measurement  of  the  sedimentation  coefficient  and 
diffusion  coefficient  for  hexokinase  provided  a  molecular 
weight  from  the  Svedburg  equation: 
M  SÜ  (Svedbýrg,  1925) 
DTP) 
Using  values  of  5.53  for  S20. 
w,  . 
47  µm2/s  for  D20yw 
and  0.728  for  v,  the  molecular  weight  was  estimated  to 
be  105,000. 
From  the  diffusion  coefficient,  an  indication  of  the. 
shape  of  the  molecule  is  given  by  the  frictional  ratio 
f/fo  (Svedblkg  and  Pedersen,  1940).  The  observed  molecular 
frictional  coefficient  is  given  by: 
f 
kT 
D 
The  calculated  molecular  frictional  coefficient  for  a 
sphere  of  molecular  weight  M  is  given  by: 
(23MO  3 
"--  fo=  6nß 
Y' 
4nN 
In  the  present  instance,  (M  =  105,000,0=  0.728, 
D 
20.  w  =  47  µm2/s),  the  frictional  ratio  f/fo  is  1.46.  For 
an  hydration  of  0.3  g  water  per  g  protein,  the  above  ratio '215 
indicates  an  axial  ratio  of  6:  1  for  a  prolate  ellipsoid 
according  to  Oncley  (1941).  Although  the  above  treatment 
is  an  oversimplification,  it  suggests  a  certain  degree  of 
assymmetry  in  the  hexokinase  molecule.  This  assymmetry 
in  molecular  structure  has  also  been  found  for  G6PD 
(Cohen,  1969),  6-PGD  (Pearse,  1972)  and  glutathione  reduct- 
ase  (Worthington,  1974). 
(11)  Sedimentation  equilibrium 
Photographic  results-of  two  sedimentation  experiments, 
are  shown  in  Figures  9.12  and  9.15.  In  all  sedimentation 
equilibrium  experiments  10  mM  glucose,  1  mM  EDTA  and  0.1% 
(v/v)  2-mercaptoethanol  were  present  in  solution.  Also  the 
centrifugation  continued  for  70  hours  at  a  rotor  speed  of 
6,995  r.  p.  m.  and  at  a  temperature  of  10°C.  The  initial 
concentration  was  calculated  from  the  corresponding  bound- 
ary  forming  experiment. 
Table  9.9  shows  the  results  from  four  sedimentation 
equilibrium  experiments.  A  general  feature  is  the  incon- 
sistency  of  Mz  and  Mw  values,  indicating  'he  torogeneitY  Of 
material  in  these  experiments. 
A  complication  was  observed  with  sedimentation  equil- 
ibrium  experiments  No  2,3  and  4  i.  e.  at  the  bottom  of 
the  cell  a  dense  band  was  observed  as  can  be  seen  from  the 
photograph  of  Figure  9.15.  Anomaly  with  the  ultracentri- -  --  --.  :  --.  .  -.  -.  - 
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`  _.  fuge}  optics  is  unlikely  as-no  sucht  band  was.  observed'with 
the  boundary  '  forming..  experiments..,  °%.  This  band  may-  represent 
either  very  high  polymers  in  solution  or  gelation. 
The`higher"mole  culdr  species-observed  through  the  sol- 
ution  must  represent  polymers  of'hexokinase  pröduced  only 
during  the  sedimentation  equilibrium  experiment,  -since 
subsequent  sedimentation  velocity  experiments  did  not  re- 
veal  ,  such  protein'  species. 
' 
Factors.  "-that-would  favour  the 
,  production  of  polymers  'to 
-a 
*greater-  extent.  inl-"sedimentation 
equilibrium  than  in  sedimentation  velocity  experiments 
(once  a  tendency  for  polymerization  exists)  are  the  much 
longer  time  of  the  experiment,  the  lower  pressure  (due  to 
lower  speed)  and  the  higher  concentration  of  proteins  to- 
wards  the  bottom  of  the  cell. 
The  fact  that  polymers  appear  even  at  high  salt  conc- 
entration  (2  M  KCl)  and  in  the  presence  of  2-mercapto- 
ethanol,  suggests-that  ionic  or  disulfide  bands  are  un- 
likely  to  participate  in  polymerizat16n.  Therefore  hydro- 
phobic  forces  are  more  likely  candidates. 
Another  common  characteristic  is  that  the  six  points 
measured  from  the  meniscus  fall  into  a  line,  as  can  be 
seen  from  graphical  representations  of  two  of  the  experi- 
ments  (Figures  9.13,  *9.11  and  9.16,9.17).  This  suggests 
the  presence  of  a  discrete  protein  species,  at  the  meniscus. 
Table  9.10  shows  the  Mw  and  Mz  values  calculated  at  the 
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Table  9.10.  Molecular  wei  ghts  calculated  near  the 
meni  scus 
Results  are  presented  for  the  same  sequence  of  sediment- 
ation  equilibrium  runs  as  in  Table  9.9.  Molecular  weights 
at  the  meniscus  we  re  calculated  from  the  first  six  points 
from  the  meniscus. 
No  Buffer  pH  KC1  I  Mw  x  103  Mz  x  103 
"  (M) 
J 
1  Phosphate  7.0  -  0.1  88.11"  110.8 
2  Phosphate  7.0  -  0.1  85.48  138.0 
3  Phosphate  7.0  2  2.1  86.24  138.1 
4  Tris-HC1  8.0  0.2  0.21  97.12  133.9 219 
Fi;  pre'9.12.  Sedimentation  equilibrium  of  hexokinase  in 
phosphate  buffer  pH  _  7.0,  I=0.1 
. 
The  top  photograph  shows  the  equilibrium  pattern  after 
centrifugation  at  6,995  r.  p.  m.  for  70  hours  at  10°C.  The 
lower  photographs  show  the  schlieren  pattern  at  30  and  62 
minutes  respectively,  after  boundary  formation.  Schlieren 
plate  angle  60°. 
I 
- iý 
i', 221 
1.6 
1.5 
V 
0 
01.3 
v 
ö  1..  2 
1.1 
1.0 
48  49  50  51  52 
r2  (cm2) 
Figure  9.13.  Sedimentation  equilibrium  of  hexokinase  in 
phosphate  buffer  pH  =  7.0,  I=0.1 
The  figure  shows  the  logarithm  of  the  concentration  plotted 
against  the  square  of  the  radial  displacement  after  70  hours 
at  6,995  r.  p.  m.  The  temperature  was  10°C. 222 
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Figure  9.14.  Sedimentation  equilibrium  of  hexokinase  in 
phosphate  buffer  pH  =  7.0',  I=0.1.  " 
The  figure  shows  the  ratio  of  the.  concentration  'gradient 
to  radial  displacement  versus  the  difference  in  concentra- 
tion  from  that  at  the  meniscus.  After  70  hours  at  6,995 
r.  p.  m.  and  at  10°C. 223 
Figure  9.15.  Sedimentation  equilibrium  of  hexokinase  in 
Tris-HC1  buffer  pH  8.0,  I=0.01  containing  0.2  M  KCl. 
The  top  photograph  shows  the  equilibrium  pattern  after 
centrifugation  at  6,995  r.  p.  m.  for  70  hours  at  10°C.  The 
lower  photographs  show  the  schlieren  pattern  at  28  and  60- 
minutes  respectively,  after  boundary  formation.  Schlieren 
plate  angle  65.  ° 224 .  225 
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Figure  9.16.  Sedimentation  equilibrium  of  hexokinase  in 
Tris-HC1  buffer  pH  =  8.0.  I=0.01  +  0.2  M  KCl. 
The  figure  shows  the  logarithm  of  the  concentration,  plotted 
against  the  square..  of  the  radial  displacement  after  70 
hours  at  6,995  r.  p.  m.  The  temperature  was  100C. ý 
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Figure  9.17.  Sedimentation  equilibrium  of  hexokinase  in 
Tris-HC1  buffer  pH  =  8.0,  I=0.01  +  0.2  M  KC1 
The  figure  shows  the  ratio  of  the  concentration  gradient 
to  radial  displacement  versus  the  difference  in  concentra- 
tion  from  that  at  the  meniscus.  After  70  hours  at  6,995 
° 
r.  p.  m.  and  at  10C. 
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meniscus.  With  the  freshest  material  ('experiment  No  1), 
Mz  at  the  meniscus  was  found  equal  to  110,800  near  to  the 
value  obtained  by  gel  filtration  and  the  combined  s20. 
w 
and  D2Ö. 
w 
coefficients.  The  lower  value  calculated  for 
Mw  from  this  experiment  at  the  meniscus,  implies  the  poss- 
ible  removal  of  material  from  the  solution  to  the  bottom  of 
the  cell.  The  higher  Mz  values  at  the  meniscus  for  the 
other  sedimentation  equilibrium  experiments  may  have  been 
caused  by  the  presence  of  dimer  at  the  meniscus. 
Size  heterogeneity-due  to  suggested  hexokinase  poly- 
mers  was  also  observed  for  the  porcine  heart  enzyme  by 
Easterby  (1971).  Rat  brain'  (Chou  and  Wilson,  1972)  and  rat 
skeletal  muscle  (Holroyde  and  Trayer,  1976)  hexokinases 
were  reported  to  be  homogeneous  by  high-speed  sedimentation 
equilibrium  experiments.  This  method"revealed  homogeneity 
for  porcine  heart  hexokinase  whereas  low  speed  sediment- 
ation  equilibrium  for  the  same  enzyme  showed  heterogeneity 
(Easterby,  1971). 
(c)  Glucose  6-phosphate  mediated  dimerization 
(1)  Resolution  of  two  sedimentation  boundaries 
"  The  effect  of  glucose  6-phosphate  on  the  sediment- 
ation  pattern  of  human  heart  hexokinase  is  shown  in 
Figures  9.18  to  9.20. "  228 
The  appearance  of  two  sedimentation  boundaries  is 
clearly  seen  in  the  presence  of  glucose  6-phosphate.  The 
slower  one  corresponded  to  the  single  boundary  observed  in 
the  absence  of  glucose  6-phosphate,  while  the  faster  one 
corresponded  to  a  sedimentation  coefficient  of  7.4  to  8.2 
depending  on  buffer  conditions. 
The  increase  in  sedimentation  of  the,  faster  boundary 
is  difficult  to  explain  by  a  change.  of  the  frictional  ratio 
alone.  Therefore  dimerization  is  suggested.  The  ratio 
of  sedimentation  coefficients  of  the  monomer,  calculated 
in  the  absence  of  glucose  6-phosphate,  and  the  dimer  cal- 
culated  in  the  presence  of-this  ligand  was  equal  to  1.43 
(in  Tris-HC1  buffer  pH  =  8.0,  I  =0.01  +  0.2  M  KC1;  protein 
concentration  8  mg/ml)  and  1.48  (in  phosphate  buffer 
pH  =  7.0,  I=0.1;  protein  concentration  4.5 
-  6.5  mg/ml). 
These  ratios  are  less  and  near  to  the  expected  ratio  of 
1.59,  for  a  monomer-dimer  relation  with  no  change  in  the 
frictional  coefficient  occurring  upon  dimerization. 
The  resolution  of  two  sedimentation  boundaries  for 
a  monomer-dimer  equilibrium  may  be  caused  either  by  a  slow 
equilibrium,  as  compared  to  the  time  of  centrifugation, 
(whereas  for  a  fast  equilibrium  a  non-symmetric  peak  is 
predicted;  Gilbert,  1955),  or  by  a  fast  equilibrium  when 
a  concentration  gradient  of  unbound  ligand  (mediating 
dimerization)  is  maintained  iri  the  ultracentrifugo  cell, 229 
lop 
due  to  differential  transport  of  monomer  and  dimer  (Cann 
and  Goad,  1970a,  1970b). 
The  effect  of  glucose  6-phosphate  in  dimerization  of 
hexokinase  has  been  reported  for  bovine  brain  (Chakrabarti 
and  Kenkare,  1974)  and  porcine  heart  hexokinase  (Easterby, 
1975).  The  latter  author  reported  evidence  for  the  exist- 
ence  of  the  monomer-dimer  equilibrium  even  in  the  absence 
of  glucose  6-phosphate  but  in  favour  of  monomer. 
(2)  Sedimentation  pattern  at  different  protein  and  gluc- 
ose  6-phosphate  concentrations 
If  the  protein  concentration  was  lowered  from  9  to 
4.5  mg/ml,  in  the  presence  of  1  mm  glucose  6-phosphate, 
the  area  under  the  faster  boundary  became  less  in  favour  of 
the  slower  one,  whereas  the  sedimentation  coefficient  of 
the  faster  boundary  did  not  change  (Figure  9.18). 
If  the  glucose  6-phosphate  concentration  was  increased 
from  50  µM  to  1  mM,  at  a  protein  concentration  of  4.5  mg/ml, 
the  area  under  the  faster  boundary  increased  (Figure  9.19). 
Dimerization  was  not  complete  even  at  saturating 
glucose  6-phosphate  concentration.  This  suggests  the  exist- 
ence  of  at  least  two  distinct  equilibria,  one  for  monomer 
and  the  ligand  and  the  other  for  ligand  bound  monomer  and 
dimer.  The  smaller  degree  of  dimerization  at  50  }.  LM  gluc- 
ose  6-phosphate  may  be  explained  by  the  low  Ki  of  mammal- -k 
230 
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Figure  9.18.  Sedimentation  pattern  of  hexokinase  in  the 
presence  of  1  mM  glucose  6-phiosphate  at  two  protein  conc- 
entrations 
(A)  Protein  concentration  9  mg/ml  (- 
,  7.40  s) 
(B):  :  Protein  concentration  4.5  mg/ml  (- 
,  7.45  S) 
The  buffer  was  Tris-HC1  pH  =  8.0,  I  =0.01  containing 
0.2  M  KC19  1  mM  EDTA,  0.1%1o  (v/v)  2-mercaptoethanol  and 
1  mM  glucose  6-phosphate.  Photographs  were  taken  90  min- 
utes  after  reaching  the  speed  of  59,780  r.  p.  m.  at 
schlieren  plate  angles  of  (A)  55°,  (B)  45°.  The  temp- 
erature  was  10  °C. 
Values  inside  the  brackets  represent  the  sedimentation 
coefficients,  s20. 
w, 
for  the  slow  and  fast  sedimentation 
boundaries,  while  dashes  inside  brackets  mean  insufficient 
resolution  for  the  estimation  of  the  respective  sediment- 
ation  coefficient. 231 
(A)  (B) 
Figure  9.19.  Sedimentation  pattern  of  hexokinase  at  two 
£lucose  6-phosphate  concentrations 
(A)  50  }1M  glucose  6-phosphate  (5.4U  S,  -) 
(B)  1  mM  glucose  6-phosphate  (-,  7.115  ti) 
The  buffer  was  Tris-HC1  pH  =  8.0,  I=0.01  conta  ining  0.  -1  M 
KCl,  1  mM  EDTA  and  0.1%  (v/v)  2-mercaptoethanol.  Photo- 
graphs  were  taken  90  minutes  after  reacin¬;  the  speed  of 
59,780  r.  p.  m.  at  schlieren  plate  angles  of  (A)  ZIO0, 
(})  450.  The  protein  concentration  was  11,5  m,;  /ml  and  t,  he 
temperature  was  100C. 232 
ian  hexokinases  for  this  ligand  i.  e.  50  µM  for  glucose 
6-phosphate  versus  fructose  for  porcine  heart  hexokinase 
(Easterby  and  O'Brien,  1973)  and  10.8  p,  M  for  glucose  6- 
phosphate  versus  MgATP2  for  human  erythrocyte  hexokina  e 
(Rijksen  and  Staal,  1977). 
Chakrabarti  and  Kenkare  (1974  reported  complete 
dimerization  of  bovine  brain  hexokinase  at  100  JIM  glucose 
6-phosphate  whereas  at  10  p,  M  glucose  6-phosphate  50110'  di- 
merization  occurred.  They  also  observed  that  by  lowering 
protein  concentration  dimerization  diminished  and  at 
1  mg/ml  protein  concentration  no  noticeable  difference 
between  the  sedimentation  behaviour  of  the  enzyme  in  the 
presence  and  absence  of  glucose  6-phosphate  was  found. 
Easterby  (1975)  reported  only  50%  dimerization  even 
at  saturating  glucose  6-phosphate  concentration  (1  mM)  . 
Less  dimerization  was  observed  at  20  µM  glucose  6-plios- 
phate. 
ý3ý  Reversibility  of  glucose  6-phosphate  mediated  cli.  mor- 
ization 
The  effect  of  glucose  6-phosphate  was  reversible  as 
shown  by  restoring  the  initial  sedimentation  velocity 
after  removal  of  the  ligand  by  dialysis  Figure  9.20). 
The  same  phenomenon  was  observed  for  bovine  brain  and 
porcine  heart  hexokina.  se  (Chakrabarti  and  Kenkare,  '19711; t 
233 
Figure  9.20.  The  reversibility  of  the-effect  of  glucose 
6-phosphate  on  the  sedimentation  pattern  of  hexokinase 
(A)  Absence  of  glucose  6-phosphate  (5.60  S) 
ýn)  Sample  (A) 
after  dialysis  against  1  mM  glucose 
6-phosphate  (- 
, 
8.20  S) 
(C)  Sample  (B) 
after  removal  of  glucose  6-phosphate 
by  dialysis  5.50  S) 
The  buffer  was  phosphate  pH  =  7.0,  I=0.1  containing 
10  mM  Glucose,  1  mM  EDTA  and  0.1ö  (v/v)  2-mercaptoethanol. 
Photographs  were  taken  90  minutes  after  reaching  the  speed 
of  59,780  r.  p.  m.  at  schlieren  plate  angle  of  55°.  The 
protein  concentration  was  8  mg/ml  and  the  temperature  10°C. (A) 
______J\  I 
4m 
S 
ýý I 
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Easterby,  1975).  The  reversibility  of  the  dimerization 
mediated  by  glucose  6-phosphate  is  an  obvious  prerequisite 
for  the  suggested  monomer-dimer  equilibrium. 
However  if  human  heart  hexokinase  at  a  concentration 
of  4.5  mg/ml  was  dialysed  against  acetate  buffer  pH  =  6.0, 
I  0.1  containing  0.2  M  KCl,  1  mM  EDTA,  0.1%  (v/v)  2- 
mercaptoethanol  and  1  mM  glucose  6-phosphate,  a  heavy 
precipitate  was  developed  suggesting-extensive  polymßriz- 
ation  under  these  conditions.  If  this  suspension  was 
. 
dialysed  against  Tris-HCl  buffer  pH  =  8.0,  I=0.01  con- 
taining  0.2  M  KC1,10  mM  glucose,  1  mM  EDTA  and  0.1%  (v/v) 
2--  mercaptoethanol,  the  precipitate  redissolved  and  upon 
ultracentrifugation  a  pattern  similar  to  that  of  hexokinaso 
in  the  absence  of  glucose  6-phosphate  was  observed  (Fig- 
ure  9.21),  thus  indicating  the  reversibility  of  this 
effect.  - 
(Z)  Effect  of  fructose  6-phosphate 
Fructose  6-phosphate  at  a  concentration  of  5  mM  was 
found  to  promote  dimerization  (Figure  9.22).  However  this 
ligand  was  not  found  to  promote  dimorization  with  bovine 
brain  (Chakrabarti  and  Kenkare,  1974)  and  porcine  heart 
(Easterby,  1975)  hexokinases  even  at  a  concentration  of 
10  mM  of  fructose  6-phosphate  for  the  latter  enzyme. 
One  possibility  is  that  fructose  6-phosphate  used  in 236 
Figure  9.21. 
0  ,4 
Buffer  conditions  are  described  in  text.  The  protein  conc- 
entration  was  2-3  mg/ml.  The  schlieren  plate  angle  was 
110°  (j.!  IOS)  . 
Photographs  were  taken  90  minutes  after 
reaching  the  speed  of  59,80  r.  p.  m.  The  temperature  wit,,, 
1000. 
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Figure  9.22.  Effect  of  fructose  6-phosphate  on  -,  eciiment- 
ation  pattern  of  liexokinase 
The  buffer  was  Tris-HC1  pH  =  8.0,  I-0.01  containing 
10  mM  glucose,  1  mM  EDTA,  0.10  (v/v)_2-mercaptoothanoi 
and  5  m1  fructose  6-phosphate.  The  protein  concentration 
was  4.5  mg/ml  and  the  schlieren  plate  angle  las°,  (5.20  S, 
7.35  S)" 
'Photographs  were  taken  90  minutes  after  reaching  the 
speed  of  59,780  r.  p.  m.  The  temperature  was  10°C. 238 
this  experiment  was  contaminated'  with  glucose  6-phosphate. 
Commercial  preparations  of  fructose  6-phosphate  by 
Boehringer  and  Sigma  are  reported  by  the  manufacturers  to 
contain  less  than  2%  and  less  than  1%  glucose  6-phosphate 
respectively. 
Another  possibility  is  that  fructose  6-phosphate 
binds  at  the  same  hexokinase  site  as  glucose  6-phosphate 
although  -with  less  affinity  promoting  the  needed  conform- 
ational  change  for  dimerization.  Fructose  6-phosphate  is 
generally  accepted  not  to  be  an  inhibitor  of  mammalian 
hexokinase  including  the  human  enzyme  (do  Verdier  and 
Garby,  1965;  Gerber  et  al.,  1974).  Recently  however, 
. 
Rijksen  and  Staal_(1977)  reported  that  fructose  6-phosphate 
was  inhibiting  human  erythrocyte  hexokinase  competitively 
with  respect  to  MgATP  with  Ki  =  0.16  mM.  It  is  possible 
-therefore  that  fructose  6-phosphate  mediated  inhibition 
and  dimerisation  are  properties  peculiar  to  human  hexo- 
kinase. 
(5)  Effect  of  other  ligands  on  the  glucose  6-phosphate 
Promoted  dimerization 
(i)  Glucose 
Glucose  at  10  mM  final  concentration  had  no  obvious 
effect  either  promoting  or  releasing  glucose  6-phosphate 
mediated  dimerization,  as  shown  in  Figure  9.23. 239 
Figure  9.23.  The  effect  of  glucose  6-phosphate  on  the 
sedimentation  Pattern  of  hexokinase  in  the  Presence  and  " 
absence  of  glucose 
(A)  :  10  MM  glucose,  no  glucose  6-phosphate  (5.20  S) 
(B)  :  No  glucose,  1  mM  glucose  6-phosphate  (-,  7.45  S) 
(C)  :  10  mM  glucose,  1  mM  glucose  6-phosphate  (-9'7-50  S) 
The  buffer  was  Tris-HC1  pH  =  8.0,  I=0.01  containing 
0.2  M  KC1,1  mM  EDTA  and  0.1%  (v/v)  2-mercaptoethanol. 
Photographs  were  taken  90  minutes  after  reaching  the 
.  speed  of  59,780  r.  p.  m.  at  a  schlieren  plate  angle  of  450 
The  protein  concentration  was  4.5  mg/ml  and  the  temp- 
erature  10°C. 2110 
(A) 
ý;  B) 
(L) . 
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This  finding  is  in  accordance  with  similar  observ- 
ations  for  bovine  brain  (Chakrabarti  and  Kenkare,  1974) 
=  and  porcine  heart  hexokinase  (Easterby,  1975).  It  is  also 
in  accordance  with  kinetic  observations  for  non-compet- 
itive  inhibition  of  human  erythrocyte  hexokinase  by  glucose 
6-phosphate  versus  glucose  (Gerber  et  al.,  1974;  Rijksen 
and  Staal,  1977). 
(ii)  MgATP2- 
1  mm  MgC12  did  not  change  the  sedimentation  pattern 
of  human  heart  hexokinase  (Figure  9.24  B).  However  in 
the  presence  of  2  mM  MgCl2  and  1  mM  ATP  a  small  dimeriz- 
ation  was  observed  (Figure  9.24  C).  Therefore  it  seems 
that  MgATP2  can  bind  to  hexokinase  in  the  absence  of 
glucose.  Dimerization  persisted  in  the  presence  of  2  mM 
MgCl2,1  mM  ATP  and  1  mM  glucose  6-phosphate  (9.24  D). 
For  bovine  brain  hexokinase  (Chakrabarti  and  Kenkare, 
1974)  ATP  at  a  concentration  of  5  mM,  in  the  presence  of 
0.1  mNM  glucose  6-phosphate,  reversed  the  sedimentation 
pattern  to  that  of  the  monomer.  For  porcine  heart  hexokin- 
ase 
(Easterby,  1975),  at  50  µM  glucose  6-phosphate,  ATP  up 
to  a  concentration  of  10  mM  slightly  abolished  dimerization 
whereas  1  mM  ATP  and  2  mM  MgC12  almost  completely  abolish- 
{ 
ed  dimerization.  The  effect  of  MgATP  was  found  to  be  com- 
petitive.  with  respect  to  glucose  6-phosphate. 242 
Figure  9.24.  The  effect  of  Mgt+,  MgATP2  and  glucose 
6-phosphate  plus  MgATP2  on  the  sedimentation  pattern 
of  hexokinase 
(A)  :1  mNI  glucose  6-phosphate  (-,  7.45  s) 
(B).  :1  MM  MgC12  (5.30  s) 
(C)  :2  mM  MgCl2  and  1  mM  ATP  (5.30  S,  8.00 
. 
S) 
(D)  2  mM  MgCl 
2' 
1  mM  ATP  and  1  mM  glucose  6-phosphate 
(5.55  S,  7.90  S)  -  : 
The  buffer  was  Tris-HC1  pH  -  8.0,  I-0.01  containing 
0.2  M  KC1f  1  mM  EDTA  and  0.1%  (v/v)  2-mercaptoethanol.. 
Photographs  were  taken  90  minutes  after  reaching  the 
speed  of  59,780  r.  p.  m.  at  schlieren  plate  angle  of  (A) 
45°,  (B).  40°,  (C)  40°  (D)  40°.  The  protein  concentra- 
tion  was  4.5  mg/ml  and  the  temperature  10°C. 2t+3 
(A)  (B) 
(C)  (D) ..  =  yr 
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However,  both  reports  for  bovine  brain  and  porcine 
heart  hexokinase  do  not  mention  sedimentation  experiments 
2- 
with  MgATP  alone  i.  e.  in  the  absence  of'glucose 
phosphate. 
(iii)  Pi 
"  Comparison  of  Figures  9.18A  and  9.20ß  i.  e.  effect  of 
1  mm  glucose  6-phosphate  in  Tris-HCl  buffer  pii.  8.0, 
"I  =0.01  +  0.2  M  KCl  and  in  phosphate  buffer  p11  =  7".  0, 
10.1  (47  mm  Pi)  shows  no  significant  differences  in 
-sedimentation  patterns.  Therefore  no  significant  effect 
of  Pi  is  suggested  at  1  mM  glucose  6-phosphate  concentra- 
tion. 
For  bovine  brain  hexokinase  (Chakrabarti  and  Kenkaro, 
1974)  10  mM  Pi  reverted  the  enzyme  to  its  normal  sediment- 
ation  behaviour  in  the  presence  of  0.1  mM  glucose  6-phos- 
phate.  For  porcine  heart  hexokinase  (Easterby,  1975) 
10  mM  potassium  phosphate  did  not  appreciably  affect  the 
dimerization  promoted  by  1  mM  glucose  6-phosphate,  whereas 
when  glucose  6-phosphate  concentration  was  lowered  to 
50  µM  the  proportions  changed  in  favour  of  the  monomer. 
(6)  comments 
º  Two  questions  arise:  the  underlying  mechanism  for 
polymerization  and  the  physiological.  significance  of  this 
phenomenon.  Although  complete  answers  must  await  further 245 
investigation,  certain  comments  can  be  made  for  the  human 
heart  enzyme. 
Sedimentation  equilibrium  experiments  showed  a  tend- 
ency  for  polymerization  in  the  presence  of"glucose  under 
the  experimental  conditions  used.  '  Extensive  and  reversible 
dimerization  was  observed  by  sedimentation  velocity  experi- 
ments  in  the  presence  of  glucose  6-phosphate.  Dimerization 
ýý 
-  was  also  promoted  possibly  by  fructose  6-phosphate  and  to 
a  lesser  extent  by  MgATP2 
Hexokinase  may  exist  in  an  equilibrium  betwoon  two 
conformations,  the  dominant  one  having  less  tendency  to 
dimerize.  '  The  effect  of  the  above  ligands  is  to  shift  the 
equilibrium  to  the  other  conformation  with  concomitant 
dimer  formation. 
Glucose  6-phosphate  does  not  bind  at  the  glucose  bind- 
ing  site,  since  glucose  does  not  affect  the  dimorization 
produced  by  glucose  6-phosphate.  Thus,  since  glucose 
binds  at  the  active  site,  the  binding  of  glucose  6-phos- 
phate  could  occur  at  an  allosteric  site.  It  has  boon  sug- 
gested  that  low  Km  hexokinases  have  evolved  by  gene  dupli- 
cation  of  an  ancestral  glucokinase-like  gone'(Eastorby, 
1971)"  On  the  basis  of  one  glucose  binding  site  (Ellison 
al.,  1974),  the  other  initial  active  site  may  have  boon 
transformed  to  an  allosteric  site.  However  kinetic  observ- 
ations  of  human  erythrocyte  hbxokinaso  show  competitive "246 
inhibition  of  glucose  6-phosphate  against  MgATP2-  and 
non  competitive  against  glucose  , 
(Gerber  et  al.,  1974; 
Rijksen  and  Staal,  1977),  thus  implying  overlapping  of 
the  glucose  6-phosphate  binding  site  with  that  of  MgATP 
in  the  active  site.  The  conformational  change,  and  dimor- 
ization,  of  hexokinase  may  arise  from  binding  of  glucose 
6-phosphate  to  the  MgATP  site,  or  to  another,  allosteric 
site. 
MgATP  (in  the  absence  of  glucose)  promoted  some  di- 
merization  of  hexokinase.  Therefore,  either  binding  at 
the  active  site  influences  the  conformational  equilibrium. 
or  the  allosteric  site  binds  MgATP2  ds  well  as  glucose 
6-phosphate.  The  effect  of  MgATP  on  the  enzyme  also 
implies  that  it  can  bind  in  the  absence  of  glucose  accord- 
ing  to  a  random  mechanism  (e.  g.  for  the  human  erythrocyte 
'enzymi;  Gerber  et  al.,  1973)" 
The  dimerization  by  glucose  6-phosphate  was  observed 
for  the  human  erythrocyte  enzyme  (Chapter  8)  as  well  as  for 
the  heart  enzyme.  Since  hexokinases  from  bovine  brain 
(Chakrabarti  and  Kenkare,  1974)  and  procino  heart 
(Easterby,  1975)  also  dimerize  in  the  presence  of  glucose 
6-phosphate,  this  phenomenon  appears  to  be  a  common  prop- 
erty  of  the  enzyme  from  mammalian  sources'. 
The  present  experiments  also  indicate  that  fructose 
6-phosphate,  in  high  concentration,  can  also  promoto  dimor- 247 
3=  ization  of  the  enzyme.  Presumably  this  metabolite  can 
" ;  - 
bind  at  the  same  location  as  glucose  6-phosphate. 
_  _ 
`"-  The  process  of  dimerization  does  not  involve  the  form- 
'`  ation  of  disulfide  bonds  since  it  was  observed  -in  the 
presence  of  2-mercaptoethanol.  Although  dimerization  por- 
sisted  at  0.3  ionic  strength,  ionic  interactions  can  not 
be  excluded  since  glucose  6-phosphate  also  promoted  a  pii- 
dependent  precipitation  of  the  enzymo.  The  incroaso  in 
>-...  sedimentation  coefficient  of  the  native  enzyme  at  pii  =  6.0 
_"  suggests  some  association  even  in  the  absence  of  glucose 
" 
6-phosphate. 
Although  it  was  observed  in  physiological  concentra- 
tion  of  glucose  6-phosphate,  dimerization  may  not  occur  at 
the  enzyme  concentration  found  inside  the  human  cell. 
There  appeared  to  be  less  dimer  formation  by  glucoso  6- 
phosphate  when  the  protein  concentration  was  docroased 
(Figure  9.18). 
. 
Although  dimerization  may  not  have  a  direct  physiolog- 
ical  role,  it  reflects  the  conformational  change  produced 
by  glucose  6-phosphate.  This  conformational  change  may 
'`.  be  an  essential  property  in  the  control  of  hoxokinase 
and  hence  the  glycolytic  flux),  by  inhibition  and  alter- 
ation-in  the  subcellular  distribution  of  the  enzyme. "  248 
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